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10  Chapter One 
 
Cardiovascular disease encompasses various pathologies in which the heart or the 
vasculature is inflicted, such as atherosclerosis, hypertension, myocardial infarction and heart 
failure. In the Netherlands, as in most westernized countries, cardiovascular disease is a 
leading cause of death in both women and men. In 2002, cardiovascular disease caused one 
third of all occurring deaths in the Netherlands (Koek, Leest, Verschuren, & Bots, 2003). The 
etiology of cardiovascular disease is complex, with many different factors contributing to an 
increased risk of developing cardiovascular disease (Brotman, Walker, Lauer, & O'Brien, 
2005).  
 It is well-known that cardiovascular disease tends to run in families (Acton, Go, & 
Roseman, 2004; Rissanen, 1979; Deutscher, Ostrander, & Epstein, 1970). This familial 
influence on variation in cardiovascular physiology finds support in studies reporting that 
subjects with a parental history of CVD have an increased relative risk for developing CVD 
(Sesso et al., 2001), have higher blood pressure (van den Elzen et al., 2004) and demonstrate 
an enhanced stress response to laboratory stressors and a delayed recovery (Schneider, Jacobs, 
Gevirtz, & O'Connor, 2003), whereas subjects without a parental history do not. Familial 
influences can derive from the genetic resemblance between family members or from shared 
environmental influences. The importance of genetic factors in the familial clustering of 
cardiovascular disease is most clearly illustrated by findings from the Swedish twin register 
(Marenberg, Risch, Berkman, Floderus, & de Faire, 1994; Zdravkovic et al., 2004). They 
followed 21,004 twins, born between 1886 and 1925, for 26 years and showed that the 
probability of dying from coronary heart disease (CHD), when one member of the twin pair 
had died before the age of 55, was much higher among monozygotic twins compared to 
dizygotic twins. Heritability estimates for susceptibility to death from CHD in this sample 
were 57% and 38% for males and females, respectively.  
In spite of this substantial heritability, finding the actual genes for cardiovascular 
disease has proven a very difficult task. It is increasingly appreciated that genetic 
epidemiological studies of complex diseases may benefit from the use of more narrowly 
defined risk factors -also called endophenotypes - over broadly defined disease phenotypes 
(Rice, Saccone, & Rasmussen, 2001). The model in figure 1.1 shows the biological pathways 
along which genes (here denoted as QTL for ‘quantitative trait loci’), environmental history 
(indicated by ENV), and ongoing psychosocial stress (indicated by STRESS), work together 
to increase the risk to develop cardiovascular disease (CVD).  
A substantial number of physiological risk factors for cardiovascular disease have 
been identified over the past decades that can be used as endophenotypes in the search for 
genes that influence the development of cardiovascular disease. Endophenotypes explain only 
a part of the disease risk, are situated more upstream towards the genetic sources, and are 
influenced by only a subset of genes relevant to the disease. The crucial characteristic of these 
genes is that they explain a larger part of the variance in the endophenotype than they do in 
the disease. Therefore, they are easier to find through the endophenotype than through the 
disease itself. Potential endophenotypes include among others reduced heart rate variability 
(Dekker et al., 2000; Mussalo et al., 2001; Huikuri et al., 2003), increased blood pressure 
(Pickering & Devereux, 1987; Verdecchia, Schillaci, Reboldi, Franklin, & Porcellati, 2001; 
Verdecchia, 2000), increased heart rate (Palatini & Julius, 2004), a shift from vagal to  
sympathetic activity (Arnlov, Ingelsson, Riserus, Andren, & Lind, 2004; Pellerin, Larrazet, 
Cohen, Witchitz, & Veyrat, 2003) and a dysfunctional HPA axis (Rosmond & Bjorntorp, 
2000). Within the population, large individual differences in these physiological parameters 
exist (e.g. Cacioppo, Uchino, & Berntson, 1994b; Smyth et al., 1997; Ben Lamine et al., 
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2004). Identifying the mechanisms that underlie these individual differences will contribute to 
a better understanding of the complex etiology of cardiovascular disease.  
The main objective of this present thesis is to determine the relative contribution of 
genetic and environmental sources of variation to the individual differences in physiological 
risk factors for cardiovascular disease.   




Hypertension, or an increased blood pressure, is a main risk factor for cardiovascular 
disease (Franklin et al., 2001; Verdecchia et al., 1998; Pickering & Devereux, 1987) that is 
linked to sympathetic hyperactivity (Mussalo et al., 2001). As arteries narrow, due to the 
build-up of atherosclerotic plaques, blood flow is restricted and blood pressure increases. 
With high blood pressure, the sympathetic stimulation of the heart increases, since the heart 
has to work harder to maintain normal circulation. This causes the heart muscle to grow, 
which is detrimental to proper blood flow. This downward spiral may result in heart failure 
and myocardial infarction.  
A vast amount of twin and family studies have reported on the genetics of blood 
pressure and hypertension. Many laboratory studies have reported a substantial contribution 
of genes to the variation in blood pressure (e.g. McCaffery, Pogue-Geile, Debski, & Manuck, 
































Figure 1.1 The endophenotype approach 
CVD = cardiovascular disease, HRV = Heart rate variability, RSA = respiratory sinus 
arrhythmia, PEP = pre-ejection period, QTL = quantitative trait loci, ENV = environmental 
factors (e.g. prenatal, early childhood trauma, past major life events) STRESS = current 
psychosocial stressors (e.g. work stress, marital conflict, recent major life events). 
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Treiber, 2003; Fagard, Loos, Beunen, Derom, & Vlietinck, 2003), and have linked this 
variation to many regions on the genome, for example to variation in genes coding for 
proteins, enzymes and receptors that are associated with the renin-angiotensin aldosterone 
system (Brand-Herrmann et al., 2004; Castellano et al., 2003). In addition, it is well-known 
that environmental factors are important in the etiology of hypertension. For example, 
experiencing chronic stress (Matthews et al., 2004) or having increased central body fat  
(Allemann et al., 2001) (which actually may have both genetic and environmental origins, 
Cui, Hopper, & Harrap, 2002), are known to increase blood pressure, and to predict future 
hypertension. Only a few studies though, have based their genetic analyses on ambulatory 
blood pressure (Somes, Harshfield, Alpert, Goble, & Schieken, 1995; Fagard et al., 1995). 
 
Heart rate and heart rate variability 
Both a reduced heart rate variability and an elevated heart rate are caused by the 
withdrawal of parasympathetic control (Schwartz, et al., 1988; La Rovere, Bersano, Gnemmi, 
Specchia, & Schwartz,  2002) or increased sympathetic control over the heart (Palatini, & 
Julius, 2004) and both are independent predictors of cardiovascular morbidity and mortality 
(Bigger, Fleiss, Rolnitzky, & Steinman, 1993; Tsuji, et al., 1996; Dekker, et al., 1997; Nolan, 
J. et al., 1998; Dekker, et al., 2000; Huikuri, et al., 2003; Palatini, & Julius, 2004; Kannel,  
Kannel, Paffenbarger, & Cupples, 1987).  
Heritability studies on resting heart rate have shown that genetic factors contribute 
significantly to the individual differences in heart rate (Singh, et al., 1999, Martin, 2004; 
Jedrusik et al., 2003). Additionally, linkage studies have identified significant regions of 
linkage in humans (Wilk et al., 2002; Martin et al., 2004), associated with the β1-adrenergic 
receptor and excitation-contraction coupling.  
Genetic predisposition also plays a role in heart rate variability. Results of various 
studies in laboratory and clinical settings show heart rate variability to be moderately heritable 
(up to 39%) (Boomsma, van Baal, & Orlebeke, 1990; Sinnreich, Friedlander, Luria, 
Sapoznikov & Kark, 1999; Busjahn. et al., 1998; Snieder, et al., 1997; Singh, et al., 1999). 
Further evidence for a genetic modulation of heart rate variability comes from association 
studies. Heart rate variability was found to be associated with allelic variation in a common 
polymorphism of the gene coding for the angiotensin-converting enzyme (Thayer et al., 2003) 
and with variation in the acetylcholine transporter gene, that plays a role in parasympathetic 
acetylcholine neurotransmission (Neumann, Lawrence, Jennings, Ferrell, & Manuck, 2005).  
At the same time environmental and lifestyle factors are also known to influence heart 
rate and heart rate variability. For example, exercise decreases heart rate and increases heart 
rate variability (Sandercock, Bromley, & Brodie, 2005), whereas low SES is associated with 
high heart rate and low heart rate variability (Steptoe A, Kunz-Ebrecht SR, Wright C et al. 
2005). 
 Until now only short-term (< 2 hours) recordings of heart rate (variability) have been 
used in twin and family studies. It remains to be determined whether genetic influences play a 
similarly important role in heart rate and heart rate variability over prolonged periods, in a 
naturalistic setting. 
 
Sympathetic control over cardiac contractility  
The sympathetic nervous system plays an important role in regulating cardiac 
contractility (Kaye et al., 1995; Swedberg, Eneroth, Kjekshus, & Wilhelmsen, 1990). The 
innervation of the cardiac ventricles is almost completely of sympathetic origin (Vander, 
Sherman, & Luciano, 2001). Sympathetic control over contractility has been suggested to 
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play a vital role in the risk for left ventricular hypertrophy and heart failure (Rundqvist et al., 
1997; Kaye et al., 1995; Swedberg et al., 1990). Specifically, a chronic state of sympathetic 
activity with chronically high contractility is thought to lead to functional down-regulation of 
myocardial β-receptors (El Armouche et al., 2003; Bogaert & Fraeyman, 1991; Andersson, 
1986; Xiao et al., 1999). Only very few studies have reported on the genetics of left 
ventricular function Genetic association studies comparing the genotypes of patients with  
heart failure to those in non-(cardiac)patients have shown promising results for 
polymorphisms of the renin-angiotensin-aldosterone system and the sympathetic system 
(Bleumink et al., 2004). In twin and family studies the heritability estimates of 
echocardiographic measures of left ventricular function range between 26% and 52% (Bielen, 
Fagard, & Amery, 1991; Tang et al., 2000). Whole genome screens have putatively linked 
variation in left ventricular function to a region on chromosome 11 that codes for the cardiac 
myosin-binding protein (Arnett et al., 2001; Tang et al., 2002).  
 No studies to date have reported on the genetics of measures of sympathetic control 
over cardiac contractility based on impedance cardiography, like the Heather index or the pre-
ejection period (PEP), although this method has been well-developed in the field of 
psychosomatic medicine (Sherwood et al., 1990). 
 
Cortisol 
Recently, the hypothalamus-pituitary-adrenal (HPA) axis has also been implicated in 
the etiology of cardiovascular disease. Cortisol, the end product of the HPA axis, is an 
important steroid hormone in the regulation of normal physiology. Continued or frequently 
repeated stressful events may deregulate HPA axis function and basal cortisol may be 
chronically secreted in excess. Prolonged glucocorticoid exposure may lead to hypertension 
(Mantero & Boscaro, 1992) and cardiovascular disease (Rosmond & Bjorntorp, 2000) 
because of the continued stimulation of sympathetic drive and the stimulation of the 
metabolism of fat cells. In addition, chronic secretion of cortisol may influence the many 
immunological parameters that play a role in the development of sclerotic plaques (Girod & 
Brotman, 2004).  
Several smaller studies in adults (Wüst, Federenko, Hellhammer, & Kirschbaum, 
2000a; Kirschbaum, Wüst, Faig, & Hellhammer, 1992; Young, Aggen, Prescott, & Kendler, 
2000) and one large study in children (Bartels, de Geus, Kirschbaum, Sluyter, & Boomsma, 
2003a) have investigated the role of genes in the determination of basal salivary cortisol 
levels. These studies report heritability estimates lying between 40 and 52% for several 
cortisol parameters. In children, the awakening period seems to be influenced most by genes. 
A meta-analysis performed by Bartels et al. (2003b), taking together all available cortisol 
studies in which a comparable design was used, found morning cortisol to be heritable for 
62%. Confidence intervals of the estimate were large, however, and none of the adult samples 
had a sufficient size to detect small additive genetic or common environmental effects.  
 
Ambulatory monitoring 
To date, studies reporting on the impact of genetic factors on cardiovascular 
physiology have almost exclusively been based on laboratory data (Boomsma et al., 1990; 
Singh et al., 1999; Sinnreich et al., 1999; Snieder et al., 1997; Busjahn et al., 1998). Different 
genetic pathways may affect cardiovascular physiology assessed in short-term standardized 
laboratory conditions, however, compared to cardiovascular physiology recorded over 
prolonged periods of time in naturalistic settings. Yet, preciously little is known about the 
sources of individual differences in cardiovascular physiology in real life settings.  
   
 
14  Chapter One 
 
In the past decade, ambulatory monitoring has evolved from an innovative tool in 
fundamental research to a widely used method in fundamental as well as clinical and applied 
research settings. Ambulatory monitoring is a method of acquiring physiological data in 
subjects who are free to go about their normal daily activities, outside the confines of the 
laboratory or hospital environment. Since ambulatory monitoring takes place during everyday 
life, in the subject’s own environment (naturalistic settings), such measurements have high 
ecological validity. A specific advantage of prolonged ambulatory monitoring over laboratory 
assessment of physiological parameters can be expected for the assessment of individual 
differences in reactivity to psychosocial stressors. In psychosomatic medicine, negative 
consequences of excessive reactivity are expected on cardiovascular health. Such 
consequences will derive from frequent exposure to realistic stressors, encountered repeatedly 
at home or in the work setting. It has been found that generalization of cardiovascular stress 
reactivity from standardized laboratory situations to actual real life situations is only moderate 
at best (Kamarck, Schwartz, Janicki, Shiffman, & Raynor, 2003; Doornen, Knol, Willemsen, 
& Geus, 1994; Gerin, Rosofsky, Pieper, & Pickering, 1994). 
The advantage of ambulatory recording is not limited to stress effects. Measurement of 
resting baseline in the laboratory may suffer from the “white coat effect”. This effect is often 
observed when blood pressure is measured in a hospital or laboratory setting. In these settings 
blood pressure is often higher than it would be when blood pressure was measured at home, 
because subjects tend to feel more anxious in the clinic or laboratory as compared to familiar 
surroundings. There is no reason to assume that this white coat effect would be limited to 
blood pressure only; more likely, it affects many other physiological measures as well. 
Directly assessing cardiovascular function in naturalistic settings, including leisure time at 
home and sleep, can circumvent the “white-coat” phenomenon. 
Finally, and perhaps most convincingly, previous reports have suggested that 
ambulatory measures are better predictors for cardiovascular morbidity and mortality than 
laboratory or office measurements (Pickering & Devereux, 1987; Verdecchia et al., 1994; 
Verdecchia et al., 1998; Verdecchia, Schillaci, Reboldi, Franklin, & Porcellati, 2001) and it is 
likely that genetic studies based on ambulatory measurement of cardiovascular function can 
provide a more solid basis for future linkage and association studies. 
 
This thesis 
Twenty four hour ambulatory cardiovascular measurements were carried out in a large 
twin family population to estimate “ambulatory heritability” of three established risk factors 
(heart rate, heart rate variability and blood pressure). In addition, the present study examined 
the genetic contribution to ambulatory measures that reflect the activity of the three major 
components of autonomic function, the sympathetic and parasympathetic nervous system and 
the hypothalamus-pituitary-adrenal (HPA) axis.  
Chapter 2 discusses the general design of the study, and will give details on the twin 
methodology. The advantages of the extension of the classical twin design by including the 
singleton siblings are discussed, including the possibility to examine a special “twin-
environment“. The ensuing chapters focus on the heritability of one or more of the selected 
physiological risk indicators for cardiovascular disease. Chapter 3 deals with the heritability 
of ambulatory blood pressure and focuses on the question whether exclusion of hypertensive 
subjects is detrimental to the estimates of heritability. Chapter 4 presents the results on the 
heritability of heart rate variability, using two widely used variables in cardiology, SDNN 
index and RMSSD. In chapter 5 the report on heart rate variability is continued by focusing 
on a measure that is more often used in a psychophysiological context, respiratory sinus 
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arrhythmia (RSA). In this chapter, a trivariate genetic analysis of respiration rate, RSA and 
heart period is presented. The heritability of sympathetic control of cardiac contractility is the 
topic of chapter 6. This study is the first to present heritability estimates for impedance-
derived systolic time intervals and cardiac contractility.  
In Chapter 7 the results on the heritability of basal diurnal salivary cortisol levels are 
presented. In the general discussion (Chapter 8), the results presented in the previous chapters 
are summarized and discussed in the light of existing literature.  
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The extended twin design 
The purpose of the study described in this thesis was to investigate the relative 
influence of genetic and environmental factors on ambulatory measured physiological risk 
factors for cardiovascular disease. To this end, a large twin family population was 
approached. Comparing the similarity for a trait of identical, or monozygotic (MZ) twins (that 
share 100% of their segregating genes) with the similarity for that trait of fraternal, or 
dizygotic (DZ) twins (that share on average 50% of their segregating genes) renders 
information on the relative contribution of genes and environment to the variance in the trait 
(Falconer & Mackay, 1996). This thesis made use of an extended twin design, meaning that, 
in addition to the twin pair, singleton siblings were included. This adds three types of sibling 
pairs that share on average 50% of their segregating genes (like DZ twin pairs): an MZ twin 
with a singleton brother or sister, a DZ twin with a singleton brother or sister, a singleton sib 
with another singleton sib. The extended twin design has several advantages over a classical 
twin design that includes only identical and fraternal twins. Adding one or more singleton 
siblings increases statistical power to distinguish between genetic influences and common and 
unique environmental influences (Posthuma & Boomsma, 2000). Table 2.1 shows the number 
of families that participated, stratified by twin type and the number of additional siblings.  
 
Table 2.1 Number of families with additional siblings  
  Number of additional siblings  
  0 1 2 3 4 5 6 Totals 
MZ Twin pair 51 43 8 5 1 - 1 109 
 Single twin 5 10 1 - - - - 16 
          
DZ Twin pair 47 23 10 1 - - - 81 
 Single twin 11 16 1 2 - 1 - 31 
          
DOS Twin pair 34 12 2 - - 1 - 49 
 Single twin 6 18 3 - 1 - - 28 
No twin  16 12 1 1 - - 30 
Total number of 
families 
153 138 35 9 3 2 1 341 
MZ = monozygotic twin, DZ = dizygotic twin, DOS = dizygotic twin of opposite sex. 
In total this adds up to 816 participants eligible for the study. 
 
When using an extended twin design however, one cannot blindly assume that means 
and variances of all variables are equal in singletons and twins. Twins weigh less at birth than 
their singleton siblings. The hypothesis that a baby with lower birth weight will have an 
increased risk for several chronic diseases, also called the “Barker effect of birth weight”, has 
been confirmed in several twin and non-twin studies (Ijzerman, Stehouwer, & Boomsma, 
2000; Phillips et al., 2000; Ijzerman, Stehouwer, van Weissenbruch, De Geus, & Boomsma, 
2001; Fall et al., 1995; Massin, Withofs, Maeyns, & Ravet, 2001). If twins systematically 
differ from their singleton siblings, this would compromise the gain in power obtained by 
including singleton siblings in a twin family design. In that case, the parameter estimates for 
dizygotic twins could not be equated to those for singleton siblings. Although no twin-
singleton differences were found for resting blood pressure (de Geus, Posthuma, Ijzerman, & 
Boomsma, 2001; Loos, Fagard, Beunen, Derom, & Vlietinck, 2001), it is not clear that such 
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differences will not be found in heart rate (variability) or autonomic nervous system activity. 
The extended twin design gives us the opportunity to specifically test the presence of twin-
singleton differences and differences between the sexes for each variable measured in our 
twin family sample. When no differences are apparent, further genetic analyses are conducted 
with one correlation for the MZ group en one correlation for the DZ/sibling group.  
 
Selection of participants 
All participants were registered with the Netherlands Twin Register (NTR) and had 
participated in longitudinal surveys on health, lifestyle and personality. The entire study 
consisted of several phases: (1) the selection phase, (2) the DNA collection phase, and (3) the 
ambulatory monitoring phase. An overview of these phases is presented below in table 2.1. 
In 1991, the NTR started a longitudinal survey study of health, lifestyle and 
personality among adolescent and adult twins and their family members. Addresses of twin 
families were obtained by asking Dutch city councils of 252 cities for addresses of twins aged 
13 to 22 years. In addition, twins volunteered to register with the NTR. Every two to three 
years questionnaire booklets were sent out to all adolescent and adult twins and their family 
members who were registered with the NTR. Twins were always included, parents of twins 
were included in 1991, 1993 and 1995, and siblings were included from 1995 onward. The 
booklets contained questions on health (e.g. subjective health, presence of specific diseases) 
life style (e.g. smoking behavior, alcohol consumption), socio-economic status (SES), and 
personality (e.g. depression, anxiety scales). Depending on their year of entry in the study, 
participants were sent a minimum of one and a maximum of four questionnaire booklets 
between 1991 and 1997.  
To select sibling pairs (fraternal twins, twin-sibling or sibling-sibling pairs) for a 
linkage study on the genetics of anxiety and depression (NETSAD), a genetic factor score of 
anxious depression was computed for each subject, based on a genetic multivariate analysis of 
the questionnaires assessing anxiety, somatic anxiety, depression, and neuroticism. This factor 
score gives an estimate of a subject’s genetic vulnerability for anxious depression. The 12% 
concordant highest scoring sibling pairs and the 12% concordant lowest scoring sibling pairs 
in the anxious depression distribution were selected. In addition, discordant pairs were 
selected in which one member scored in the top 20% and the other in the bottom 20% of the 
distribution. If the selected sibling pairs had additional siblings with complete survey 
information, these were also included in the study. For a more extensive description of the 
selection procedure and the anxious depression factor score see Boomsma et al. (2000). 
Although part of the sample (at least two family members of each family) was originally 
selected based on extreme scores for anxiety and depression, the inclusion of additional 
siblings ensured that the distribution of anxious depression in the final sample was near 
normal, with only small kurtosis (Boomsma et al., 2000). Nonetheless, for each of the 
ambulatory physiological variables the relationship between the anxious depression factor 
score will be tested to determine whether the results were unbiased by this selection 
procedure.  
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Table 2.1 Selection of participants   
Questionnaire data 
N = 14.428 
 
 
Selection of extreme 
scores on anxious 
depression 






buccal swab) 77.5%  
N = 1332 
Successfully contacted  






health interview  
Participation: 80.9%  
N = 816  
 
68 subjects agreed to be 
tested twice 
These subjects filled out biannual 
questionnaire at least once  
 
 
Selection criteria: Anxious depression 
factor score. Selected were 12% 
concordant high or low scoring sibling 
pairs and 20% extremely discordant 
sibling pairs  
 
 
All members of the families of the 
selected sibling pairs were invited to take 
part in the DNA collection 
 
Exclusions: pregnancy (13), heart 
transplantation (-), pacemaker (1) and 
known ischemic heart disease (1), 
congestive heart failure (-), or diabetic 
neuropathy (-), presence of metal rods, 
screws or plates for repair of complicated 
bone fracture (1) 
 
Refusals:  
1st test: disease (2), foreign country (5), 
too demanding (174) 
Retest: pregnancy (1), foreign country 



























All selected participants and their parents received an invitation letter for the study and 
a DNA collection package. If they agreed to give a DNA sample, they were also asked to give 
informed consent. The buccal swabs were sent back in a prepaid envelope, using regular mail 
services. Next, the buccal swabs were sent to TNO (Leiden, the Netherlands) for DNA 
isolation. 
 
NETAMB: Ambulatory monitoring   
 Of the 1332 twins and siblings that were selected and returned a DNA sample, 1008 
were contacted for participation in the ambulatory monitoring study. Participants were 
excluded from the ambulatory recording selection in case of a pregnancy, a heart 
transplantation, presence of a pacemaker and known ischemic heart disease, congestive heart 
failure, or when subjects had metal rods in their body because of complicated bone fractures. 
Pregnant women were approached again half a year after delivering the baby. When refusing 
to participate, the reason most often stated was that participation seemed too demanding. 
Ambulatory monitoring took place in two data collection waves, the first taking place 
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between August 1998 and July 2000 and the second between October 2001 and June 2003. In 
total, 816 subjects were willing to participate, giving a response rate of 80.9%. These selected 
subjects received an invitation for the ambulatory measurements by mail, followed by a 
phone-call to make an appointment. They were asked to schedule the appointment on a 
representative (working) day. The participants were visited at home, before starting their 
normal daily activities. After providing informed consent, the cardiovascular monitoring 
devices were attached, and the procedures were explained. In addition, saliva sampling 
instructions were given. Instruction cards (see appendix III) for problem solving were 
available and telephone support could be reached during waking hours. A short health 
interview was held that contained questions on family history of cardiovascular disease, 
consumption behavior (i.e. cigarette, alcohol, and coffee consumption), exercise, health, 
medication, contraceptive medication, menstrual cycle, and anthropometrics. All measures 
taken during the visit and the ambulatory recording period are summarized in table 2.2. The 
total visit took about 45 minutes. The following day subjects were visited again to collect the 
equipment. Participants received their heart rate and blood pressure results of the monitoring 
period by mail. 
In contrast to a laboratory experiment, there are no standardized conditions in an 
ambulatory study. In addition, the number of factors that influence physiology during the day 
is enormous. Therefore, it is necessary to obtain a detailed report of the activities the subject 
has engaged in during the measurement period. One very practical option, used in the present 
study, is to ask subjects to keep a detailed diary. Subjects were asked to keep a chronological 
account of their activities during the measurement day. Every 30 minutes the VU-AMS 
device prompted them to write down their activities, postures, social situation, location, and to 
give a subjective stress score to that half hour. An example of the diaries kept by the subjects 
is displayed in appendix I (in Dutch). At the end of the day subjects also reported on their 
mood state using the shortened Profile Of Mood Scale (POMS, Wald & Mellenbergh, 1990) 
and the next morning they filled out a short questionnaire on subjective sleep quality 
(Meijman, De Vries-Griever, De Vries, & Kampman, 1988). See appendix II for these 
questionnaires (in Dutch). 
 
Measurement of cardiovascular function 
The 24-hour electrocardiogram (ECG) and impedance cardiogram (ICG) were 
recorded using the Vrije Universiteit Ambulatory Monitoring System (VU-AMS46, De Geus, 
Willemsen, Klaver, & Van Doornen, 1995; de Geus & van Doornen, 1996; Willemsen, De 
Geus, Klaver, Van Doornen, & Carroll, 1996). Ambulatory systolic and diastolic blood 
pressure was recorded using a Spacelabs 90207 device (Redmont, Washington, USA). Figure 
2.1 shows one of the subjects wearing the cardiovascular equipment. In addition, it shows the 
electrode configuration that was employed. The ECG and ICG signals were recorded using 6 
disposable, pregelled Ag/AgCl electrodes (Conmed, NY, USA). The first ECG electrode is 
placed on the sternum over the first rib between the two collarbones. This electrode also 
serves as an ICG measuring electrode. The second ECG electrode is placed on the apex of the 
heart over the ninth rib at the left lateral margin of the chest approximately 3 cm under the left 
nipple. The third ECG electrode is a ground electrode and is placed over the right abdomen. A 
second ICG measuring electrode is placed over the tip of the xiphoid complex of the sternum. 
The ICG current electrodes are placed on the back over cervical vertebra C4 and between 
thorax vertebras T8-T9. Electrode resistance is kept below 10 KOhm by cleaning the skin 
with alcohol and rubbing. 
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Table 2.2 Overview of the measured variables 
Ambulatory measures of the cardio-respiratory system 
Measures  Derived variables 
Systolic blood pressure (SBP) 
Diastolic blood pressure (DBP) 
  
Heart period (HP)  RMSSD, SDNN index 
Respiration rate (RR)  Respiratory sinus arrhythmia 
(RSA) 
Pre-ejection period (PEP) 
Left ventricular ejection time (LVET) 
 Systolic time ratio 
Heather index (HI) 
Stroke volume (SV)  Cardiac output (CO) 
Total peripheral resistance 
(TPR) 
   
Anthropometric measures  
Measures  Derived variables 
Height (q)   
Weight (q)  BMI 
Waist circumference (m)  Waist-to-hip ratio 
Hip circumference (m)    
Gross body movement (m)    
    
Hormone Measures  Derived variables 
Salivary cortisol (at visit, 11:00h, 15:00h, 20:00h, 22:30h, 
awakening, 30 min. post-awakening) 
Cortisol Awakening Response 
(CAR) 
Diary & Questionnaire Measure 
Mood Miscellaneous Health behavior Health & disease 
Mood profile Socio-economic status 
(SES) 
Smoking Medication use 
 Alcohol or caffeine use Family history of CVD  
 Exercise Sleep quality  
Subjective stress 
score (repeated each 
half hour during the 
ambulatory recording 
period) 
 Use of contraceptives   
Q= derived from questionnaire, M= measured variable 
 
Measures from the ECG 
The electrocardiogram (ECG) is used to evaluate the electrical events within the heart. 
The electrical current through the heart that occurs at each heart beat can be detected by 
recording electrodes at the surface of the skin. From the ECG a multitude of measures can be 
derived. The studies described in the present thesis use the ECG to measure the intervals 
between successive electrical pulses in the heart. The time-domain variables that are 
calculated based on these intervals include the mean inter-beat-interval (IBI) and the mean 
heart rate (HR). The beat-to-beat fluctuation in the inter-beat-interval duration is known as 
heart rate variability (HRV). The present study will make use of two commonly used time-
domain measures of HRV derived from the ECG: the square root of the mean squared 
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successive differences in R-R intervals (RMSSD) and the standard deviation of the R-R 
intervals averaged over 5 minute periods (SDNN index).  
 
Figure 2.1 Equipment 
 
  
Left: one of the participants equipped with the ambulatory monitors, in close-up on the left 
the blood pressure monitor and on the right the VU-AMS ECG/ICG monitor. Right: electrode 
configuration for the VU-AMS monitoring device.  
 
Measures from the ICG  
A further method to measure ambulatory cardiac activity is impedance cardiography 
(ICG). This technique is used to measure sympathetic and parasympathetic influences on the 
heart. Impedance cardiography (ICG) uses 4 electrodes at the skin surface to record the 
change in bio-impedance (dZ) over the thorax. The dZ signal contains three major 
components: high frequent impedance changes due to the ejection of blood into the aorta 
during systole, low frequent impedance changes due to arm and upper body movement, and, 
in between these frequencies, the thoracic impedance changes due to respiration. 
After appropriate filtering, several measures of sympathetic and parasympathetic 
activation can be extracted. This present study made use of the impedance changes due to 
respiration to determine respiratory sinus arrhythmia (RSA), a measure of heart rate 
variability that is almost completely parasympathetic in origin. RSA was determined using the 
peak-to-trough method (Fouad, Tarazi, Ferrario, Fighaly, & Alicandri, 1984; Grossman, van 
Beek, & Wientjes, 1990; Grossman & Kollai, 1993), which combines respiratory time 
intervals and the heart period time series to obtain an RSA value at each breath. RSA is 
calculated as the difference between the shortest inter-beat-interval during heart rate 
acceleration in the inspiration phase and the longest inter-beat-interval during heart rate 
deceleration in the expiration phase.  
The dZ/dt signal that reflects the high frequent impedance changes due to the ejection 
of blood into the aorta during systole can be seen in figure 2.2. Three characteristic time 
points are identified. First, there is the moment of the upstroke or B-point at which the 
ventricular valves open and the blood starts streaming into the aorta. Then the dZ/dtmin point 
follows, at which moment the change in impedance is at its minimum and the velocity of the 
blood is at its maximum. Finally, the incisura or X-point can be detected, at which moment 
the ventricular valves close again. The area under this impedance curve reflects the amount of 
blood that is ejected per heart beat, and is called stroke volume.  
   
 
24  Chapter Two 
 
The cardiac pre-ejection period (PEP) is a systolic time interval that embodies specific 
sympathetic cardiac activation. PEP reflects the time interval between the onset of the 
electromechanical systole (Q-wave onset) and the onset of left ventricular ejection at the 
opening of the aortic valves (the B-point in the ICG). Pharmacological blockade studies 
(Schachinger, Weinbacher, Kiss, Ritz, & Langewitz, 2001; Cacioppo et al., 1994a) have 
shown PEP to be a reliable indicator of sympathetic inotropic control over cardiac 
contractility. The other systolic time interval is the left ventricular ejection time (LVET), 
which is used as a sympathetic chronotropic index (LVET, Thayer & Uijtdehaage, 2001). 
LVET is defined as the time interval between the opening (B-point) and closing (X-point) of 
the aortic valves. The present study will use two other measures of sympathetic control over 
cardiac contractility: the ratio of PEP to LVET, which is less preload dependent measure than 
PEP alone, and the Heather index for myocardial contractility that is more related to the 
cardiac output. The Heather index is defined as the level of impedance (in Ohm) at the 
moment of minimal change in impedance (dZ/dtmin) divided by the time between the R-top in 
the ECG and the time of the occurrence of the dZ/dtmin point, corrected for basal impedance. 
 











Systolic and diastolic blood pressures were measured during waking hours using an 
inflatable cuff wrapped around the upper arm on the non-dominant side, and an ambulatory 
monitor (Spacelabs 90207, Redmont, Washington, USA) that automatically inflated and 
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deflated the cuff for pressure measurement. Arm circumference was measured to choose the 
appropriate arm-cuff size. The Spacelabs monitor uses the oscillometric method of detection. 
Measurements were initiated automatically every 30 minutes during waking hours. The blood 
pressure recordings were read from the devices using Spacelabs software.  
 
Data loss 
In a number of subjects, either blood pressure data or AMS data were entirely missing. 
One AMS recording failed because of a large metal internal fixation device for repair of a 
complicated bone fracture. Ten AMS recordings failed due to errors in uploading the data to 
the computer or due to equipment failure during the recording period. Blood pressure 
measurements were absent for 20 participants. Three subjects were too obese to fit the largest 
arm cuff; one person had a muscle disease making blood pressure measurement impossible, 
and 16 blood pressure recordings were lost due to Spacelabs equipment failures that could not 
be solved by the participants. 
 Reasons for partial loss of signal in both ECG/ICG and blood pressure monitors were 
multiple: a loose or dried electrode, a wire dysfunction, non-compliance of the subjects to 
keep arm relaxed during a blood pressure measurement, non-compliance of subjects to solve a 
distress signal from any of the cardiovascular devices. In some cases, subjects did not want to 
wear the devices anymore and aborted the measurement.  For 5 subjects both AMS and blood 
pressure recordings were actively discarded by ourselves. Four of these subjects had drunk 
excessively the evening before the measurement and for the fifth subjects no diary was 
present.  
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 The present study estimated the genetic influences on ambulatory systolic and diastolic 
blood pressure and on hypertensive status derived from ambulatory levels, in a family sample 
of 535 twins and 257 singleton siblings. This “extended twin design” was used to explicitly 
test the possibility that results obtained in singleton siblings are different from those obtained 
in twins. To examine the effects of excluding (medicated) hypertensive subjects, the genetic 
analyses were first performed under strict exclusion (medication and/or blood pressure > 
135/85 mmHg), next without the medicated subjects and finally without any exclusion. For 
the latter analysis, the untreated blood pressure values in subjects taking antihypertensive 
medication were estimated by augmenting the observed blood pressure by the published 
efficacy of the specific antihypertensive medication used. No evidence was found for 
differential means, variances or covariances of ambulatory blood pressure in singletons 
compared to twins. This indicates that estimates of heritability of ambulatory blood pressure 
from twin studies can be generalized to the singleton population. Heritability of hypertension, 
defined as a mean daytime blood pressure > 135/85 mmHg or antihypertensive medication 
use, was 61%. Genetic contribution to ambulatory blood pressure was highest when all 
subjects were included (systolic: 44-57%; diastolic: 46-63%) and lowest under strict 
exclusion (systolic: 32-50%; diastolic: 31-55%). We conclude that exclusion of (medicated) 
hypertensives removes part of the true genetic variance in ambulatory blood pressure. 
 
 




A large number of twin and family studies have shown significant genetic 
contributions to individual differences in blood pressure (Evans et al., 2003; Boomsma, 
Snieder, de Geus, & van Doornen, 1998; Colletto, Cardon, & Fulker, 1993; McCaffery, 
Pogue-Geile, Debski, & Manuck, 1999; Snieder, Harshfield, & Treiber, 2003). Most of these 
studies have based their genetic analyses on conventional office blood pressure 
measurements. The genetics of ambulatory blood pressure (ABP) may differ, however, 
because it is unaffected by the ‘white-coat’ effect (Mancia & Parati, 2004). The added value of 
ABP measurements is best illustrated by studies showing that ABP is a better predictor of target 
organ damage (Pickering & Devereux, 1987), cardiovascular morbidity and mortality 
(Verdecchia et al., 2001; Verdecchia, 2000) than conventional office blood pressure.  
 To date, only four twin studies (Fagard et al., 1995; Somes et al., 1995; Vinck et al., 
2001; Fagard et al., 2003) and one family study (Kotchen et al., 2000) reported heritability 
estimates for daytime or 24-hr ABP. Estimates ranged from 22% to 62% for systolic blood 
pressure (SBP) and from 38% to 63% for diastolic blood pressure (DBP). With the exception 
of Vinck et al. (2001) and Fagard et al. (2003), sample sizes for the twin analyses have been 
rather small, i.e. at most 66 pairs in total. Thus, there is a relative paucity of adequately 
powered twin studies on ambulatory measures. One way of increasing statistical power is to 
include singleton siblings. Such an extended twin design (Posthuma & Boomsma, 2000) 
further provides an optimal design to address the question whether results from twin studies 
on the genetics of ABP may be generalized to the singleton population, because it matches 
twins and singletons for familial factors like SES, diet habits and maternal behaviors during 
pregnancy.  
 Existing twin and family studies of ABP have excluded subjects taking antihypertensive 
medication (Fagard et al., 2003; Vinck et al., 2001), or have performed their analyses on 
normotensive subjects only (Fagard et al., 1995; Somes et al., 1995), thereby removing an 
important part of the population variance of interest (Palmer, 2003). The present study 
estimated the genetic influences on hypertensive status and ambulatory SBP and DBP in a 
large sample of twins and their singleton siblings. To examine the effects of exclusion, the 
genetic analyses on ABP were first performed on normotensive subjects only, secondly after 





The study sample was composed of  230 monozygotic (MZ) twins (85 men), 305 
dizygotic (DZ) twins (111 men) and 257 singleton siblings (98 men) from 339 families, all 
registered in the Netherlands Twin Register (NTR). Families were originally asked to 
participate in a genetic linkage study of anxious depression, which is described elsewhere 
(Boomsma et al., 2000). Of the 1332 offspring who returned a DNA sample (buccal swabs) 
for the linkage study, 1008 were successfully contacted for the cardiovascular ambulatory 
monitoring study, of which 192 subjects refused or were excluded. Reasons for a priori 
exclusion were pregnancy, heart transplantation, pacemaker and known ischemic heart 
disease, congestive heart failure, or diabetic neuropathy. In 24 subjects, no data were available 
due to equipment failures, or data were judged unreliable. 
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 In total, 792 subjects from 339 families participated. In 132 families only the twin 
pair participated, in 74 families the twin pairs and 1 sibling participated, in 25 families the 
twin pair and two or more sibs participated. In some families only the (singleton) siblings 
participated (these include families in which one of the twin pair participated with one or 
more singleton siblings). In 45 families, one sib participated, while in 51 families, two 
singleton sibs participated. In the remaining 12 families between three and six sibs 
participated. Their average age was 31.3 (SD = 11.2) years. Zygosity of the twins was 
determined by DNA typing. The Ethics Committee of the Vrije Universiteit approved of the 
study protocol and all subjects gave written consent before entering the study. No payment 




Subjects were visited in the morning before going to work and were requested to 
refrain from intense physical activity both on the preceding and the ambulatory monitoring 
day. A Spacelabs 90207 ABP monitor (Redmont, Washington, USA) and an ambulatory 
ECG/ICG recorder (Vrijkotte, van Doornen, & de Geus, 2000), which includes a vertical 
accelerometer, were attached to the subject and their operation was explained. Arm 
circumference was measured to choose the appropriate arm-cuff size. Blood pressure 
measurements were initiated automatically every 30 minutes. Before inflating, the device 
gave an auditory two-tone beep to warn participants to keep their arm as still and relaxed as 
possible. Subjects were unable to observe their own blood pressure readings. The monitor was 
programmed to retake a measurement two minutes after a misreading. Every 30 (± 10) 
minutes subjects were prompted by an auditory beep to write down a chronological account of 
activity (e.g. deskwork, housekeeping, watching TV), posture (lying, sitting, standing, 
walking and bicycling), and location (e.g. at home, at work, at a public place). When they 
went to bed, participants removed the blood pressure monitor. The signal from the vertical 
accelerometer was combined with the diary information to check the diary entries on posture 
and physical activity for accuracy. 
 
Data reduction 
Previous recommendations for excluding artifacts and outliers from ambulatory 
recordings were followed (Berardi, Chau, Chanudet, Vilar, & Larroque, 1992). The reported 
times of diner and lunch, awakening and bedtime were used to compute mean SBP and DBP 
across all readings in the morning, afternoon, and evening. To assess the confounding of 
different physical activity patterns on ABP levels, we also computed the average ABP on the 
three periods of the day using only blood pressure values obtained during sitting activities. 
Applying ESH criteria, hypertension was considered present when subjects were currently on 
prescribed antihypertensive medication or when mean daytime ABP was higher than 135/85 
mmHg (O'Brien et al., 2003).  
 
Statistical analysis 
Heritability estimates of hypertension and daytime ABP were obtained from structural 
equation modeling of the MZ and DZ/sib variances and covariances using the structural 
equation program Mx (Neale, Boker, Xie, & Maes, 2003). The ‘raw data’ option was used to 
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Hypertension - Heritability of hypertension was assessed using a liability-threshold model, 
which assumes a latent, normally distributed liability to disease that is manifest as a 
categorical phenotype (Falconer & Mackay, 1996). For hypertension the underlying 
distribution was modeled to have one threshold, which allows for two categories, affected and 
unaffected. Linear effects of age and sex were allowed to influence the liability threshold. 
Sources of variation in hypertension liability considered in the modeling were additive genetic 
factors (A), shared environmental factors (C), and unique environmental (E) factors. Nested 
submodels were compared to the full (ACE) model in order to arrive at the most parsimonious 
and best fitting model. The fit and parsimony of the various models was judged using 
likelihood ratio tests.  
 
Ambulatory BP - Quantitative analyses of ABP were carried out in several steps. First, a series 
of increasingly constrained univariate biometrical genetic models were fit for each period of 
the day, for SBP and DBP separately, to test assumptions of homogeneity of means and 
variances for MZ twins, DZ twins, and singleton siblings, and the homogeneity of correlations 
of males versus females and of DZ twins versus singletons (Neale & Cardon, 1992; Neale et 
al., 2003). The resulting most parsimonious saturated model indicated to what extent we could 
limit the number of estimated parameters in the ensuing analyses. Next, two theoretically 
distinct trivariate biometric models were fit to estimate the relative contribution of genetic and 
environmental influences to the variance and covariance of mean SBP and DBP across the 
three periods of the day. The first model was an independent pathway model, which specifies 
three common factors. One for genetic (A) sources of variance, one for shared environmental 
sources of variance (C) and one for unique environmental (E) sources of variance, while it 
also allows for period-specific influences of A, C and E for all periods of the day. This model 
is depicted in figure 3.1a. We tested whether the ACE variance decomposition for both the 
common and the specific factors could be reduced to an AE or CE model. A common pathway 
model was fit next. This model is more stringent and hypothesizes that the covariation 
between ABP measured at the three periods of the day is determined by a single, common 
latent variable, called “systolic (or diastolic) blood pressure”. “Systolic (or diastolic) blood 
pressure” itself can be influenced by A, C and E. As in the independent pathway model, there 
are still genetic and environmental effects specific for BP measured at each period of the day. 
This model can be seen in figure 3.1b. It was tested whether this more parsimonious common 
pathway provided a better description of the data than the independent pathway model, and 
whether specific genetic influences could be dismissed. To evaluate the relative fit of the 
various nested models we used Akaike’s Information Criterion (AIC, Akaike, 1987), an index 
of goodness-of-fit for which a larger negative value indicates greater parsimony of the model. 
Significance tests of the individual path coefficients were carried out by constraining paths to 
zero and applying likelihood ratio tests.  
The above analyses on ABP were performed thrice, in three different sets of subjects. 
In the normotensive set we excluded all subjects diagnosed with hypertension (ABP > 
135/85) and subjects on antihypertensive medication. In the second and unmedicated set we 
only excluded the 29 subjects on antihypertensive medication. The third set included all 
available subjects. To obtain ABP values in these medicated subjects, drug-class specific 
treatment effect averages, obtained from a recent large systematic review of the effect of 
antihypertensive treatment on ambulatory blood pressure (Mancia & Parati, 2004) were added 
to the observed pressures. Unlike substitution methods, this adjustment makes no assumptions 
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Figure 3.1a Independent Pathway Model 
AC CC EC 
The figure illustrates both the independent (a) and common pathway model (b). The rectangles 
contain the observed systolic or diastolic ABP at the three periods of the day; the circles 
represent the latent factors: AC= common additive genetic factor, CC= common shared 
environmental factor, EC= common unique environmental factor, PL= latent underlying 
phenotype. AS=specific additive genetic factor, CS= specific shared environmental factor, ES= 
specific unique environmental factor.  The lambda (λ) paths represent factor loadings for the 
three measurements (morning, afternoon, evening) on the latent daytime ambulatory blood 




On average 27 (± 4) blood pressure measurements (≈ 13.5 hours) took place during the 
recording period, of which on average 13 (± 5) during sitting posture (≈ 6.5 hours, which is 
48% of the total monitoring period). Although the sample was previously selected based on 
the presence of at least two family members with extreme scores on personality 
questionnaires, their scores did not correlate significantly with hypertension diagnosis, or with 
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Figure 3.1b Common Pathway Model 
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At all 3 periods, age was significantly correlated with SBP (.24-.33) and DBP (.31-.35). Both 
sex and age were kept as covariates in all further model fitting analyses. 
BMI correlated significantly with both SBP (.24-.31) and DBP (.20-.25). As several 
studies reported a genetic covariation between BP and BMI (McCaffery, Pogue-Geile, 
Debski, & Manuck, 1999; Carmelli, Cardon, & Fabsitz, 1994; North et al., 2004) and since 
genetic variance is removed when shared genes influence both variable and covariate, we 
intentionally did not include BMI as covariate. 
 
Hypertension 
In our sample, 115 (14.5%) of the 792 subjects received a hypertension diagnosis 
based on their ambulatory recording, 29 of them receiving antihypertensive medication. 
Among the hypertensive were 31 monozygotic twins. The homogeneity of covariances over 
the sexes and between DZ twins and siblings was confirmed and no evidence for a difference 
in twin pair versus singleton sibling pair correlation in hypertensive risk was found. The 
liability threshold was higher for women compared to men, and higher for younger vs. older 
subjects. The sex and age-corrected tetrachorical correlations for the liability dimension were 
.62 for MZ twins and .29 for DZ twins, indicating genetic influences. This was confirmed by 
model fitting, the results of which are shown in table 3.1. Leaving out both shared 
environmental and genetic influences from the model (E-model) caused a large increase in χ², 
indicating a significant worsening of the fit. This shows a clear influence of familial factors 
on hypertension. Statistical power was insufficient to discriminate between genetic influences 
and shared environmental influences, but given the pattern of twin correlations and the AICs 
of the AE and CE models, it is most likely that the AE model is the preferred model. In the 
AE model, variance in hypertension diagnosis is for 61% explained by genetic influences.  
 
Table 3.1 Model Fitting Results for Hypertension 
Model ∆χ2 ∆df p AIC A C E 
ACE - - - - 61% (0-83) 0% (0-49) 39% (17-75) 
AE 0 1 1.000 -2.000 61% (33-83) - 39% (17-67) 
CE 2.355 1 0.125 0.356 - 37% (18-56) 63% (44-82) 
E 18.914 2 0.000 14.914 - - 100% 
Shown are delta chi-square (∆χ2) values and gain in df of the models and accompanying 
estimates for additive genetic (A) and shared (C) and unique environmental (E) influences.  




Table 3.2 presents the mean ABP for the three periods of the day in the normotensive, 
unmedicated and full set of subjects. It illustrates the impact of excluding subjects with 
hypertension and/or using antihypertensive medication. Although the means do not 
dramatically change (2% to 4.5%), strict exclusion brings about a 30% to 39% reduction in 
the standard deviation in comparison to the “true” population. Exclusion of medicated 
subjects led to much smaller changes in means (-0.5% to 0.5%) and moderate reductions in 
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Full set of 
subjects 
(772<N<786)  
M 129.8 (9.1) 133.5 (11.4) 134.2 (12.1) SBP  
F 124.2 (8.3) 125.9 (10.1) 126.7 (11.3) 
M 79.3 (6.4) 82.5 (8.7) 83.2 (9.4) 
Morning 
DBP F 77.4 (6.5) 80.8 (7.5) 81.3 (8.3) 
M 129.6 (8.1) 132.6 (10.1) 133.2 (10.9) SBP F 122.9 (8.5) 125.9 (10.1) 125.3 (10.2) 
M 77.4 (6.4) 80.4 (8.2) 81.1 (8.9) Afternoon DBP F 77.4 (6.0) 78.6 (7.1) 79.1 (7.7) 
M 129.0 (8.5) 132.1 (10.4) 132.7 (10.9) SBP F 122.9 (8.1) 124.7 (10.1) 125.3 (10.8) 
M 76.0 (6.3) 79.3 (8.7) 79.9 (9.2) Evening DBP F 76.6 (6.8) 77.9 (7.8) 78.4 (8.4) 
M= males, F = females 
 
Next, the resemblance between MZ twins and between DZ twins or sibling pairs was 
examined by calculating age-adjusted Pearson correlations, stratified by sex, as shown in table 
3.3. Throughout a larger MZ than DZ correlation is evident, suggesting the presence of 
additive genetic and unique environmental influences.  
 
Table 3.3 Resemblance between MZ and DZ/sib pairs for ambulatory SBP and DBP 
SBP  DBP Period of 
day 
Sex of 
pairs rMZ rDZ/sib  rMZ rDZ/sib 
M .72 / .60 / .68 .38 / .38 / .41  .42 / .63 / .68 .21 / .34 / .40 
F .44 / .56 / .49 .13 / .23 / .27  .34 / .51 / .51 .21 / .28 / .33 Morning 
OS  .09 / .16 / .26  - .16 / .12 / .10 
M .40 / .62 / .60 .27 / .25 / .32  .63 / .70 / .65 .38 / .39 / .43 
F .59 / .68 / .64 .18 / .23 / .27  .62 / .72 / .73 .30 / .30 / .35 Afternoon 
OS - .08 / .18 / .26  - .19 / .14 / .15 
M .34 / .49 / .59 .35 / .32 / .39  .31 / .49 / .56 .17 / .45 / .43 
F .19 / .35 / .40 .18 / .19 / .27  .21 / .43 / .45 .18 / .21 / .27 Evening 
OS - .17 / .11 / .24  - .18 / .09 / .15 
Shown are the age-corrected correlations for the normotensive set of subjects / the set 
excluding medicated subjects / the full set of subjects (with ABP corrected for medication). M 
= males, F = females, OS = opposite sex. Correlations that are significant at a .05 level are 
printed bold faced. 
 
Multivariate genetic analyses - The means and variances of both SBP and DBP were equal for 
MZ and DZ twins, and singleton siblings. Importantly, we found no twin-singleton 
differences in ABP in all three sets of subjects, suggesting that results obtained in twins can 
be generalized to singletons.  
 Multivariate model fitting resulted in the preference for a model without shared 
environmental factors (AE model) over the full model (ACE model) for all three sets of 
subjects. Statistical power was sufficient to discern the AE and CE model, since quantitative 
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analyses have higher statistical power than the ordinal analyses performed for hypertension 
status. Although there was sufficient power (at β = .80, α = 0.05) to detect effects of 23% or 
higher, no significant common environmental effect was found. We further tested the 
hypothesis that a common latent trait was underlying blood pressure at all three periods of the 
day (common pathway model). 
 
Table 3.4 Heritability estimates for SBP and DBP under the common pathway model 
Common influences Specific influences BP Period of day 
Genetic Environment Environment 
Normotensive set of subjects 
Morning 40% (28 to 53) 23% (13 to 35) 37% (31 to 44) 
Afternoon 55% (39 to 70) 30% (19 to 47) 15% (09 to 21) DBP 
Evening 31% (20 to 41) 17% (10 to 28) 52% (46 to 59) 
Morning 38% (24 to 51) 29% (18 to 44) 32% (27 to 38) 
Afternoon 50% (32 to 65) 38% (24 to 56) 12% (07 to 18) SBP 
Evening 32% (19 to 44) 24% (14 to 38) 44% (38 to 50) 
Unmedicated set of subjects 
Morning 52% (39 to 63) 23% (15 to 36) 24% (20 to 29) 
Afternoon 61% (46 to 73) 27% (17 to 41) 12% (07 to 14) DBP 
Evening 43% (32 to 53) 19% (12 to 30) 37% (32 to 42) 
Morning 49% (34 to 62) 30% (18 to 45) 22% (18 to 26) 
Afternoon 57% (41 to 71) 35% (22 to 51) 09% (06 to 12) SBP 
Evening 42% (29 to 54) 26% (16 to 39) 38% (27 to 36) 
Full set of subjects 
Morning 55% (43 to 65) 23% (15 to 35) 22% (18 to 26) 
Afternoon 63% (50 to 74) 27% (17 to 39) 10% (07 to 14) DBP 
Evening 46% (35 to 56) 19% (12 to 29) 35% (30 to 39) 
Morning 50% (38 to 61) 30% (20 to 42) 20% (17 to 24) 
Afternoon 57% (44 to 69) 34% (24 to 48) 09% (06 to 12) SBP 
Evening 44% (33 to 55) 27% (18 to 38) 29% (25 to 34) 
Shown are the heritability estimates for the normotensive set of subjects, the unmedicated set 
of subjects and the full set of subjects. The 95% confidence intervals are given between 
parentheses. 
 
Indeed this model was preferred over the initial independent pathway model in all 3 sets of 
subjects. We found no specific genetic influences for each of the daily periods and the largest 
part of unique environmental influences was also common to all 3 periods. Table 3.4 shows 
the common pathway estimates for A, which corresponds to the heritability, and for E which 
corresponds to the influence of the common environmental factor. The specific E estimates 
represent unique environmental influences that are specific to each of the periods of the day.  
The highest heritability estimates were found in the full set of subjects. In comparison 
to the results on the normotensive subjects heritability estimates were substantially higher 
(SBP: +7 to 12%, DBP: +8 to 15%). Furthermore, confidence intervals were wider for the 
normotensive subjects compared to the full set of subjects. An increase in heritability was 
already seen when unmedicated subjects were included, but only when medicated subjects 
were included we found non-overlapping confidence intervals with the normotensives. 
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Individual differences in daily physical activity on the measurement day did not 
confound the genetic analyses of ABP. When above analyses were repeated using BP 




Based on daytime ambulatory measurements of SBP and DBP, obtained in 792 twins 
and singleton siblings, the present study showed that the individual differences in 
hypertension status are for 61% genetically determined. Heritability estimates for ambulatory 
SBP and DBP were between 44-63% when no exclusion criteria were upheld. These estimates 
correspond well to those found in previous ambulatory and laboratory/clinical studies in 
another large adolescent and adult healthy twin samples (Evans et al., 2003; Fagard et al., 
1995; Fagard, Loos, Beunen, Derom, & Vlietinck, 2003; Vinck, Fagard, Loos, & Vlietinck, 
2001). Our study had a number of strengths in design that provide confidence in its outcome. 
The extended twin design increases the statistical power to distinguish between components 
of A, C and E compared to a design including only MZ and DZ twins (Posthuma & 
Boomsma, 2000). Furthermore, it allowed us to test the possibility that results obtained on 
singleton sibling pairs differed somehow from those obtained in twin pairs. This is important 
because the lower birth weight in twins might be considered to reflect an impaired fetal 
environment, which, according to the “Barker hypothesis”, may impact on BP regulation 
(Law & Shiell, 1996). By comparing singletons with twins from the same family, the two 
comparison groups are perfectly matched for familial influences (same parents, same womb 
although at a different time, same family environment). Our analyses showed that MZ and DZ 
twins and singleton siblings did not differ from each other in means or variances on any of the 
ABP measures. Importantly, sibling-sibling covariance did not differ from sibling-twin or 
DZ-twin covariance, which strongly argues against a special twin intrauterine disadvantage 
with deleterious effects on adult ABP. The absence of any twin-singleton difference repeats 
previous findings in resting laboratory blood pressure (de Geus et al., 2001) and indicates that 
estimates of the heritability of ABP from twin studies are not systematically biased and can be 
generalized to the general population.  
Exclusion of hypertensive subjects clearly distorted MZ and DZ twin correlations, as 
well as the variances. Excluding medicated subjects further increased the distortion, although 
the effect was only very minor in this population. Our results showed that restricting the 
sample to normotensives only, not only caused a decrease in total variance but specifically 
reduced heritability estimates. With this result we extend the earlier findings (Cui, Hopper, & 
Harrap, 2003) on conventional office BP, to prolonged BP measurements in naturalistic 
settings. The effect of excluding groups of subjects, on grounds of hypertension and/or 
medication is undesirable as the reduced heritability estimates directly lead to a loss of power 
in linkage studies. This effect was convincingly illustrated by Hunt et al. (Hunt et al., 2002) 
who showed that removing medicated subjects from the sample led to the disappearance of a 
QTL for conventional office SBP on chromosome 6. 
The substantial heritability of office blood pressure has motivated many large scale 
efforts to identify hypertension predisposing genes through linkage (Province et al., 2003) 
approaches. Because ABP is a better predictor of target organ damage (Pickering & Devereux, 
1987), cardiovascular morbidity and mortality (Verdecchia et al., 2001; Verdecchia, 2000) than 
office BP, these gene finding attempts may be well served by using ABP. Here we show that 
genetic variance of ABP is sufficiently high to justify its use in genome searches. The repeated 
measures structure inherent in ambulatory monitoring brings further advantages. We separated 
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the entire ambulatory recording into 3 daily periods, allowing for the possibility that different 
genetic factors would affect blood pressure regulation during leisure (evening) and work 
(morning, afternoon) periods. For both SBP and DBP a common factor influenced all 3 
periods. There were no separate genetic factors influencing blood pressure at different periods 
of the day. From a gene finding point of view, the common genetic factor structure is 
advantageous on two accounts. The repeated measures structure increases statistical power to 
find genes in linkage analysis (Evans, 2002). Additionally these genes, by virtue of having a 




 An important limitation to our study is the lack of nighttime recordings. We opted 
not to burden our subjects by asking them to continue wearing the blood pressure monitor at 
night. In our experience, this causes large attrition in non-patient populations. In family-based 
studies, the loss of a single subject is more hard-felt than in population samples, where an 
additional randomly drawn subject can be easily recruited without loss to the overall study 
design. It is possible, however, that different genetic factors come into play during the day 
than at night. Some indication for this possibility, although the confidence intervals of the 
estimates for the three daily periods were overlapping, is seen in the systematically lower 
heritability in the evening compared to morning and, particularly, afternoon recordings. 
 Our sample consisted of young Caucasian adults aged mainly between 20 and 40, 
with an age range between 15 to 81 years. Therefore, generalization of our results beyond the 
main age range or to a population of different ethnicity should be done only hesitantly. A 
recent family study performed an age-stratified longitudinal genetic analysis of office blood 
pressure and found little variation in the genetic architecture over time (Brown et al., 2003). 
This suggests that a common set of genes may be contributing to the observed variation in BP 
across a wide age range. In our sample, separating the analyses of ABP over multiple age 
cohorts would have compromised statistical power to detect, for instance, twin singleton 
differences.    
 
Perspectives  
Genetic contribution to the variance in blood pressure is very likely to be polygenic, 
with only very small contributions of the individual quantitative trait loci to the final 
hypertensive risk. Future gene finding studies, particularly linkage studies, should therefore 
aim to maximize statistical power. In this regard, ABP monitoring has a number of 
advantages over conventional office measurements. Heritability of ABP is comparable to 
office blood pressure, but the genes underlying ABP are likely to have better predictive validity 
for target organ damage (Pickering & Devereux, 1987) and cardiovascular morbidity and 
mortality (Verdecchia et al., 2001; Verdecchia, 2000). Ambulatory recording has an intrinsic 
multivariate nature and the repeated, highly correlated blood pressure measures can be 
exploited to reduce measurement error and improve the estimation of the latent genetic factor. 
Our findings further show that a part of the genetic variance in ABP is lost when hypertensive 
(and/or medicated) subjects are excluded. In future linkage and association studies such 
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Reduced heart rate variability (HRV) is a prognostic factor for cardiac disease and cardiac 
mortality. Understanding the sources of individual differences in HRV may increase its 
diagnostic use and provide new angles for preventive therapy. To date, the contribution of 
genetic and environmental factors to the variance in HRV has not been investigated during 
prolonged periods of ambulatory monitoring in a naturalistic setting.  
In 772 healthy twins and singleton siblings, ambulatory ECG was recorded during 24 hours. 
Two time-domain measures of HRV were used: the standard deviations of all normal to 
normal intervals across 5-min segments (SDNN index) and the root mean square of 
successive differences between adjacent normal RR intervals (RMSSD). Multivariate genetic 
analyses across 4 periods of day (morning, afternoon, evening, night) yielded significant 
estimates for genetic contribution to the mean ambulatory SDNN index (ranging from 35% to 
47%) and the mean ambulatory RMSSD (ranging from 40% to 48%). 
Ambulatory HRV measures are highly heritable traits that can be used to support genetic 










Heart rate variability is a clinically relevant cardiovascular phenotype. Reduced heart 
rate variability is an independent predictor of cardiac disease and cardiac mortality (Dekker et 
al., 2000; Nolan et al., 1998; Huikuri et al., 2003; Dekker et al., 1997; Tsuji et al., 1996; 
Bigger et al., 1993). The major explanation for this predictive effect is that reduced heart rate 
variability reflects a shift in cardiac sympathovagal balance from parasympathetic to 
sympathetic control over the heart rhythm (Schwartz et al., 1988; La Rovere et al., 2002). 
Understanding the sources of individual differences in heart rate variability may increase its 
diagnostic use and, if these differences can be traced to genetic polymorphisms, may provide 
new angles for preventive therapy. The first step in the establishment of genetic contribution 
to a clinical phenotype is the estimation of its heritability in samples of genetically related 
subjects.  
In laboratory studies, a significant genetic contribution to heart rate variability has 
been established by twin and family studies. Heritability estimates at rest range from 13-39% 
(Boomsma et al., 1990; Sinnreich et al., 1999; Busjahn et al., 1998; Snieder et al., 1997; Singh 
et al., 1999), but during exposure to various stress tasks the genetic contribution increases up 
to 51% (Boomsma et al., 1990). This suggests that genetic influences are more pronounced 
when the subject is challenged by mentally and emotionally taxing tasks. Accordingly, we 
hypothesize that heritability of heart rate variability measures will be even higher when 
recorded over prolonged periods in a naturalistic setting.  
To date, the genetics of heart rate variability in such recordings have not been 
investigated. The purpose of the present study was to estimate the contribution of genetic and 
environmental factors to the variance in ambulatory measured heart rate variability, using a 





Participants were registered with the Netherlands Twin Register (NTR). All families 
were selected for a genetic linkage study in search of genes influencing personality traits as 
described in detail elsewhere (Boomsma et al., 2000). Briefly, the families were selected to 
have two siblings (dizygotic twin pair, or sib-twin pair, or sib-sib pair) discordant or 
concordant for anxiety, neuroticism or depression. In addition to these siblings, however, all 
other family members have been recruited for study and the resulting distribution of anxiety, 
neuroticism and depression scores was near-normal with only mild kurtosis. 
Of the 1332 offspring who returned a DNA sample (buccal swabs) for the linkage 
study, 1008 were successfully contacted for a cardiovascular ambulatory monitoring study, of 
which 192 refused or were excluded. Reasons for exclusion were pregnancy, heart 
transplantation, pacemaker and known ischemic heart disease, congestive heart failure, or 
diabetic neuropathy. In 14 of the remaining 816 subjects, no data were available due to 
equipment failures. Ten subjects showed a very noisy ECG signal and were excluded from the 
analyses. Subjects (20 in total) using rhythm-altering medication (n=2), and HRV-reducing 
antidepressants (tricyclic antidepressants (n=2) and benzodiazepines (n=10)) and 
antihypertensive medication (β-blockers (n=13)), or a combination of these, were excluded 
from the analysis. The final sample consisted of 218 monozygotic (MZ) twins (79 men), 301 
dizygotic (DZ) twins (107 men) and 253 singleton siblings (97 men) from 339 families. For 
the majority of the twin pairs, zygosity was determined by DNA typing; in a small part (8%) 
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zygosity questionnaires were used. The mean age was 31.3 years (SD = 10.6) for men and 
30.8 years (SD = 10.9) for women. The Ethics Committee of the Vrije Universiteit approved 
of the study protocol and all subjects gave written consent before entering the study. No 
payment was made for participation. 
 
Study design 
Subjects were visited at home on a weekday, before starting their normal daily 
activities. They were subjected to an interview on health status and current medication use. 
The Vrije Universiteit Ambulatory Monitoring System 46 (VU-AMS device, de Geus, 
Willemsen, Klaver, & van Doornen, 1995; de Geus & van Doornen, 1996) was attached and 
its operation explained. Subjects wore the VU-AMS device the entire day and night up until 
awakening the next morning. Every 30 (± 10) minutes the ambulatory device produced an 
audible alarm beep to prompt them to fill in a detailed diary. They wrote down a 
chronological account of activity, posture, location, presence of other persons, and amount of 
perceived stress during each past 30 minutes. On the following day the research assistant 
collected the device at home.  
  
Heart rate variability  
The VU-AMS device continuously recorded the electrocardiogram (ECG) from a six-
electrode configuration. Two heart rate variability measures were extracted from the IBI time 
series: the standard deviations of all normal to normal intervals (SDNN) and the root mean 
squares of the successive differences between adjacent normal to normal intervals (RMSSD). 
In addition to cardiac measures, the device also recorded vertical acceleration as a proxy for 
gross body movement. The vertical accelerometer information was combined with the diary 
information to divide the entire recording into smaller fragments that were stationary with 
regard to physical activity and posture, e.g. within each fragment no shifts in activity/posture 
occurred. The fragments were never shorter than 5 minutes or longer than 1 hour. They were 
coded for posture (lying, sitting, standing, walking and bicycling), activity (e.g. deskwork, 
housekeeping, watching TV), and location (e.g. at home, at work, at a public place). SDNN 
was computed across all 5-minute periods that fitted in the coded fragment, effectively 
yielding the SDNN index. SDNN index and RMSSD were averaged over the entire fragment. 
Based on the reported times of diner and lunch, awakening and bedtime, mean RMSSD and 
SDNN index were computed across all fragments in the morning, afternoon, evening and 
nighttime sleep periods. In 8% of the subjects the exact time of diner, lunch, awakening or 
bedtime could not be extracted from either diary or body movement. For these subjects, the 
missing time was imputed using the mean times of these events in the rest of the sample. 
 
Statistical analysis 
Confounding - The individual differences in ambulatory heart rate variability were expected 
to be sensitive to three main confounders: differences in sex and age (Antelmi et al., 2004), 
and differences in physical activity patterns on the measurement day (Osterhues, Hanzel, 
Kochs, & Hombach, 1997). All analyses below were age and sex-adjusted, to control for the 
first two of these confounders. Because ambulatory recorded subjects may differ in their 
activity patterns, the potential influence of physical activity and postural changes on 
interindividual variance in heart rate variability measures needs to be taken into account. This 
was done here by calculating the twin correlations twice: once including the entire recording, 
containing data during all postures, and once including those fragments of the recording 
during which a subject was either sitting or lying. 
 
 




Twin correlations - MZ twins share all their genetic material, while DZ twins and siblings 
share on average 50% of their segregating genes. A larger resemblance of MZ than DZ twins, 
or other first degree relatives, thus indicates that their larger genetic resemblance is associated 
with a larger phenotypic resemblance (Boomsma, Busjahn, & Peltonen, 2002). To determine 
the extent to which monozygotic twin pairs are more similar than dizygotic or sibling pairs, 
Pearson correlation coefficients were calculated per zygosity using SPSS-11 (SPSS Inc., 
Chicago, USA). All possible MZ and DZ/sib pairs were used. 
 
Structural equation modeling - To answer the question to what extent genes, shared and non-
shared environment contribute to the variance of SDNN index and RMSSD, biometrical 
genetic models were fitted to the data using the structural equation program Mx (Neale et al., 
2003). First, nested univariate unconstrained models were fitted to test assumptions of the 
(extended) twin model. For each period of day, we tested the equality of means and variances 
for MZ twins, DZ twins, and singleton siblings. Likewise, we examined the presence of sex 
and age effects on the means and variances. In a final step, we tested for heterogeneity of 
correlations of males versus females and of DZ twins versus singletons.  
The resulting most parsimonious unconstrained models were the ones against which 
the variance decomposition models were tested. The observed variance was decomposed into 
3 sources: additive genetic influences (A), shared environment (C), and non-shared 
environment (E) following Neale and Cardon (1992). For DZ twins and sibling pairs 
similarity in shared environmental influences was fixed at 100% and similarity of additive 
genetic influences at 50%. For MZ twins similarities of additive genetic, and shared 
environmental influences were fixed at 100%. Non-shared environmental influences are 
uncorrelated in all twin and sibling pairs. After establishing the most parsimonious variance 
components model (ACE, AE, CE, or E) for each period of day, a full 4-variate Cholesky 
decomposition was used to test whether the same or different genetic and environmental 
factors influenced heart rate variability at each of the 4 periods of the day.  A priori, we 
expected a single genetic factor to underlie the variance across all 4 periods for both SDNN 
index and RMSSD. This was tested by contrasting a full Cholesky decomposition against a 
genetic factor model, which allows for a common genetic factor and specific additive genetic 
influences at each period. It was further tested whether unique environmental influences could 
also be better described by such a factor structure, or that a Cholesky decomposition should 
be preferred.   
 Nested models were compared by likelihood ratio test, using twice the difference 
between the log-likelihoods of two models, which is asymptotically distributed as χ2. A high 
χ2 against a low gain in degrees of freedom will generate a significant p-value and denotes a 






















Table 4.1 Means (SD) of SDNN index and RMSSD for all daily periods 
N=number of subjects (varies slightly per daily period), MZM=monozygotic male twins, DZM=dizygotic male twins, MZF=monozygotic female 
twins, DZF=dizygotic female twins, DOS=dizygotic twins of opposite sex. Sib m and sib f are male and female singletons.  















Morning 82.3 (30.9) 78.6 (19.5) 67.8 (18.1) 67.3 (18.9) 81.4 (20.9) 72.7 (18.6) 73.9 (21.7) 69.7 (19.4) 
Afternoon 78.5 (28.5) 77.1 (19.9) 64.7 (18.6) 62.5 (16.2) 77.6 (24.3) 68.8 (19.1) 69.0 (20.8) 64.9 (19.9) 
Evening 78.7 (26.4) 83.6 (22.8) 69.7 (23.1) 63.5 (18.0) 82.1 (22.8) 68.4 (20.1) 73.5 (24.4) 66.4 (20.4) 
SDNN 
index (ms) 
Night 89.0 (31.7) 98.8 (26.8) 70.8 (28.9) 70.8 (22.7) 98.2 (27.4) 80.7 (27.2) 88.1 (29.7) 73.7 (24.0) 
Morning 41.1 (26.6) 41.5 (30.1) 31.8 (14.3) 31.8 (16.0) 41.1 (18.7) 36.7 (22.4) 36.1 (17.7) 34.2 (19.1) 
Afternoon 38.7 (22.7) 40.7 (24.5) 32.5 (15.8) 30.5 (12.6) 40.7 (19.5) 36.5 (23.9) 32.9 (14.8) 32.1 (17.9) 
Evening 39.7 (22.4) 46.5 (21.8) 40.5 (21.3) 34.0 (15.3) 46.2 (22.1) 42.2 (39.0) 40.4 (23.2) 36.7 (19.5) 
RMSSD 
(ms) 
Night 57.4 (35.5) 70.8 (35.2) 58.7 (33.9) 49.1 (30.5) 72.0 (37.5) 60.9 (37.1) 59.1 (33.8) 50.7 (25.4) 
Sitting and lying postures only          
Morning 73.5 (25.1) 73.8 (17.0) 64.4 (18.4) 63.3 (20.3) 79.4 (20.4) 67.3 (17.9) 70.7 (23.5) 65.9 (21.4) 
Afternoon 73.3 (26.0) 72.8 (18.4) 61.7 (19.0) 59.0 (16.8) 74.8 (21.7) 65.1 (20.0) 65.7 (20.4) 61.5 (20.5) 
Evening 72.6 (25.0) 77.0 (20.1) 67.0 (24.3) 60.6 (19.8) 80.1 (23.4) 62.6 (17.7) 69.0 (22.9) 63.8 (22.1) 
SDNN 
index (ms) 
Night 85.4 (30.4) 97.1 (25.4) 77.5 (26.2) 69.8 (21.2) 94.7 (23.9) 78.4 (23.0) 85.0 (26.1) 72.4 (21.8) 
Morning 43.7 (28.8) 46.0 (40.1) 35.4 (16.9) 34.6 (19.7) 43.5 (25.7) 43.5 (25.7) 38.7 (21.6) 38.4 (22.8) 
Afternoon 41.0 (26.2) 43.2 (28.8) 36.4 (19.1) 33.4 (14.3) 42.3 (25.2) 42.3 (25.2) 35.5 (17.3) 36.0 (21.6) 
Evening 40.5 (23.6) 47.1 (22.7) 45.2 (27.2) 36.5 (18.1) 46.4 (32.6) 46.4 (32.6) 41.9 (23.9) 40.2 (22.6) 
RMSSD 
(ms) 









The valid ambulatory recording time was on average 22:13 hours (SD = 3:21 hrs), of 
which 51% was spent in a sitting or lying posture. Although the sample was previously 
selected based on the presence of at least two family members with extreme scores on 
personality questionnaires, their scores did not correlate significantly with both SDNN index 
and RMSSD at all, which points out that the results were not biased by this selection criterion. 
At all four periods of day SDNN index was significantly correlated with RMSSD (morning r 
= .83, afternoon r = .86 evening r = .87 and night r = .87). Since the RMSSD distribution was 
skewed at all time periods, its natural logarithm was used in all further analyses. Table 4.1 
presents the untransformed means and standard deviations for SDNN index and RMSSD 
separately for each subject group, using heart rate variability from all postures (upper panel) 
or from fragments of sitting/lying only (lower panel).  
 
Twin & sibling correlations  
Table 4.2 shows the resemblance between MZ and DZ/sibling pairs for SDNN index 
and RMSSD. All correlations were calculated twice: once on all available data and once using 
only fragments where subjects were either sitting or lying. In spite of the potentially large 
effects of differences in posture and physical activity on heart rate variability similarity in 
twins and siblings, the correlations based on sitting/lying-only fragments differed only 
marginally from those that included the entire recording. Although the potential confounding 
by mixing data across different postures had little actual impact, we decided to restrict further 
model fitting to the most “pure” data, i.e. fragments where subjects had been sitting or lying 
(sleep). 
 
Table 4.2 Age-adjusted twin/sibling correlations for SDNN index and RMSSD 
 SDNN index   RMSSD*
 rMZ rDZ&sib  rMZ rDZ&sib 
Men .64/.58 .41/.37  .54/.50 .32/.27 
Women .58/.45 .22/.18  .51/.45 .24/.23 Morning 
OS - .27/.04  - .11/.08 
Men .66/.65 .36/.26  .53/.59 .27/.28 
Women .57/.51 .21/.21  .49/.58 .17/.23 Afternoon 
OS - .27/.07  - .26/.13 
Men .45/.41 .24/.13  .57/.56 .30/.25 
Women .44/.48 .26/.28  .49/.56 .18/.28 Evening 
OS - .17/.13  - .12/.09 
Men .71/.69 .25/.25  .63/.57 .36/.31 
Women .55/.55 .17/.18  .47/.46 .13/.15 Night 
OS - .15/.12  - .18/.14 
* RMSSD was ln transformed to approach normality in the data. Shown are 1) twin correlations based 
on the entire recording including all postures, 2) twin correlations based exclusively on the fragments 
of the recording where subjects were either sitting or lying. OS= opposite sex. Correlations that were 
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Structural equation modeling  
First, we fitted a series of univariate unconstrained models. The means and variances 
of both SDNN index and RMSSD were equal for MZ and DZ twins, and singleton siblings. 
Importantly, equating male or female correlations or DZ correlations to correlations across 
any of the other sib-sib pairings (MZ twin – singleton sibling, DZ twin - singleton sibling, 
singleton sibling – singleton sibling) yielded no significant worsening in the fit of the model. 
This allowed us to reduce the number of parameters to be estimated, but also implies that the 
results obtained in twins can be generalized to singletons. Both RMSSD and SDNN index 
decreased with age in accordance with previous findings (Antelmi et al., 2004) and were 
higher in males at all periods of day. The sex difference for SDNN index and RMSSD repeats 
previous findings (Umetani, Singer, McCraty, & Atkinson, 1998) although the opposite has 
been found for RMSSD (Antelmi et al., 2004). In view of their effects, sex and age were 
retained as covariates in the final variance components analyses. 
 
Table 4.3 Summary of the model fitting results 
RMSSD* 
Model -2LL df p-value Vs. ∆χ² ∆df AIC 
ACE 1 15868.505 2939      
AE 2 15868.720 2949 1.000 1 0.215 10 -19.785 
CE 3 15888.039 2949 .034 1 19.534 10 -0.466 
E 4 15941.199 2959 .000 1 72.694 20 32.694 
ACE 5  15875.789 2941 .026 1 7.284 2 3.284 
AE 6 15875.789 2951 1.000 5 0.000 10 -20.000 
AE 7 15907.917 2953 .000 6 32.128 2 28.128 
SDNN index 
Model -2LL df p-value Vs. ∆χ² ∆df AIC 
ACE 1 24169.084 2874      
AE 2 24169.375 2884 1.000 1 0.291 10 -19.709 
CE 3 24192.712 2884 .000 1 23.337 10 3.337 
E 4 24245.154 2894 .000 1 76.07 20 36.07 
ACE 5 24173.498 2876 0.110 1 4.414 2 0.414 
AE 6 24173.498 2886 1.000 5 0.000 10 -20.000 
AE 7 24192.774 2888 .000 6 19.276 2 15.276 
 Summary of the model fitting results for RMSSD and SDNN index. *To approach normality 
in the data, RMSSD was ln transformed. AIC = Akaike’s information criterion. Bold = best 
fitting model. 
1. Multivariate ACE model in full Cholesky decomposition 
2. Multivariate AE model in full Cholesky decomposition 
3. Multivariate CE model in full Cholesky decomposition 
4. Multivariate E model in full Cholesky decomposition 
5. ACE independent pathway model for A, Cholesky decomposition for C and E 
6. AE independent pathway model for A, Cholesky decomposition for E 
7. AE independent pathway model for all factors 
 
The resulting most parsimonious unconstrained models were contrasted against 
different multivariate variance components models (ACE, AE, CE, and E). Only additive 
genetic (A) and non-shared environmental (E) sources significantly contributed to individual 
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variation in SDNN index and RMSSD. For the additive genetic variance the genetic factor 
model showed the best fit. Unique environmental variance had to be left in full Cholesky 
decomposition. In this final model the common genetic factor explained between 28% and 
45% of the variance in SDNN index and between 32% and 48% of the variance in RMSSD 
(see table 4.3). Specific genetic influences on SDNN index were always present except for the 
afternoon and added between 2% and 12% to total heritability. Specific genetic influences on 
RMSSD were only present in the afternoon and during nighttime sleep and added 2% and 8% 




Individuals characterized by low heart rate variability are at increased risk for cardiac 
events (Tsuji et al., 1996; Dekker et al., 2000; Nolan et al., 1998; Huikuri et al., 2003), sudden 
cardiac death (Bigger et al., 1993) and overall mortality (Tsuji et al., 1996; La Rovere et al., 
1998). Based on prolonged measurements of heart rate variability in naturalistic settings 
obtained in a sample of 772 twins and singleton siblings, the present study showed that 
individual differences in two often used HRV measures, SDNN index (Task Force of the 
European Society of Cardiology and the North American Society of Pacing and 
Electrophysiology, 1996; Janszky et al., 2004) and RMSSD (Task Force of the European 
Society of Cardiology and the North American Society of Pacing and Electrophysiology, 
1996) are to a large extent determined by additive genetic factors. For ambulatory SDNN 
index, heritability estimates from genetic model fitting ranged from 35% to 47%. For 
ambulatory RMSSD, heritability estimates ranged from 40% to 48%. 
 
Table 4.4 Multivariate heritability estimates for SDNN index and RMSSD 
 SDNN index RMSSD*
 Common h2 Specific h2 Total Common h2 Specific h2 Total  
Mo 28% (14 to 44) 7% (2 to 14) 35% 41% (27 to 53) 0% (-4 to 4) 41% 
Af 36% (20 to 50) 0% (-4 to 4) 36% 46% (32 to 59) 2% (-6 to 6) 48% 
Ev 45% (31 to 58) 2% (-8 to 8) 47% 48% (35 to 60) 0% (-3 to 3) 48% 
Ni 31% (18 to 45) 12% (4 to 21) 43% 32% (19 to 45) 8% (2 to 15) 40% 
* RMSSD was ln transformed to approach normality in the data. Mo = morning, Af = 
afternoon, Ev = evening, Ni = night. Shown are the heritability estimates (h2) for SDNN index 
and RMSSD. Total heritability has been specified into heritability caused by shared genetic 
components and heritability caused by time-specific genetic components. Between 
parentheses the 95% confidence intervals are presented. 
 
 Our heritability estimates correspond well to those in a previous study using much 
shorter ambulatory recording periods (<4 hours). Using segregation analysis, the Kibbutzim 
family study (Sinnreich et al., 1999) found genetic influences to account for 45% of age and 
sex-corrected RMSSD. However, our estimate for SDNN index is substantially larger than the 
estimate from a family study based on the Framingham Heart Study and the Framingham 
Offspring study (Singh et al., 1999). In this latter study, SDNN was obtained rather than 
SDNN index. SDNN was averaged over a two-hour fragment obtained during a routine, 
scheduled examination at the Framingham Heart Study clinic. Genetic factors accounted for 
only 19% of the inter-individual variation in SDNN. A major difference in the genetic study 
design might account for these diverging findings. The Framingham studies used spouse and 
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sibling correlations to produce synthetic estimates of variance components. Because a 
significant spouse correlation was found, the resemblance between siblings was attributed in 
part to a shared household. Spouse correlation, however, may also reflect assortative mating 
for exercise behavior, a variable known to be associated with SDNN index (Pardo et al., 
2000). It is of note that the age-corrected sibling correlations in the Framingham study (.23-
.26) correspond very closely to our age-corrected sibling correlations, suggesting that, where 
the studies can be directly compared, they are actually very consistent.  
Our study made use of an extended twin design which strongly increases statistical 
power to distinguish between components A, C and E compared to a design including only 
MZ and DZ twins (Posthuma & Boomsma, 2000). Although there was sufficient power (at 
β=.80, α=0.05) to detect effects of 23% or higher, no significant common environmental 
effect was found. 
The extended twin design further allowed us to test the possibility that results obtained 
on singleton sibling pairs were identical to those obtained in twin pairs. This is important 
because the much lower birth weight in twins might be considered to reflect an impaired fetal 
environment, which according to the “Barker hypothesis” may influence autonomic function 
(IJzerman et al., 2003; Phillips et al., 2000). Monozygotic or dizygotic twins did not differ 
from singleton siblings in means, variances and covariances on any of the measures. The 
absence of any twin-singleton difference repeats previous findings in other cardiovascular risk 
factors (de Geus et al., 2001) and indicates that our results can safely be generalized to the 
population at large. 
We separated the entire ambulatory recording into four periods of day, to allow for the 
possibility that different genetic factors would affect heart rate regulation during awake and 
sleeping periods, or during leisure (evening) and work (morning, afternoon) periods. 
Although evidence was found for separate genetic factors influencing heart rate variability at 
different daily periods, their contribution to the total genetic variance was marginal in 
comparison to the common genetic factor that influenced heart rate variability at all times of 
day. From a gene finding point of view, the common genetic factor structure is advantageous 
on at least two accounts. Using highly genetically correlated multivariate phenotypes can 
yield higher statistical power to find genes in linkage analysis (Allison et al., 1998). Secondly, 
these genes, by virtue of having a pervasive influence on heart rate variability across all 
situations, will also have the largest clinical relevance. This assumes that the genes causing 
low heart rate variability in this relatively young population remain of importance in later life. 
Note that we cannot exclude expression of different heart rate variability genes throughout the 
life span. 
In conclusion, this study provides a strong confirmation that genes are important in the 
regulation of ambulatory heart rate variability, a clinically relevant phenotype for a wide 
range of cardiovascular diseases (Janszky et al., 2004; Huikuri et al., 2003; Tsuji et al., 1996; 
Bigger et al., 1993). The next step is to trace to actual genetic polymorphisms that influence 
ambulatory heart rate variability to provide new angles for preventive therapy. Already, the 
first whole genome screens and candidate gene studies have been initiated (Busjahn et al., 
1998; Singh et al., 2002), and these initiatives should be rapidly extended. Because the power 
to detect genes increases with the availability of genetically correlated repeated 
measurements, we believe ambulatory heart rate variability to be an important asset in the 














Kupper, Nina, Willemsen, Gonneke, van den Berg, Mireille, 
de Boer, Dolf, Posthuma, Daniëlle, Boomsma, Dorret I., de 





Psychophysiology. 2005; 42, 2: 202-212 
 
 




This study assessed the heritability of ambulatory heart period, respiratory sinus arrhythmia 
(RSA), and respiration rate and tested the hypothesis that the well-established correlation 
between these variables is determined by common genetic factors. In 780 healthy twins and 
siblings, 24-hr ambulatory recordings of ECG and thorax impedance were made. Genetic 
analyses showed considerable heritability for heart period (37%-48%), RSA (40%-55%) and 
respiration rate (27%-81%) at all daily periods. Significant genetic correlations were found 
throughout. Common genes explained large portions of the covariance between heart period 
and RSA and between respiration rate and RSA. During the afternoon and night, the 
covariance between respiration rate and RSA was completely determined by common genes. 
This overlap in genes can be exploited to increase the power of linkage studies to detect 








The difference in heart period during the inspiratory and expiratory phases of the 
respiratory cycle is known as respiratory sinus arrhythmia (RSA). RSA is affected in a dose-
response way by muscarinergic blockers or vagal cooling and is regarded to be a valid 
non-invasive index of cardiac vagal tone (Berntson et al., 1997; Task Force of the European 
Society of Cardiology and the North American Society of Pacing and Electrophysiology, 1996). 
Various time and frequency domain measures of RSA have become available that produce 
highly comparable results in both clinical and experimental settings (Grossman et al., 1990; 
Penttila et al., 2001; Bigger, Jr. et al., 1992; Grossman, Wilhelm, & Spoerle, 2004).  
Studies in males and females in all age groups, using either patients or healthy controls, 
have collectively shown the existence of large individual differences in RSA (Grossman & 
Kollai, 1993; Ben Lamine et al., 2004). Studies examining these individual differences have 
demonstrated that lower values of RSA are associated with higher risk for cardiac disease 
(Singer et al., 1988; Bigger, Jr. et al., 1995; La Rovere et al., 1998) and hypertension (Liao et al., 
1996; Mussalo et al., 2001). Reduced RSA is also associated with anxiety (Thayer, Friedman, & 
Borkovec, 1996; Watkins, Grossman, Krishnan, & Sherwood, 1998), posttraumatic stress 
disorder (Cohen et al., 1997) and, prospectively, with major depressive disorder (Rottenberg, 
Wilhelm, Gross, & Gotlib, 2002). The link between RSA amplitude and behavioral engagement 
can already be found in children of 3 months of age (Bazhenova, Plonskaia, & Porges, 2001) and 
children aged 5 to 6 years (Doussard-Roosevelt, Montgomery, & Porges, 2003).  
In view of the potential relevance of individual differences in RSA to index future 
disease, insight is needed into its genetic and environmental origins. The twin design is a 
powerful method to do so (Boomsma et al., 2002; Neale & Cardon, 1992). A twin study 
compares the intra-pair resemblance for a certain trait in identical twins to the trait resemblance 
in fraternal twins. This allows the estimation of the relative contribution of genetic and 
environmental factors to variance in the trait. In addition, separate contributions can be estimated 
for environmental factors shared by all family members (“C”) and environmental factors unique 
(“E”) to each family member (including measurement error). Shared environment may include 
effects of parental socioeconomic status, diet, rearing style and parental guidance in lifestyle 
choices (e.g. exercise). To obtain sufficient statistical power to detect significance of such shared 
environmental influences, large samples of twins are needed. Power can be further increased by 
adding one or more non-twin siblings of the twins (Posthuma & Boomsma, 2000). This 
“extended twin design” was adopted in the current study, where RSA was obtained in 527 twins 
and 253 of their singleton siblings. 
In previous twin studies, a significant genetic contribution to RSA has already been 
established. Heritability estimates ranged from 13% to 39% (Boomsma et al., 1990; Sinnreich 
et al., 1999; Snieder et al., 1997; Singh et al., 1999; Busjahn et al., 1998). The above 
estimates, however, were all based on the variance in RSA observed under resting conditions. 
Additional variance may appear under physical and psychological challenge, which is known to 
significantly reduce the mean value of RSA in most subjects, although large individual 
differences in the magnitude of RSA responsiveness are found (Houtveen, Rietveld, & De 
Geus, 2002; Cacioppo et al., 1994b). Using a comparable set of stressors, two large twin studies 
have shown a relative increase in genetic variance during stress (Boomsma et al., 1990; Snieder 
et al., 1997). Heritabilities for RSA level found at rest (24% in the adolescents, 31% in the 
middle-aged) increased substantially during a reaction time and mental arithmetic task (up to 
51% in adolescents, and 43% in the middle-aged). This suggests that genetic influences are 
more pronounced when the subject is challenged by mentally and emotionally taxing tasks. 
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Accordingly, we hypothesize that heritability of RSA will be even higher when recorded over 
prolonged periods of time in a naturalistic setting since such challenges are more likely to be 
encountered in daily life. A first aim of the present study is to assess heritability of 
ambulatory measured RSA levels across an entire day and night. 
 Many studies have documented a significant covariance between RSA and heart 
period at rest and during laboratory challenges (Sahar, Shalev, & Porges, 2001; Medigue et 
al., 2001). Short heart periods, just as low levels of RSA, have been shown to predict 
cardiovascular disease (Dyer et al., 1980; Kannel, et al., 1987; Jouven, Zureik, Desnos, 
Guerot, & Ducimetiere, 2001). In addition, heart period is significantly shorter in subjects 
with psychiatric disorders (Carney et al., 1988; Austen & Wilson, 2001; Rechlin, Weis, 
Spitzer, & Kaschka, 1994; Lehofer et al., 1997). A straightforward interpretation of RSA and 
heart period covariance is that low RSA and short heart period both index low cardiac vagal 
tone. These correlated risk factors may further reflect a common genetic susceptibility, for 
instance through genes influencing parasympathetic nervous system activity. Only a single 
study has addressed the possibility of a genetic contribution to this association (De Geus, 
Boomsma, & Snieder, 2003). Common genes were indeed found to explain a large part of the 
association between the resting levels of heart period and RSA, although significant 
contribution was also found for unique environmental factors. To date, no studies have tested 
the contribution of genes and environment to the association of heart period and RSA under 
mentally challenging or naturalistic conditions. 
  A similar state of affairs applies to the significant covariance between RSA and 
respiration rate. Many studies have testified to the robustness of this association, at rest, 
during laboratory challenges, and during ambulatory recordings (Kollai & Kollai, 1992; de 
Geus et al., 1995; Snieder et al., 1997; Grossman & Kollai, 1993; Grossman et al., 2004), but 
only a single study has examined the source of the association in a genetically informative 
design (Snieder et al., 1997). Here, respiration rate-RSA covariance seemed to be due to 
overlap in both genetic and nonshared environmental factors contributing to these variables, 
both at rest and during a set of mental stress tasks. Nothing is currently known, however, 
about the genetics of the respiration rate-RSA covariance in naturalistic settings. 
 In short, the previous two bivariate twin studies on the genetics of RSA and heart 
period and the genetics of RSA and respiration rate were performed in a laboratory setting. 
No study has addressed the genetic architecture of the association between ambulatory heart 
period and RSA and ambulatory RSA and respiration rate. Furthermore, no trivariate genetic 
analysis of heart period, RSA and respiration rate has been performed to date, and the possible 
contribution of common genes to heart period and respiration rate remains to be determined. 
A second aim of this study, therefore, is to estimate the relative contribution of common 
genetic and environmental factors to the covariance between heart period, RSA and 





Subjects were all registered in the Netherlands Twin Register (NTR). Their families 
were originally selected for a genetic linkage study searching for genes for depression, which 
is described elsewhere (Boomsma et al., 2000). Of the 1332 offspring who returned a DNA 
sample (buccal swabs) for the linkage study, 1008 were successfully contacted for a 
cardiovascular ambulatory monitoring study, of which 192 refused or were excluded. In total 
816 subjects were willing to participate in cardiovascular ambulatory monitoring. A priori 
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reasons for exclusion were pregnancy, heart transplantation, presence of a pacemaker and 
known ischemic heart disease, congestive heart failure, or diabetic neuropathy. For 14 of the 
816 subject recordings were unavailable due to equipment failures while 8 subjects had either 
a noisy ECG or a noisy thorax impedance signal, and were therefore excluded from the 
analysis. Fourteen subjects using rhythm-altering medication, heart rate variability-reducing 
antidepressants (tricyclic antidepressants and benzodiazepines), antihypertensive medication 
(β-blockers), or a combination of these were excluded from the analysis. The final sample 
consisted of 222 identical twins (80 men), 305 fraternal twins (109 men) and 253 singleton 
siblings (97 men) from 339 families. Mean age was 31.0 years (SD = 10.8). Zygosity of the 
twins was determined by DNA typing. The Ethics Committee of the Vrije Universiteit 
approved of the study protocol and all subjects gave written consent before entering the study. 
No payment was made for participation, but all subjects received an annotated review of their 
ambulatory ECG recording.  
 
Ambulatory measurements 
The Vrije Universiteit Ambulatory Monitoring System 46 (VU-AMS) continuously 
recorded the electrocardiogram (ECG) and changes in thoracic impedance (dZ) from a six-
electrode configuration (de Geus et al., 1995; de Geus & van Doornen, 1996; Riese et al., 
2003). The device automatically detects each R wave in the ECG signal, at which it reads out 
and resets a millisecond counter to obtain the heart period time series. The thoracic impedance 
(Z), assessed against a constant current of 50 KHz, 350 microamperes, was amplified and lead 
to a precision rectifier. The rectified signal was filtered at 72 Hz (low pass) to give basal 
impedance Z. Filtering Z at 0.1 Hz (high pass) supplied the dZ signal, which contains three 
major components: high frequent impedance changes due to the ejection of blood into the 
aorta during systole, low frequent impedance changes due to arm and upper body movement, 
and, in between these frequencies, the thoracic impedance changes due to respiration. 
Intervals of 100 seconds of the dZ signal were band-pass filtered with 0.1 and 0.4 Hz cut-offs 
after tapering with (sin(x))2 to yield the respiration signal. 
 VU-AMS software (www.psy.vu.nl/vu-ams) was used to display the recorded heart 
period time series as a cardiotachogram together with the respiration signal. Suspected 
erroneous R wave detection (e.g. due to ectopic beats) was automatically tagged for deletion. 
The starting points of inspiration and expiration were automatically scored for each breath, 
but interactive visual inspection allowed correction of erroneous respiration scoring or the 
selective removal of noisy signal fragments. From the corrected signal, mean heart period, 
respiration rate and RSA were computed. RSA was determined using the peak-to-trough 
method (Grossman et al., 1990; Fouad et al., 1984; Grossman & Kollai, 1993), which 
combines respiratory time intervals and the heart period time series to obtain an RSA value at 
each breath. This method yields highly comparable results to frequency domain based 
methods (Grossman et al., 1990) and has the advantage of additionally providing the 
respiratory frequency. RSA was computed for each breath as the difference between the 
shortest heart period during heart rate acceleration in the inspirational phase (which was made 
to include 1000 milliseconds from the following expiration to account for phase shifts) and 
the longest heart period during deceleration in the expirational phase (including 1000 
milliseconds from the following expiratory pause/ inspirational phase). When no phase-
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Procedure 
Subjects were visited at home, before starting their normal daily activities. During a 
short interview, information on health status and current medication use was obtained. The 
VU-AMS was attached and its operation explained. Subjects were instructed to wear the 
device the entire day and night up until awakening the next morning. Written instructions 
were supplied that explained how to respond to potential alarm beeps (e.g. on loose electrode 
contacts), and telephone assistance was available during waking hours. Subjects were asked to 
keep a detailed diary. Every 30 (± 10) minutes the device produced an audible alarm beep to 
prompt them to write down a chronological account of activity, posture, location, social 
situation, and amount of perceived stress during each past 30 minutes. On the following day 
the researcher collected the device at home.  
 
Statistical analysis 
Data reduction - In addition to the cardio-respiratory measures, the VU-AMS device also 
recorded vertical acceleration. Accelerometer output was averaged every 30 seconds, and 
used as a proxy for gross body movement. Time-stamped information from the diary about 
activity and posture was combined with an interactive graphical display of body movement as 
a function of time, which made it possible to accurately specify the exact start and end times 
of the changes in activity or posture that the subjects had reported in the diary. We divided the 
entire recording into smaller intervals that were completely stationary with regard to physical 
activity and posture. Each interval was coded for posture (lying, sitting, standing, walking and 
bicycling), activity (e.g. deskwork, housekeeping, watching TV), and location (e.g. at home, 
at work, at a public place). The coded intervals were never shorter than 5 minutes or longer 
than 1 hour. Based upon the reported times of dinner and lunch, awakening and bedtime, 4 
averages were computed over all coded intervals available for each of the 4 periods of the 
day: morning, afternoon, evening and nighttime. Averages were computed once using all 
posture data and once using only those intervals when subjects were sitting or lying. In 8% of 
the subjects the exact time of dinner, lunch, awakening or bedtime could not be extracted 
from either diary or body movement. For these subjects, the missing time was imputed using 
the mean times of these events in the rest of the sample.  
 
Confounding variables - Individual differences in the ambulatory physiological variables 
were expected to be sensitive to three main confounding variables: differences in age, sex (De 
Meersman, 1993; Umetani et al., 1998), and physical activity patterns (Sacknoff, Gleim, 
Stachenfeld, & Coplan, 1994; Osterhues et al., 1997). To control for the first two of these 
variables, all correlation coefficients were age-adjusted, and calculated separately for the 
sexes. In model fitting analysis it was specifically tested whether the effects of sex and age on 
the means and variances could be dismissed from the model. To examine the influence of 
possible individual differences in physical activity patterns, analyses were performed twice; 
once using the averages based on all postures and once using the averages based on the data 
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Twin correlations - To determine to what extent monozygotic twins are more similar than 
dizygotic twins or singleton siblings Pearson correlation coefficients were calculated for all 
groups, using SPSS software (SPSS Inc., Chicago, USA). In the computation of these 
correlations, fraternal twin pairs and singleton siblings were regarded as a single group, since 
these pairs all share on average 50% of their genetic material (this assumption was tested in 
the model fitting). All possible fraternal twin pairs or sib pairs that could be formed within a 
family were used. 
 
Structural equation modeling - In order to answer the question to what extent genes, common 
environment and unique environment contribute to the variances and covariances between the 
three variables (heart period, RSA and respiration rate), a biometrical genetic model was fitted 
to the observed data using the structural equation program Mx (Neale et al., 2003). First, a 
series of unconstrained models was fitted to test the equality of means and variances for 
identical twins, fraternal twins, and singleton siblings. We then examined the presence of sex 
effects on the means and variances. Next, the significance of a linear regression of age on the 
three variables was tested. Lastly, we tested for heterogeneity of correlations of males versus 
females and of fraternal twins versus singletons. The resulting most parsimonious saturated 
model indicated to what extent we could limit the specification of the variance components 
models. 
 The main questions were addressed in various nested trivariate (heart period, RSA and 
respiration rate) variance components models. In a twin study, the observed variance can be 
decomposed in four possible latent sources of variance: additive genetic effects (A), non-
additive genetic effects (D), shared environment (C), and non-shared environment (E) 
following Neale and Cardon (1992). However, in a design that includes identical twins, 
fraternal twins and sib pairs, estimates of C and D are confounded and the observed variances 
and covariances only provide sufficient information to model either an ACE model or an 
ADE model, but not both. Based on the pattern of twin and sibling correlations we choose to 
model A, C and E. For identical twins, fraternal twins and sibling pairs alike, similarity in 
shared environmental influences was fixed at 100%. Similarity of additive genetic influences 
was fixed at 50% for siblings and fraternal twins and at 100% for identical twins. Per 
definition, there was no similarity in the non-shared environmental influences. 
 For each of the four periods of day, a full trivariate ACE model in Cholesky 
decomposition (Neale & Cardon, 1992) was tested against the nested more parsimonious AE, 
CE or E models. The resulting best fitting model was used to further test the source of the 
observed covariance between the three variables. Specifically we tested the comparative fit of 
models with the genetic or environmental correlations set to zero, and of models with genetic 
or environmental correlations set to 1, i.e. models in which a single genetic or environmental 
factor influenced heart period, RSA, and respiration rate. 
  Throughout, nested models were compared using the likelihood ratio test. In addition, 
Akaike's Information Criterion (AIC= χ2 – 2df) (Akaike, 1987) was calculated for each 
model, which offers a quick approach to judging the fit of nested models. Those with lower 
(i.e., larger negative) values fit better than models with higher values. The final best fitting 
most parsimonious model was used to estimate the genetic and environmental contribution to 
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Table 5 .1 Means (SD) and correlations for heart period, RSA and respiration rate 
 Morning Afternoon Evening Night 
Heart period (ms)    
Men 847 (126) 811 (121) 854 (122) 1058 (139) 
Women 764 (101) 752 (94) 793 (104) 937 (109) 
lnRSA (ln(ms))    
Men 3.8 (0.4) 3.7 (0.5) 3.7 (0.5) 3.9 (0.5) 
Women 3.9 (0.5) 3.8 (0.5) 3.9 (0.5) 4.0 (0.5) 
Respiration rate (breath/minute)   
Men 16.3 (1.4) 16.7 (1.4) 17.5 (1.6) 15.4 (2.0) 
Women 16.3 (1.3) 16.8 (1.3) 17.4 (1.6) 16.1 (2.0) 
Heart period & lnRSA correlation   
Men .48** .52** .48** .46** 
Women .47** .48** .47** .43** 
Respiration rate & lnRSA correlation   
Men -.26** -.23** -.26** -.32** 
Women -.21** -.14* -.23** -.28** 
Shown are means (SD) and correlations for each period of day, separately for the sexes.   




The average duration of valid measurement was 22:13 hrs (sd = 3:21 hrs). RSA was 
skewed at all daily periods and its natural logarithm was used in all further analyses. Figure 
5.1 gives scatterplots of heart period and lnRSA and of lnRSA and respiration rate. Complete 
measurements during sitting activities were obtained in 689 subjects for all four periods of the 
day, in 91 subjects one or more periods were missing. Since part of the sample (two in each 
family) was originally selected for a study in search for genes influencing anxious depression, 
Pearson correlation coefficients were computed between a summary score of anxious 
depression (see (Boomsma et al., 2000) for more details) and our ambulatory variables. No 
meaningful association was found suggesting that the sample selection was unbiased.  
Repeated measures ANOVA showed a significant between-subject effect of sex for 
heart period (F (1,688) = 112.6, p < .001), lnRSA (F (1,688) = 7.8, p < .01) and respiration 
rate (F (1,688) = 4.3, p < 0.05). Male heart period, lnRSA and respiration rate were lower than 
female heart period, lnRSA and respiration rate at all periods of day. A significant effect of 
the daily period was found for heart period (F (3,686) = 1263.8, p < .001), lnRSA (F (3,686) = 
55.4, p < .001) and respiration rate (F (3,686) = 203.9, p < .001). This was entirely due to a 
decrease in respiration rate together with an increase in heart period and lnRSA during sleep 
in contrast to all three waking periods. Means and standard deviations of the variables are 
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Table 5.2 Age-adjusted twin and sibling correlations for heart period, RSA and 
respiration rate 
 Respiration rate lnRSA Heart period 
 MZ DZ/sib MZ DZ/sib MZ DZ/sib 
Morning Corr. .21 .15 .46 .21 .60 .31 
 N pairs 90 573 91 573 91 573 
Afternoon Corr.  .42 .22 .51 .24 .55 .34 
 N pairs 90 570 91 570 92 570 
Evening Corr.  .50 .21 .58 .24 .46 .28 
 N pairs 89 589 90 589 90 589 
Night Corr. .83 .50 .61 .27 .62 .38 
 N pairs 87 543 88 543 88 543 
Correlations that were significant (p<.05) are printed boldfaced. MZ = identical twin pairs, 
DZ/sib = fraternal twin or sibling pairs N pairs = number of pairs of subjects. 
 
Twin & sibling correlations  
Correlations were computed twice. For the waking periods (morning, afternoon, 
evening) data were used 1) from the entire recording period, that is including different levels 
of physical activity and multiple postures, or 2) from periods with sitting activities only. In 
spite of the potential confounding effects of individual differences in the frequency of postural 
changes and physical activity, virtually identical patterns of twin and sibling correlations were 
obtained when either all data were used or sitting only data. To avoid possible interpretations 
based on movement artifact, however, we confined further analyses to intervals which 
involved a constant sitting posture (which comprised 51% of the total recording time).  
Table 5.2 shows the resemblance between identical twins and fraternal twins/sibling 
pairs for heart period, lnRSA and respiration rate. It is immediately obvious from the 
systematically larger identical twin than fraternal twin/sib correlations that genetic factors 
influence all three variables. The increase in identical twin correlation for respiration rate at 
night further suggests higher heritability during sleep.  
 
Structural equation modeling  
Several assumptions of the extended twin design were tested in a series of unconstrained 
models. All morning, afternoon, evening and nighttime means of heart period, lnRSA and 
respiration rate could be set equal for identical twins, fraternal twins and siblings without a 
significant loss of fit of the model. Dropping the linear regression effect of age or sex on all 
variable means, however, significantly worsened the fit. The variances were homogeneous 
across zygosity and across sex. Likewise, testing for heterogeneity in the correlations across 
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Figure 5.1 Scatter plots for daytime and nighttime 
 
Plots are collapsed over sex, visualizing the relation between lnRSA and respiration rate and 
between lnRSA and heart period respectively.  HP= heart period, RR= respiration rate. 
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Importantly, equating fraternal twin correlations to correlations across any of the other 
sib-sib pairings (identical twin - singleton sibling, fraternal twin - singleton sibling, singleton 
sibling - singleton sibling) produced no significant worsening in the fit of the model. 
Although the main aim here was to reduce the number of parameters to be estimated, note that 
these results imply that the estimates obtained in twins can be generalized to singletons.  
The resulting most parsimonious model (no sex or twin-singleton effects on variances or sib-
pair covariances) was used to test four separate trivariate variance decomposition models, for 
each period of day (morning, afternoon, evening, and night). For all three variables the shared 
environmental component (C) could be removed without a significant loss in fit (see table 
5.3). This resulted in models that included only the additive genetic and unique environmental 
variance components (AE model). From this AE model we could not dismiss any of the 
genetic correlations between respiration rate, lnRSA, and heart period. The full three factor 
model also had to be maintained for most of the unique environmental influence, with a few 
notable exceptions, visualized as the non-significant paths in figure 5.2. A striking reduction 
in the importance of the environmental influences was seen at night, when both the covariance 
between respiration rate and heart period and between respiration rate and lnRSA became 
entirely genetic in origin. The final best fitting models for each of the periods of day are 
shown in figure 5.2.  
Heritability is sum of the genetic variance due to factors A1 to A3 divided by the total 
variance (see footnote figure 5.2 for a computational example). Table 5.4 gives the heritability 
estimates for respiration rate, lnRSA and heart period under the best fitting models (boldfaced 
rows in table 5.3). Heritability estimates for respiration rate were all significant, but varied 
greatly over the four daily periods. During waking hours, heritability ranged between 27% 
and 50%. At night, however, it increased up to 81%. To investigate whether it is a decrease of 
environmental variance or an increase of genetic variance that causes the heritability estimate 
to increase so dramatically at night, we examined the changes in absolute variances. We 
found that variance attributed to genetic effects increased much more over the four periods of 
day compared to the decrease found in the variance ascribed to unique environmental effects. 
As can be seen in figure 5.2 the increase in genetic variance from evening to night for 
respiration rate is 196.3 (=18.02-11.32), while the decrease in environmental variance is 52.0 
(=8.72 – 11.32). Thus, the increased heritability for respiration rate during the night is caused 
mainly by increased genetic variance in respiration rate during the night.  
Heritability estimates for lnRSA ranged from 40% in the morning to 55% in the 
evening. As can be calculated from the path coefficients, the contribution of genes shared 
with respiration rate (genetic factor A1) to the heritability of lnRSA was between 8% 
(evening) and 16% (night). Since it has been suggested that RSA corrected for respiration rate 
would be a better predictor than uncorrected RSA (Grossman et al., 2004), we did an 
additional genetic analysis for respiratory-corrected RSA. These heritability estimates were 
38%, 47%, 46% and 46% for the daily periods respectively, which is lower than the estimates 
for uncorrected RSA in the multivariate analyses. 
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Figure 5.2 The most parsimonious decomposition of variances and covariances for 
respiration rate (RR), lnRSA and heart period (HP) 
Afternoon 
 
For each of the daily periods, factor A1 represents the genetic influences on respiration rate, 
which are partly shared with lnRSA and heart period. Factor A2 represents the genetic 
influences on lnRSA, which are partly shared with heart period, but unshared with respiration 
rate. Factor A3 represents the remaining genetic influences on heart period that are unshared 
with respiration rate and lnRSA. Notation for the unique environmental factors (E1 through 
E3) follows analogous reasoning. The numbers next to the paths represent the unstandardized 
path coefficients. Non-significant paths are indicated by dotted lines. Heritability can be 
computed by standardizing these coefficients following path tracing rules. For example, 
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 Table 5.3 Summary of the model fitting results  
Morning 
Model Versus ∆df χ2 p AIC 
ACE       
AE ACE 6 3.644 0.725 -8.356 
CE ACE 6 11.128 0.085 -0.872 
E ACE 12 80.956 0.000 56.956 
Reduced AE1  AE 7 4.295 0.420 -9.705 
Afternoon 
Model Versus df χ2 p AIC 
ACE  - - - - - 
AE ACE 6 1.963 0.923 -10.037
CE ACE 6 15.354 0.018 3.354 
E ACE 12 89.743 0.000 65.743 
Reduced AE2  AE 7 3.171 0.272 -10.829
Evening 
Model Versus ∆df χ2 p AIC 
ACE       
AE ACE 6 1.51 0.959 -10.49 
CE ACE 6 23.93 0.001 11.93 
E ACE 12 120.773 0.000 96.773 
Night 
Model Versus ∆df χ2 p AIC 
ACE       
AE ACE 6 4.164 0.654 -7.836 
CE ACE 6 40.584 0.000 28.584 
E ACE 12 222.107 0.000 198.107
Reduced AE3  AE 8 5.606 0.486 -10.394
Summary of the model comparison results for each daily period.  
1 no rE between respiration rate and heart period, 2 no rE between respiration rate and 
lnRSA, 3 no rE between respiration rate and lnRSA and between respiration rate and heart 
period. Shown are fit statistics for models with additive genetic, common environmental and 
unique environmental (ACE) influences, additive genetic and unique environmental (AE) 
influences, common and unique environmental (CE) influences and unique environmental (E) 
influences. The full models include all genetic (rA) and unique environmental (rE) 
correlations between respiration rate, lnRSA and heart period. All associations between the 
variables have been tested for significance, only the best fitting most parsimonious model is 
presented. Boldfaced rows represent the model that fitted the data best. Low p values denote 
significant worsening of fit. AIC = Akaike’s Information Criterion.  
 
Heritability estimates for heart period ranged from 37% in the morning to 48% at 
night. The contribution to this heritability of genes that are shared between respiration rate 
and heart period was between 1% (morning) and 4% (afternoon). The contribution of genes 
shared only with lnRSA (genetic factor A2), which may reflect genes affecting cardiac vagal 
control, was between 6% (night) and 17% (afternoon). This leaves a substantial unique 
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genetic influence (genetic factor A3) on heart period, which may reflect genetic effects on the 
intrinsic pacemaker frequency and the sympathetic nervous system. 
Table 5.5 shows the standardized covariances (correlations) between respiration rate, 
lnRSA and heart period (upper off-diagonal elements), as well as the standardized genetic 
contributions to the covariance between these three variables (lower off-diagonal elements). 
The genetic contribution to the covariance between two variables is calculated as the ratio of 
the genetic covariance (which is the genetic correlation between two variables and the product 
of the squared roots of the two heritabilities) to the total observed covariance. The remaining 
part of all covariances is explained by unique environmental factors. The correlation between 
morning lnRSA and respiration rate, for instance, is -0.23, with genes contributing 62% to this 
covariance and unique environment 38%. 
 
Table 5.4 Heritability estimates for respiration rate, RSA and heart period 
 Respiration rate lnRSA Heart period 
h2 morning 27% (12 to 41) 40% (27 to 54) 37% (24 to 50) 
h2 afternoon  44% (28 to 57) 49% (34 to 59) 45% (28 to 54) 
h2 evening 50% (37 to 61) 55% (43 to 65) 40% (24 to 53) 
h2 night 81% (74 to 86) 54% (41 to 64) 48% (26 to 68) 
Shown are the heritability estimates (h2) for respiration rate, RSA and heart period, under the 
best fitting models. The 95% confidence intervals are presented in parentheses. All values are 
significant at a .05 level. 
 
lnRSA and heart period covaried significantly at all four periods, with correlation 
coefficients ranging between .35 and .45. The contribution of common genetic factors to the 
heart period-lnRSA covariance between the measures varied between 30% and 52%. The 
correlations between respiration rate and lnRSA were all significant and ranged between -.17 
and -.24. The contribution of common genetic factors to the respiration rate-lnRSA 
covariance varied between 62% and 100%. The correlation between respiration rate and heart 
period was only significant at night (-.19). All of this respiration rate-heart period covariance 




This study assessed the heritability of ambulatory heart period, RSA and respiration rate 
in 339 families and tested the hypothesis that the covariance between these variables is caused by 
common genetic factors. Our study had a number of strengths in design that provide 
confidence in its outcome. The extended twin design increases statistical power to distinguish 
between genetic and common and unique environmental influences compared to a design that 
includes only identical and fraternal twins (Posthuma & Boomsma, 2000). Furthermore, it 
allowed us to show that results obtained in singleton siblings do not differ from those 
obtained in twins. The absence of any twin-singleton difference replicates previous findings in 
other cardiovascular risk factors (de Geus et al., 2001) and indicates that our heritability 
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Table 5.5a-d Standardized covariances between respiration rate, lnRSA and heart 
period and the genetic contributions to these covariances  
Morning  
 Respiration rate lnRSA Heart period 
Respiration rate - -.23  -.07  
lnRSA 62% (34 to 85) -  .42  
Heart period 100%  30% (10 to 48) - 
Afternoon  
 Respiration rate lnRSA Heart period 
Respiration rate -  -.17  .02  
lnRSA 100% -  .45  
Heart period 45% (13 to 72) 52% (32 to 66) -  
Evening  
 Respiration rate lnRSA Heart period 
Respiration rate - -.24 .01  
lnRSA 69% (37 to 96) - .42  
Heart period 49% (3 to 95) 47% (28 to 63) -  
Night  
 Respiration rate lnRSA  Heart period 
Respiration rate - -.27 -.19 
lnRSA 100% - .35 
Heart period 100% 49% (27 to 68) - 
Significance at a .05 level is indicated in bold. The upper-diagonal elements report the 
standardized phenotypic covariances between the variables (=correlations), while the lower-
diagonal elements show the genetic contributions (%) to these covariance. The 95% 
confidence intervals are presented in parentheses. Note that a non-significant correlation 
between the variables can still have significant genetic contributions, if the genetic and 
unique environmental correlations are of opposite sign, as was the case for daytime 
correlations between heart period and respiration rate.  
  
The current study estimated the heritability of RSA to lie between 40% and 55%. This 
agrees with a previous twin study, in which RSA heritability (based on spectral power in the 
heart period time series) was estimated at 39% across a short 30 minute recording interval in 
141 twin pairs (Busjahn et al., 1998). On the other hand, using a sib-parent design, Singh and 
colleagues (1999) found that genetic factors accounted for only 16% of the interindividual 
variation in high frequency power. In that study, however, high frequency power was 
obtained from a two hour interval recorded during a routine examination at the Framingham 
Heart Study clinic, which is more similar to a laboratory, rather than ambulatory, recording. 
Other laboratory twin studies have also reported more modest heritability estimates for resting 
RSA, varying from 19% to 31% (Boomsma et al., 1990; Snieder et al., 1997).  
 When RSA is measured during stressful tasks, however, heritability increases to reach 
levels comparable to those found in the current ambulatory study (Snieder et al., 1997).This 
pattern of results is in keeping with the idea that under conditions of challenge or in 
naturalistic settings other (or more) aspects of cardiovascular regulation come into play, 
allowing genetic differences between individuals to become more pronounced (See also 
Boomsma et al., 1998). However, it is unclear whether the effects of the same genetic factors 
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that operate at rest are amplified by stress, or whether new genetic factors emerge during 
stress. Heritability estimates do not tell us which genes are contributing in what way. It may 
well be that different genetic pathways operate to affect resting RSA measured in a 
standardized setting compared to ambulatory RSA recorded over prolonged periods of time in 
a naturalistic setting.  
Indeed, it is possible that genes that cause low RSA at rest act to cause high RSA 
under ambulatory conditions.  This could explain the apparent contradiction in two studies 
that have examined the genetic basis of RSA by a candidate gene approach. An ambulatory 
study by Busjahn et al. (1998) in Caucasian twins, found that subjects homozygous (DD) for 
an insertion/deletion polymorphism in intron 16 of the angiotensin-converting enzyme gene 
had significantly higher levels of ambulatory RSA. The opposite finding was found, however, 
using laboratory recordings in African American subjects (Thayer et al., 2003). Although 
ethnicity was invoked as a plausible explanation for the discrepancy in results, contribution of 
the difference in ambulatory versus laboratory design cannot be excluded.  
In the present study, heritability of ambulatory heart period is estimated between 37% 
and 48%. Previous twin studies that assessed the heritability of ambulatory heart period 
(Fagard et al., 2003; Jedrusik et al., 2003) estimated heritability of the 24 hour mean of heart 
period to be slightly higher, between 51% and 70%. When we compare all estimates from 
ambulatory studies (including our own) to the published twin data on resting laboratory 
values, we find no evidence that the heritability of heart period increases in ambulatory 
recordings over laboratory recordings as it did for RSA. Laboratory studies in adult twins 
have reported heritabilities of resting heart period to lie between 50% and 77% (Ditto, 1993; 
Russell, Law, Sholinsky, & Fabsitz, 1998; Li et al., 2001; Fagard et al., 2003). It should again 
be noted that the same heritability may arise from different genetic pathways influencing heart 
period in different measurement settings.  
 In the present study the genetic contribution to the variance in daytime respiration rate was 
between 27% and 50%. Only one previous study reported on the heritability of respiration rate. 
In that study respiration rate was measured under rest and stress conditions in a laboratory 
setting (Snieder et al., 1997). The genetic component of variance was estimated around 62% 
for the resting condition and between 51 and 60% for stress conditions. The lower estimates 
in our study compared to Snieder et al. (1997) may reflect the fact that during the laboratory 
experiment there was no talking. Talking influences respiration and increases the 
environmental component of the variance decomposition to the detriment of the genetic 
component. Interestingly, in the current study a strong increase in the heritability of 
respiration rate was seen at night, suggesting that respiration rate is more under genetic 
control during sleep. Neurobiologically, this makes good sense. During sleep respiratory 
frequency will most purely reflect intrinsic rhythmogenesis by the brainstem and some 
aspects of respiratory rhythmogenesis may even be entirely specific to sleep (Mackiewicz & 
Pack, 2003). Indeed, heritability increased mainly because of an increase in total genetic 
variance, suggesting that new genetic variation is being expressed during sleep. This clearly 
demonstrates the advantage of ambulatory recording over resting recordings, in particular the 
added value of nighttime recordings.  
 
Genetic contributions to the covariances 
RSA was significantly correlated to respiration rate and heart period. About 6% of the 
between-subject variance in RSA was explained by respiration rate, which is comparable to 
the association found in many laboratory studies (Houtveen et al., 2002; Grossman & Kollai, 
1993; Ritz, Thons, & Dahme, 2001). The association between ambulatory RSA and heart 
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period was stronger, with RSA explaining about 25% of the between-subject variance in heart 
period. This is again comparable to what is found in laboratory settings (Sahar et al., 2001; De 
Geus et al., 2003; Medigue et al., 2001). A significant association between heart period and 
respiration rate was found at night only and this association was completely due to genetic 
effects.  It should be noted that our focus was on between-subject covariance only. Much 
higher correlations between respiration rate and RSA and RSA and heart period are found in a 
pure within-subject analysis of ambulatory recordings (Grossman et al., 2004).  
 In agreement with our hypothesis, significant genetic correlations between heart period, 
RSA and respiration rate were found at all periods of the day. This suggests that common 
genes influence individual variation in respiration rate, RSA and heart period. The genetic 
correlations are not unity, though, suggesting that additional unique genes contribute to each 
of the variables. It is important to note here that our results do not reveal the exact causal 
chain of events that give rise to the common genetic factor. The common genetic factor may 
act entirely through one of the traits, i.e. they may influence respiration rate, which influences 
RSA, which in turn influences heart period. It may also primarily affect heart period, which in 
turn affects respiration rate and RSA, possibly through baroreflex action on respiratory 
generator neurons. Finally, the common genetic factor may reflect pleiotropic genes that 
influence each of the traits, but without any causal effects of the traits on each other. 
Pleiotropic genes simultaneously affecting between-subject variance in respiration rate, RSA, 
and heart period may be found at different levels. They may reflect individual differences in 
the general state of arousal, for instance as part of neuroticism or depression (Carney et al., 
2001) that would affect both respiratory drive and tonic vagal drive. A pleiotropic genetic 
basis of respiration rate, RSA and heart period may also derive from genes affecting general 
aspects of neurotransmission (e.g. serotonergic receptors or secondary signaling proteins) in 
either limbic or brainstem areas involved in cardiovascular and respiratory control (Severson, 
Wang, Pieribone, Dohle, & Richerson, 2003; Richerson, 2004). 
It has been suggested that RSA is a more valid index of between-subject differences in 
cardiac vagal control when individual differences in respiratory behavior are taken into 
account (Grossman & Kollai, 1993; Grossman et al., 2004) and that the validity of heart rate 
variability measures as predictors for cardiovascular disease could potentially improve from a 
correction for respiration rate. If, however, the genetic correlation between respiration rate 
and RSA shown in our analyses derives from pleiotropic genes, a correction for respiration 
rate could actually remove individual differences in cardiac vagal control. Our genetic 
analysis of the respiratory-corrected RSA showed heritability to decrease substantially 
compared to the estimates based on uncorrected RSA. Resolving the nature of the common 
genetic factor causing respiration rate and RSA to covary is an important future mission, but 
for now, removing genetic variance shared by RSA and respiration rate by using residualized 
scores seems unfounded. We suggest that future studies employ a multivariate design 
retaining both respiration rate and RSA as predictor variables. 
  Our results showed that RSA and heart period share another set of genes that are 
independent of respiration rate (factor A2 in figure 5.2). A putative explanation for the 
additional genetic factor A2 in figure 5.2 is that it represents respiration-independent gene 
effects on central vagal tone or the efficacy of muscarinergic effects on the sinoatrial node. 
Decreases in cardiac vagal control are well-known to increase heart period as well as decrease 
RSA (Berntson et al., 1994; Adinoff, Mefford, Waxman, & Linnoila, 1992). The significant 
genetic contribution to the covariance between heart period and RSA concurs with a previous 
investigation in a young and middle-aged twin cohort (virtually non-overlapping with the 
present cohort) in which a common genetic factor contributed 54% and 70% respectively to 
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the association between heart period and RSA (De Geus et al., 2003). In view of the clinical 
importance of cardiac vagal control in cardiology (Tsuji et al., 1996; Bigger, Jr. et al., 1995), 
finding genes influencing both heart period and RSA is an important objective.  
The power to detect such genes, particularly in linkage studies, is known to increase 
when a multivariate approach is used (Amos, de Andrade, & Zhu, 2001; Evans, 2002). This 
could be done using repeated measures of the same variable as well as using different, but 
genetically correlated, variables. The latter multivariate strategy has already successfully been 
applied in whole genome scans for blood pressure that added body mass index as a second 
phenotype (Turner, Kardia, Boerwinkle, & Andrade, 2004). Prolonged ambulatory recording 
of respiration rate, RSA and heart period has an inherent repeated measure structure and the 
three variables are highly genetically correlated. Measurement in a naturalistic setting has the 
additional advantage of providing a window on the function of the autonomic nervous system 
in the context of repeated and ecologically valid stressors. We conclude therefore, that 
ambulatory measurement of cardiovascular and respiratory signals can help shorten the search 
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Sympathetic control of cardiac contractility plays an important role in the risk for heart 
failure, but little is known about the relative contribution of genetic factors to individual 
variation in cardiac contractility. In a naturalistic setting, the extent of sympathetic inotropic 
control will vary with the demands of daily activities. Therefore, the genetic architecture of 
cardiac contractility may change across the day, or from awake to sleep periods. To establish 
heritability of cardiac contractility in a naturalistic setting, we recorded 24-hour ambulatory 
ECG and thorax impedance signals in 755 healthy adult twins and their singleton siblings. 
Three indices of cardiac contractility were derived: the pre-ejection period (PEP), the ratio of 
PEP to the left ventricular ejection time (PEP/LVET ratio), and the Heather index (HI). 
Multivariate genetic analyses across four periods of day (morning, afternoon, evening, night) 
yielded significant estimates for genetic contribution to PEP (48% to 62%). Heritability 
estimates for PEP/LVET ratio and HI ranged between 35% and 58% and between 38% and 
50% respectively. Contractility during the three waking periods was largely influenced by 
genetic factors that were common to the entire 24 hour period. During sleep additional genetic 
influences emerged that accounted for 8% and 20% respectively of the night-time heritability 
for PEP and the Heather index. In conclusion, impedance-derived measures of sympathetic 








Heart failure is a complex, progressive, and highly prevalent disorder that accounts for 
a large part of cardiac morbidity and mortality (Haldeman, Croft, Giles, & Rashidee, 1999; 
Koek et al., 2003; Hunt et al., 2001). In heart failure, there is a decrease in stroke volume that 
results from systolic dysfunction (loss of intrinsic inotropy), diastolic dysfunction (decreased 
ventricular compliance), or a combination of the two. Chronically high sympathetic nervous 
system activity plays a crucial role in the clinical progression of heart failure and may directly 
contribute to its pathophysiology (Kaye et al., 1995; Rundqvist, Elam, Bergmann-
Sverrisdottir, Eisenhofer, & Friberg, 1997; Swedberg et al., 1990). This suggests that the 
well-known genetic component in the susceptibility to heart failure (Arnett, de Las, & 
Broeckel, 2004; Bleumink et al., 2004) may derive in part from individual differences in 
sympathetic inotropic control. 
There is an unfortunate lack of information, however, on the influence of hereditary 
factors on indices of sympathetic control of cardiac contractility, such as the pre-ejection 
period (PEP), the ratio of PEP to the left ventricular ejection time (LVET), and the Heather 
index (HI). Moreover, no previous study has investigated sympathetic control of cardiac 
contractility over prolonged periods of time in a naturalistic setting. Since heart failure is a 
complex disorder that may be caused by many genetic and environmental influences or an 
interaction of these, such analyses may provide new angles for future genetic linkage and 
association studies. In this report, impedance cardiography (Cybulski, Miskiewicz, Szulc, 
Torbicki, & Pasierski, 1993; Sherwood et al., 1990) was used to measure the systolic time 
intervals (PEP, LVET) and the HI across a 24-hour period in a large group of healthy twin 
families. An extended twin design was used to estimate the heritability of these indices of 





All participants were registered in the Netherlands Twin Register. Their families were 
originally selected for a genetic linkage study searching for genes influencing anxiety and 
depression, which is described elsewhere (Boomsma et al., 2000; Middeldorp et al., in press). 
Of the first 1332 offspring who returned a DNA sample (buccal swabs) for the linkage study, 
1008 were successfully contacted for a cardiovascular ambulatory monitoring study. Of these, 
192 subjects refused or were excluded based on our a priori reasons for exclusion (pregnancy, 
heart transplantation, presence of a pacemaker and known ischemic heart disease, congestive 
heart failure, or diabetic neuropathy). A final 816 subjects were eligible and willing to 
participate in cardiovascular ambulatory monitoring. Data from 34 participants on 
cardioactive medication (including all β-blockers) were discarded. For 14 additional subjects 
recordings were unavailable due to equipment failures, while 13 subjects had either a noisy 
ECG or a noisy thorax impedance signal, and were therefore excluded from the analysis. The 
final sample consisted of 215 identical twins (77 men), 296 fraternal twins (107 men) and 244 
singleton siblings (94 men) from 339 families. Mean age was 30.6 years (SD=10.4). Zygosity 
of the twins was determined by DNA typing. The Ethics Committee of the Vrije Universiteit 
approved the study protocol and all subjects gave written consent before entering the study. 
No payment was made for participation, but all subjects received an annotated review of their 
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Procedure 
Subjects were visited at home, before starting their normal daily activities. During a 
short interview, information on health status, current and past medication use and family 
history of cardiovascular disease was obtained. The VU-AMS ambulatory ECG/ICG monitor 
was attached together with an ambulatory blood pressure monitor (Spacelabs) and their 
operation was explained. Subjects were instructed to wear both devices the entire day and 
night up until awakening the next morning. Written instructions were supplied that explained 
how to respond to potential alarm beeps (e.g. on loose electrode contacts), and telephone 
assistance was available during waking hours. Subjects were asked to keep a detailed diary. 
Every 30 (±10) minutes the ambulatory device produced an audible alarm beep to prompt 
them to write down a chronological account of activity, posture, location, social situation, and 
amount of perceived stress during each past 30 minutes. On the following day, the researcher 




The VU-AMS (version 4.6) measures the ambulatory electrocardiogram (ECG), the 
thorax impedance (Z0), the changes in impedance (∆Z) and the impedance cardiogram (ICG) 
continuously from a six-electrode configuration (de Geus & van Doornen, 1996; Riese et al., 
2003; Willemsen et al., 1996). In addition, it measures vertical acceleration, which is used as 
a proxy for gross body movement. Each R-wave in the ECG is automatically detected. At the 
R-wave peak a millisecond counter is read out and reset to obtain the IBI time series, which is 
stored continuously. To measure thorax impedance the VU-AMS device uses a 4-spot 
electrode technique. Thoracic impedance was assessed against a constant current of 50 KHz, 
350 microamperes, was amplified and led to a precision rectifier. The rectified signal was 
filtered at 72 Hz (low pass) to render basal impedance (Z). Filtering Z at 0.1 Hz (high pass) 
supplied the ∆Z signal, which in turn was filtered at 30.0 Hz (high pass) to obtain dZ/dt, the 
high frequent impedance changes due to the ejection of blood into the aorta during systole. A 
Z0 value was determined by averaging Z samples at the R-wave. ∆Z and dZ/dt were led to an 
A/D converter of the microprocessor, and digitized at 10 and 250 Hz respectively. The ECG 
and ICG signal of each 60-second period was ensemble averaged with reference to the R-
wave (Muzi et al., 1985). This assembled dZ/dt waveform will be referred to as a “60-second 
ensemble average”. The described procedure reduces the impact of single-beat fluctuations in 
the impedance signal through respiration and slow thorax movement. Systolic time intervals 
scored in the resulting 60-sec ensemble-averaged ICG correspond very closely to the mean 
systolic time intervals obtained over the (reliable) single-beat ICG waves in that same minute 
(Muzi et al., 1985; Boomsma, de Vries, & Orlebeke, 1989; Kelsey & Guethlein, 1990; Kelsey 
et al., 1998). Off-line processing of the ensemble averages of the DZ/dt signal allows the 
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Data reduction 
Using the diary entries in combination with the vertical accelerometer signal and the 
heart rate, the entire recording was divided into periods that were defined by posture, activity, 
location and social situation. To reduce the amount of visual inspection needed, the same 
ensemble averaging strategy used to obtain 60-second averages from single-beat waveforms 
was applied to obtain large-scale ensemble averages across these periods. A previous 
ambulatory study by Riese et al. (2003) showed that such a large-scale ensemble averaging 
validly recaptured the information in the original 60-second ensemble averages while 
substantially reducing the total amount of visual inspection needed. In view of the 
confounding effects of changes in posture on systolic time interval based indices of 
contractility, during the daytime recordings we carefully selected only periods when subjects 
were sitting.  
 
ICG waveform scoring 
Systolic time intervals and the dZ/dtmin were manually scored with a VU-AMS 
interactive software program (www.psy.vu.nl/vu-ams) that graphically displayed both the 60-
second ensemble averages and the large-scale ensemble averages of the dZ/dt signal. Noise 
was reduced by deleting noisy 60-second ensemble averages from the large-scale ensemble 
averages. For every large-scale ensemble average three time points were scored: the upstroke, 
or B-point, the dZ/dtmin point and the incisura or X-point (see Figure 6.1). Large-scale 
ensemble averages were deleted when there was too much noise to be able to detect the three 
ICG waveform characteristics with certainty, or when dZ/dtmin was positive.  
 Left ventricular ejection time (LVET) was defined as the time between the opening and 
closing of the aortic valves, in other words the B-X time interval. The PEP was defined as the 
time interval between the onset of the electromechanical systole (Q-wave onset) and the onset 
of left ventricular ejection at the opening of the aortic valves. The VU-AMS impedance 
cardiograph uses the R-B time interval instead of the Q-B time interval to estimate PEP 
(Sherwood et al., 1990). Previous studies have shown that there is little intra- and 
interindividual variability in the Q-R time interval (Willemsen et al., 1996) and that the R-
wave yields more reliable PEP estimates (Berntson, Lozano, Chen, & Cacioppo, 2004). We 
added a fixed Q-R interval of 48 ms to this abbreviated PEP to allow easy comparison with 
Q-wave based PEP. This also allowed us to compute the ratio of PEP/LVET, proposed as an 
index of myocardial contractility less dependent on preload (Weissler, Harris, & Schoenfeld, 
1968). The Heather Index of myocardial contractility, corrected for Z0 (HI; units/s2), was 
calculated as the ratio of dZ/dtmin to the R-Z interval, divided by Z0 (Kelsey & Guethlein, 
1990; Sherwood et al., 1990).  A reduced PEP and increased values of PEP/LVET ratio and 
HI all signal increased inotropic control, i.e. larger sympathetic drive to the left ventricle.  
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Indicated are the characteristic B-point or upstroke, the dZ/dtmin point or the top of the 
waveform, and the X-point or incisura. PEP = pre-ejection period (R-B time interval), LVET 
= left ventricular ejection time (B-X interval). 
 
Structural equation modeling 
To estimate to what extent genes, shared environment and unshared environment 
contribute to the variance in sympathetic control of cardiac contractility, biometrical genetic 
models were fit to the data on PEP, PEP/LVET ratio and HI with the use of the structural 
equation program Mx (Neale et al., 2003). Quantitative analyses were carried out in several 
steps. First, a series of increasingly constrained univariate models were fit for each period of 
the day and for each variable separately, to test the assumptions of genetic modeling with an 
extended twin design. The homogeneity of means and variances for MZ twins, DZ twins, and 
singleton siblings and for males and females were tested first. Next, homogeneity of 
correlations of male and female pairs and of DZ twins and sibling pairs was tested. The 
resulting most parsimonious unconstrained models indicated to what extent the number of 
estimated parameters could be limited in the subsequent analyses and these most 
parsimonious models were the ones against which the variance decomposition models were 
tested.  
In general, the observed variance can be decomposed in four possible latent sources of 
variance (Boomsma et al., 2002). The two environmental sources are environmental effects 
that are shared by members of a family (C), and environmental effects that are unique to each 
member of a family (E). Two kinds of genetic effects are distinguished: additive genetic 
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effects (A) and non-additive genetic effects. Non-additive genetic effects include dominance 
effects (D) and epistasis. Dominance describes the interaction between alleles at the same 
locus and epistasis describes the interaction of alleles at different loci (Neale & Cardon, 
1992). In a design that includes identical twins, fraternal twins and sibling pairs, estimates of 
C and D are confounded, and the observed variances and covariances only provide sufficient 
information to model either an ACE model or an ADE model, but not both. Based on the 
pattern of twin and sibling correlations we choose the models that were most appropriate. For 
MZ, DZ twins and sibling pairs, similarity in shared environmental influences was fixed at 
100%. For same-sex first-degree relatives, similarity of additive genetic influences was fixed 
at 50% and similarity for dominance genetic influences was fixed at 25%. For MZ twins, 
similarities of additive and dominance genetic influences were fixed at 100%. Unshared 
environmental influences are uncorrelated in all twin and sibling pairs. To reduce complexity 
of genetic modeling, we discarded data from 7 singleton siblings (1 male, 6 female) in a few 
families with more than four additional singleton siblings. To evaluate quantitative sex 
differences in the genetic architecture, parameter estimates were allowed to differ between 
males and females. Because phenotypic correlations were close to zero for opposite sex pairs 
for PEP and PEP/LVET ratio, genetic correlations in opposite-sex first degree relatives were 
constrained at zero and the log likelihood of this model was compared to the model in which 
additive and dominant genetic correlations were fixed at 0.5 and 0.25, respectively.  
After establishing the most parsimonious variance components model (ACE or ADE, 
AE, CE, or E) for each daily period, we used a full four-variate Cholesky decomposition to 
test whether the same or different genetic and environmental factors influenced cardiac 
contractility at each of the four periods of the day (morning, afternoon, evening and night). 
The Cholesky decomposition imposes a structure of stratification in several shared latent 
factors. In the case of a four-variate analysis, there is a main factor that loads on all variables, 
followed by a second factor that loads on all but the first variable, followed by a third latent 
factor that loads on the final two variables. The final factor only loads on the last variable. In 
the full model all variance components (A, D/C and E) are structured this way. A priori, we 
expected a single genetic factor to underlie the variance throughout the day and night. This 
was tested by contrasting a full Cholesky decomposition against a genetic one factor model 
(independent pathway model) for each variable. The independent pathway model specifies 
three common factors. One for genetic (A) sources of variance, one for shared environmental 
sources of variance (C) or for dominance genetic effects (D), whichever is modeled, and one 
for unique environmental (E) sources of variance, while it also allows for period-specific 
influences of A, C/D and E for all periods of the day.  
Akaike’s Information Criterion (AIC) (Akaike, 1987) was used to evaluate the relative 
fit of the various nested (and non-nested) models, which is an index of goodness-of-fit for 
which a larger negative value indicates greater parsimony of the model. Significance tests of 
the individual path coefficients were carried out by constraining paths to zero and applying 
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Table 6.1 Means (SD) for pre-ejection period (PEP), left ventricular ejection time 
(LVET), PEP/LVET ratio, and the Heather index (HI) for each period of day 
 
 N PEP (ms) LVET (ms) PEP/LVET HI (Ω/ms2) 
Morning 
Men 265 96.4 (14.9) 292.4 (34.1) .34 (.07) -.52 (.17) 
Women 457 99.6 (18.5) 289.0 (35.7) .35 (.09) -.63 (.20) 
Afternoon 
Men 271 95.9 (14.2) 284.6 (32.7) .34 (.07) -.58 (.18) 
Women 468 98.2 (17.1) 285.0 (33.9) .35 (.09) -.66 (.21) 
Evening 
Men 264 95.7 (13.6) 293.2 (33.6) .33 (.07) -.60 (.21) 
Women 456 98.0 (16.2) 297.0 (35.2) .34 (.08) -.66 (.21) 
Night 
Men 289 105.4 (15.4) 334.7 (26.6) .32 (.06) -.48 (.15) 
Women 505 104.8 (15.3) 331.5 (27.2) .32 (.06) -.54 (.16) 




General descriptive statistics 
On average, the ambulatory monitoring period had a duration of 21 hours and 20 
minutes (± 4:14h), which included an average of 43 (±12) large-scale ensemble averages of 
the dZ/dt signal. Of these, 50.5% were recorded either during sitting or lying posture. Means 
for PEP, PEP/LVET ratio and HI for all periods that subjects were sitting or lying are 
presented in Table 6.1. 
Although the sample was previously selected based on the presence of at least 2 family 
members with low or high  scores on personality traits related to the risk for anxiety and 
depressive disorder, these traits did not correlate significantly with our indices of cardiac 
contractility. 
We first tested the need to include two possible confounders, body mass index (BMI), 
and age in the genetic models. BMI had no effect on the means of any of the variables. 
Nighttime PEP was significantly shorter with increasing age, but otherwise no age effect was 
found. For all periods of day we found that with increasing age the PEP/LVET ratio 
significantly decreased. For HI, a significant influence of age (lower with increasing age 
during the day and higher with increasing age at night) on the means of all daily periods was 
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Table 6.2 Twin correlations for pre-ejection period (PEP), left ventricular ejection time 
(LVET), PEP/LVET ratio, and the Heather index (HI) for each period of day 
PEP PEP/LVET HI  
rMZ rDZ/sib rMZ rDZ/sib rMZ rDZ/sib 
Men .71 .38 .63 .28 .56 .32 
Women .72 .23 .62 .25 .55 .40 Morning 
OS - .01 - -.03 - .17 
Men .70 .42 .64 .41 .45 .26 
Women .73 .24 .64 .19 .43 .34 Afternoon 
OS - -.01 - -.09 - .12 
Men .69 .32 .80 .31 .59 .12 
Women .64 .21 .48 .22 .56 .34 Evening 
OS - -.05 - -.07 - .24 
Men .70 .25 .62 .22 .56 .08 
Women .46 .13 .50 .20 .35 .14 Night 
OS - -.08 - -.07 - .02 
PEP/LVET, HI, and nighttime PEP twin correlations were corrected for influences of age on 
the mean. OS = opposite sex. 
 
The resemblance between MZ twins and between DZ twins and/or sibling pairs was 
examined by calculating Pearson correlations (age-adjusted for nighttime PEP, PEP/LVET 
and HI), stratified by sex, as shown in Table 6.2. Throughout, a larger MZ than DZ/sib 
correlation was evident, suggesting the presence of additive genetic and unique environmental 
influences. For PEP and the PEP/LVET ratio the majority of MZ twin correlations were more 
than twice as large as the DZ correlations, indicating the possible presence of dominance 
genetic effects. For these two variables an ADE model was fitted. In addition, the opposite 
sex correlations for these variables were near zero suggesting that different genes may be 
acting in males and females. The HI correlations suggest an ACE model as the best model to 
start with.  
For HI the means and variances were equal for MZ twins, DZ twins and singleton siblings. 
Mean HI was lower in females but there were no sex-effects on the variances and covariances. 
For PEP and PEP/LVET male and female means could be set equal. Variances of PEP and 
PEP/LVET ratio, however, significantly differed between males and females. The variance 
decomposition model fitting therefore employed a scalar sex limitation (Neale & Cardon, 
1992) to account for these differences. Within the male and female group, MZ, DZ and 
singleton sibling variances could be constrained to be equal. For all variables we were able to 
reduce the covariance structure of all daily periods to one MZ correlation and one DZ/sibling 
correlation for same-sex twin and sib pairs. For DZ twins and sibling pairs of opposite sex the 
correlation could be constrained at zero without a significant loss of fit for PEP and 
PEP/LVET ratio, but not for HI. In all further genetic model fitting, the genetic correlation for 
the opposite sex pairs was constrained to zero for PEP and PEP/LVET ratio. For Heather 




Univariate genetic analysis showed that shared environment was of no importance for 
Heather index and that dominance genetic effects could be dismissed from the models for 
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PEP and PEP/LVET ratio.  For all three variables, a model including only additive genetic 
factors and unique environment (AE model) was preferred over all other possible models 
(ACE/ADE, CE or E). To test the hypothesis that a single genetic factor underlies the genetic 
variation throughout the day, one factor genetic models were compared with the fit of an AE 
Cholesky decomposition.  
 
Table 6.3 Multivariate model fitting results for pre-ejection period (PEP), left 
ventricular ejection time (LVET), PEP/LVET ratio, and the Heather index (HI) 
Model Vs. ∆χ² ∆df p-value AIC 
PEP 
1 ADE Chol.      
2 AE Chol. 1 9.035 10 .529 -10.965 
3 E Chol. 2 72.737 10 .000 52.737 
4 AE Ind. 2 2.975 2 .226 -1.025 
5 AE Ind. reduced 1 4 4.063 3 .255 -1.937 
6 AE Ind. reduced 2 5 5.463 1 .019 3.463 
PEP/LVET ratio 
1 ADE Chol.      
2 AE Chol. 1 6.283 10 0.791 -13.717 
3 E Chol. 2 57.534 10 .000 37.534 
4 AE Ind. 2 4.777 2 .092 0.777 
5 AE Ind. reduced 1 4 0.103 3 .991 -5.897 
6 AE Ind. reduced 2 5 3.08 1 .079 1.08 
HI 
1 ACE Chol.      
2 AE Chol. 1 2.851 10 0.985 -17.149 
3 CE Chol. 1 11.138 10 0.347 -8.862 
5 E Chol. 2 93.488 10 0.000 53.488 
6 AE Ind. 2 6.666 2 0.036 2.666 
7 AE Ind. reduced 1 6 1.06 3 0.787 -4.94 
8 AE Ind. reduced 2 7 21.358 1 0.000 19.358 
The most parsimonious model is printed bold faced. AIC = Akaike’s information criterion;  
Chol. = Cholesky decomposition;  
1 Independent pathway model without specific genetic influences during waking period. 
2 Independent pathway model without specific genetic influences throughout the 24 hour 
period. 
 
The multivariate model fitting results are presented in table 6.3. For PEP, PEP/LVET 
ratio and HI alike, one genetic factor was responsible for the genetic influences on the 
individual variation throughout the 24-hour recording. Heritability estimates for the final most 
parsimonious models are presented in table 6.4. Although all variables showed a decrease in 
heritability during the evening and a further decrease during the night, these were not 
significant. For PEP and HI, additional specific genetic factors were present, but only during 
the night, and accounted for 8% and 20% of the variance respectively. The remainder of the 
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Table 6.4 Heritability estimates for pre-ejection period (PEP), left ventricular ejection 
time (LVET), PEP/LVET ratio, and the Heather index (HI) 
PEP 
 Common h2 Specific h2 Total h2
Morning 62% (49-72) - 62% 
Afternoon 62% (48-72) - 62% 
Evening 55% (41-66) - 55% 
Night 40% (27-52) 08% (01-15) 48% 
PEP/LVET ratio 
 Common h2 Specific h2 Total h2
Morning 58% (43-69) - 58% 
Afternoon 56% (41-68) - 56% 
Evening 48% (32-61) - 48% 
Night 35% (19-51) - 35% 
HI 
 Common h2 Specific h2 Total h2
Morning 50% (37-60) - 50% 
Afternoon 45% (32-57) - 45% 
Evening 38% (24-52) - 38% 
Night 21% (10-33) 20% (11-28) 41% 
Age was regressed from the mean for PEP, PEP/LVET ratio and HI. For HI sex was an 
additional covariate. The 95% confidence intervals for each of the estimates are given in 




Based on prolonged measurements in naturalistic settings obtained in a sample of 755 
healthy adult twins and singleton siblings, the present study showed that individual 
differences in impedance-based measures of sympathetic control of cardiac contractility are 
substantially determined by additive genetic factors with heritability estimates varying 
between 35% and 62%. 
 Daytime generally is associated with relative sympathetic dominance while nighttime is 
characterized by parasympathetic dominance (Buijs et al., 2003a; Carrington, Walsh, 
Stambas, Kleiman, & Trinder, 2003; Hilton, Umali, Czeisler, Wyatt, & Shea, 2000). To allow 
for the possibility that different genetic factors would affect sympathetic control of the 
contractility of the heart during waking and sleeping hours or during leisure (evening) and 
work (morning, afternoon) periods the entire ambulatory impedance recording was split into 
four periods of day. Total genetic influence on variance in cardiac sympathetic control was 
found to be higher during daytime than during the evening and lowest during the night. In 
spite of the lower heritability, multivariate analysis showed that, at night, new genetic 
variance emerged for PEP and the HI. This is in keeping with studies in rodents on diurnal 
variation in gene-expression in the heart (Martino et al., 2004; Young, Razeghi, Cedars, 
Guthrie, & Taegtmeyer, 2001). These studies found variation in diurnal gene-expression to be 
driven in part by the central circadian pacemaker, but also by changes from light to dark 
phases. The presence of the night-specific genetic influences on our cardiac contractility 
indices supports the proposition by Young (2003) that the presence of night-specific gene-
expression in the hearts of rodents may be extrapolated to humans. 
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The sympathetic nervous system has long been suggested to play a vital role in the risk 
for left ventricular hypertrophy and heart failure (Rundqvist et al., 1997; Kaye et al., 1995; 
Swedberg et al., 1990). Therefore, subjects with a genetic make-up that gives rise to an 
increased β-adrenergic drive to the left ventricle, evident in a shorter PEP and lower 
PEP/LVET ratio and an increased HI value, may be at larger risk to develop heart failure than 
subjects with lower inotropic drive. Specifically, a chronic state of sympathetic hyperactivity 
is thought to enhance age-related functional down-regulation of myocardial β-receptors (El 
Armouche, Zolk, Rau, & Eschenhagen, 2003; Bogaert & Fraeyman, 1991; Andersson, 1986; 
Xiao, Cheng, Zhou, Kuschel, & Lakatta, 1999). Down-regulation in the face of chronically 
enlarged sympathetic inotropic drive might initially constitute a cardioprotective 
compensatory response, but in the long run will negatively affect cardiac output (Communal 
& Colucci, 2005; Engelhardt, Hein, Wiesmann, & Lohse, 1999; Iwase et al., 1996). The 
resulting reduction in cardiac output is initially compensated by a further increase in cardiac 
sympathetic drive, supported by increased activity level of the renin-angiotensin system. In 
the disease phase, the effectiveness of the additional sympathetic activity is further reduced 
and net contractility is lowered. Indeed, studies employing impedance cardiography have 
shown that hearts with reduced left ventricular function show an increase in PEP/LVET ratio, 
and a severity-dependent decrease in HI (Fuller, 1994). In addition, the failing heart has been 
associated with a prolonged PEP and a decrease in LVET (Weissler et al., 1968; Ahmed, 
Levinson, Schwartz, & Ettinger, 1972). 
Genes influencing cardiac inotropic drive may interact with genetic susceptibility in 
other domains. Three previous studies have reported heritabilities of left ventricular structure 
and diastolic filling, using a twin or sibling design. A study in healthy black twins showed 
that both genetic and environmental factors play a role in the individual variation in left 
ventricular mass (Harshfield, Grim, Hwang, Savage, & Anderson, 1990). A study in young 
adult twins showed that genes accounted for 43% and 26% of the variation in respectively 
early and late left ventricular filling velocity (Bielen et al., 1991), while a more recent study 
reported heritabilities of 50% and 52% for these measures of diastolic filling (Tang et al., 
2000). Finally, two recent linkage studies implicated a role for genes coding for the cardiac 
myosin-binding protein in a region on chromosome 11 in measures of left ventricular 
contractility, filling and structure (Arnett et al., 2001; Tang et al., 2002). 
  Not surprisingly, systolic time intervals and contractility measures derived from 
impedance cardiography are of increasing importance in the diagnosis and management of 
patients suffering from heart failure (Parrott, Burnham, Quale, & Lewis, 2004; Strobeck & 
Silver, 2004; Ventura, Pranulis, Young, & Smart, 2000; Rasmussen, Sorensen, & Kann, 
1975). Here, we suggest a further use of these indices, namely as endophenotypes in the 
search for genetic susceptibility causing high sympathetic inotropic drive at a young 
premorbid age. Genetic variation in the three indices of cardiac contractility throughout the 
day and night was largely explained by a common set of genes. This common genetic factor 
structure is advantageous for gene-finding on at least two accounts. First, using highly 
genetically correlated multivariate phenotypes provides higher statistical power to find genes 
in linkage analysis (Allison et al., 1998). Secondly, these genes, by virtue of having a 
pervasive influence on cardiac contractility across all situations, will also have the largest 
clinical relevance. We conclude, therefore, that these ambulatory impedance-derived indices 
of cardiac contractility provide a useful target for future gene finding studies targeting the risk 
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To understand the underlying genetic and environmental sources of individual variation in 
basal cortisol levels, we collected salivary cortisol at awakening and at six fixed time points 
during the day in adult twins and their singleton siblings. Reported time of awakening was 
verified with heart rate and body movement recordings. Cortisol data were available for 199 
MZ twins, 272 DZ twins and 229 singleton siblings from 309 twin families. No differences in 
cortisol means and variances were found between twins and singleton siblings. Additionally, 
the correlations for DZ twins and siblings were not significantly different, indicating 
generalizability of twin study results to the general population. Genetic model fitting showed 
heritability for cortisol levels during the awakening period (34% for cortisol level at 
awakening and 32% for cortisol level at 30 minutes after awakening) but not for cortisol 
levels later during the day. The current study shows that, while cortisol levels in the 
awakening period are influenced by genetic factors, cortisol levels throughout most of the day 
are not heritable, indicating that future gene finding studies for basal cortisol should focus on 









Cortisol is an important steroid hormone in the regulation of normal physiology. It is 
the end product of the hypothalamus-pituitary adrenal (HPA) axis. In response to disturbance 
of homeostasis due to physical or psychological influences, corticotrophin releasing factor 
(CRF) is expressed in the paraventricular nucleus of the hypothalamus and acts to stimulate 
the secretion of adrenocorticotrophic hormone (ACTH) in the pituitary. ACTH travels to the 
adrenals, where it stimulates the production of cortisol in the outer layer of the adrenal cortex. 
By a negative feedback mechanism, cortisol inhibits the production of both ACTH and CRF, 
thereby inhibiting its own secretion. Under influence of the central nervous system about 10 
to 15 well-defined ACTH driven pulses of cortisol are secreted over 24 hours, resulting in 
cortisol’s well-known circadian rhythm that is characterized by peak levels in the early 
morning and a nadir around midnight. Normally, stress-induced secretion is superimposed on 
the basal circadian rhythm. When the HPA axis is deregulated however, for example by 
continued or frequently repeated stress challenges, basal cortisol may be chronically secreted 
in excess, with potentially harmful effects. Prolonged glucocorticoid exposure may lead to 
muscle atrophy, decreased sensitivity to insulin, hyperlipidemia, hypercholesterolemia, 
impairment of growth (Meaney et al., 1991), osteoporosis (Adachi, 2001), immune 
destabilization (Bateman, Singh, Kral, & Solomon, 1989), hypertension and cardiovascular 
disease (Mantero & Boscaro, 1992; Girod & Brotman, 2004). In addition, deregulated HPA 
axis activity is a predictor for diabetes and stroke (Rosmond & Bjorntorp, 2000).  
Large individual differences exist in the diurnal levels of cortisol (Smyth et al., 1997) 
and a possible source of this variation is genetic makeup. Several twin studies have been 
conducted to determine the influence of genetic and environmental factors on basal cortisol 
(for a review see Bartels, van den Berg, Sluyter, Boomsma, & de Geus, 2003b). The majority 
has focused on one basal cortisol sample during the morning hours (07:45 h – 09:00 h, not 
related to awakening), and only two studies in adults (Linkowski et al., 1993; Wüst et al., 
2000a) and one study in children (Bartels et al., 2003a) report on the heritability of basal 
cortisol collected during an entire day. Linkowski and coworkers determined cortisol in blood 
samples taken every 15 minutes for 24 hours in 21 twin pairs. Genes influenced the timing of 
the nocturnal nadir and the proportion of overall temporal variability associated with 
pulsatility. No genetic effects were detected for the 24-hour mean and the timing of the 
morning acrophase (Linkowski et al., 1993). Wüst et al. collected eight saliva samples from 
awakening until 20:00 h in 104 twin pairs and reported significant genetic control (40% and 
48%) for the different measures of the early morning acrophase, while cortisol variation 
during the rest of the day was predominantly under shared and non-shared environmental 
control (Wüst et al., 2000a). The study by Bartels and colleagues in 216 children of the age of 
12 (Bartels et al., 2003a) showed a similar genetic pattern as the adult twin study by Wüst et 
al. (2000a)  with significant genetic influences  on cortisol levels an hour post-awakening 
(about 57%), and only environmental influences for the afternoon and evening levels of 
cortisol. 
These studies indicate that genes influence the cortisol levels in the early morning, no 
matter what age, but not during the rest of the day. The present study increased the power to 
detect influences of genetic and common environmental factors by increasing the sample size 
and by adding the singleton siblings of the twins to the design (Posthuma & Boomsma, 2000). 
This extended twin design has the additional advantage that it allows testing of the 









Subjects were registered with the Netherlands Twin Register (NTR) and were 
originally selected for a genetic linkage study for anxious depression (Boomsma et al., 2000; 
Middeldorp et al., in press). Briefly, families were selected when two siblings (dizygotic twin 
pair, sib-twin pair, or sib-sib pair) were extremely discordant or concordant for anxious 
depression. In addition to the sibling pair, all registered family members were recruited for the 
study. The resulting distribution of anxiety, neuroticism and depression scores was near-
normal with only mild kurtosis. Of the first 1332 offspring who returned a DNA sample 
(buccal swabs) for the linkage study, 1008 were successfully contacted for a cardiovascular 
and hormonal ambulatory monitoring study. Of these, 192 refused participation or were 
excluded. Exclusion criteria were pregnancy, heart transplantation, pacemaker and known 
ischemic heart disease, congestive heart failure, or diabetic neuropathy. As the collection of 
saliva was added to the study protocol after the study started, a further 98 subjects did not 
participate, leaving a total of 718 subjects who took part in the cortisol collection. For 18 
subjects the cortisol data had to be discarded because they used corticosteroid medication (12 
subjects), or had unreliable profiles (6 subjects) due to working a night shift or uncertainty 
about the sample order. The final study sample consisted of 700 subjects, including 199 MZ 
twins (75 males), 272 DZ twins (94 males) and 229 singleton siblings (88 males), who were 
tested in two data collection waves. For 153 families only the twin was included, while for 
144 families 1 or 2 additional siblings were included. For the remainder of the families 
between 3 and 6 additional siblings were included. Zygosity of the twins was determined by 
DNA typing. The Ethics Committee of the Vrije Universiteit approved of the study protocol 




Subjects were requested to refrain from intense physical exercise on both the 
preceding and the ambulatory monitoring days. Subjects were visited at home early in the 
morning, before starting their normal activities. They were subjected to an interview on health 
status and received instructions on the saliva sampling for cortisol assessment. In addition, a 
24-hour electrocardiogram (ECG) and impedance cardiogram (ICG) recording was made 
using the Vrije Universiteit – Ambulatory Monitoring System (VU-AMS) ambulatory 
monitor (de Geus et al., 1995; de Geus & van Doornen, 1996) that includes a vertical 
accelerometer. Furthermore, every 30 minutes blood pressure was recorded using a Spacelabs 
90207 ambulatory blood pressure monitor (Redmont, Washington, USA). Results on 
cardiovascular measures have been published elsewhere (Kupper et al., 2004; Kupper et al., 
2005a; Kupper et al., 2005b). Subjects wore the VU-AMS monitor the entire day and night 
until after awakening the next morning. In a chronological diary subjects recorded the actual 
times saliva collection took place, and indicated any deviations from the instructions.  
 
Saliva collection 
Saliva sampling was performed using Salivette® sampling devices (Sarstedt, 
Rommelsdorf, Germany). Subjects were instructed to chew gently on the polyester swab for 
45 seconds to obtain the desired amount of saliva. They were asked to refrain from brushing 
their teeth and consuming food and drinks from half an hour before saliva sampling. The first 
sample was collected in the presence of the researcher, at the start of the measurement day. 
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Instructions were to take the next samples at 11:00 h, 15:00 h, 20:00 h, 22:30 h (or prior to 
going to bed, when earlier), upon awakening the next morning (preferably while still in bed), 
and 30 minutes post-awakening. This last sample was only available for the 428 subjects who 
participated in a second data collection wave.  
 
Cortisol analysis 
All samples were stored frozen at the laboratory at a temperature of –25°C.  Cortisol 
concentration was determined in Düsseldorf, Germany, in two batches. In the first batch, 
consisting of the samples of 272 subjects from 166 families, cortisol concentration was 
determined by a time-resolved immunoassay with fluorescence detection (DELFIA, see 
Dressendorfer, Kirschbaum, Rohde, Stahl, & Strasburger, 1992). Intra and inter assay 
variability of this method were less than 10% and 12% respectively. In the samples of the 428 
subjects (from 128 families) of the second batch, cortisol concentration was determined using 
a commercial competitive chemiluminiscence immunoassay (LIA, IBL Hamburg, www.ibl-
hamburg.com). Intra and inter assay variability of this method were less than 7.7% and 
11.5%, respectively.  
 
Measures & outlier detection 
In addition to the seven diurnal cortisol samples, we computed the cortisol awakening 
response (CAR) by subtracting the cortisol concentration at awakening from the cortisol 
concentration 30 minutes later. When cortisol concentration reached values more than three 
times the standard deviation above or below the mean for that sampling time, the sample was 
discarded (this happened in 1% of all samples).  
 
Statistical analysis 
Confounders - In the past decades, a multitude of research has been published on factors 
influencing cortisol. The main factors implicated are age, gender, smoking, mood, bodily 
composition, contraceptive pills, sleep duration, sleep quality, and awakening time, although 
many studies report contradictory results (Deuschle et al., 1997; Knutsson et al., 1997; Wüst 
et al., 2000b; Ukkola et al., 2001). Therefore, we decided to test all of these potential 
confounders for their influence on basal diurnal cortisol using regression analyses in SPSS 
(SPSS Inc., Chicago, USA). The effects of sex, age, current mood state, (as measured by the 
POMS, Wald & Mellenbergh, 1990), body mass index (BMI), sleep quality (assessed by the 
Groningen Sleep Quality Scale, Meijman et al., 1988), reported sleep duration, current 
habitual smoking status (yes/no), and oral contraceptives use on the cortisol samples were 
tested. Since two methods (DELFIA and LIA) were used to determine the cortisol 
concentration in saliva, we also treated the type of immunoassay as a possible confounder in 
our genetic analyses. 
 
Genetic modeling - To answer the question to which extent genes, common environment and 
non-shared environment contribute to the variance of basal cortisol, a biometrical genetic 
model was fitted to the observed data using the structural equation modeling program Mx 
(Neale et al., 2003). A series of unconstrained models was fitted to test the assumptions of the 
extended twin model. In this series, we first tested the equality of means and variances for MZ 
twins, DZ twins, and singleton siblings and examined the presence of sex effects on the 
means and variances. Then we tested whether cortisol determination method significantly 
affected the means. Finally, we tested for heterogeneity of correlations of males versus 
females and of DZ twins versus singletons. The resulting most parsimonious saturated model 
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indicated to which extent we could limit the specification of the genetic models and provided 
correlations for the MZ group and the DZ/sibling group. 
In a twin study, the observed variance can be decomposed in four possible latent sources of 
variance. The two environmental sources are environmental effects that are shared by 
members of a family (C), and environmental effects that are unique to each member of a 
family (E). Two kinds of genetic effects are distinguished: additive genetic effects (A) and 
non-additive genetic effects. Non-additive genetic effects include dominance effects (D) and 
epistasis. Dominance describes the interaction between alleles at the same locus (Neale & 
Cardon, 1992). In a design that includes identical twins, fraternal twins and sibling pairs, 
estimates of C and D are confounded, and the observed variances and covariances only 
provide sufficient information to model either an ACE model or an ADE model, but not both. 
Based on the pattern of twin and sibling correlations we choose which model was more 
appropriate. For MZ, DZ twins and sibling pairs alike, similarity in shared environmental 
influences was fixed at 100%. Similarity of additive genetic influences was fixed at 50% for 
siblings and DZ twins and at 100% for MZ twins. In the case of dominance (when the MZ 
correlation is more than twice the DZ correlation) similarity of dominant genetic influences 
was fixed at 25% for siblings and DZ twins and at 100% for MZ twins. Per definition, there is 
no similarity in the non-shared environmental influences for all three types of sibling pairings. 
 For each of the cortisol samples, a full univariate ACE or ADE model (Neale & Cardon, 
1992) was tested against the nested more parsimonious AE, CE or E models. The resulting 
best fitting model indicated how much of the variance is attributed to genetic influences and 
how much is attributed to environmental influences. Throughout, nested models were 
compared using the likelihood ratio test. To determine whether shared genetic influences 
would underlie the two cortisol levels of the awakening period, a bivariate full ADE model in 
Cholesky decomposition was tested against more parsimonious models (AE and E models). 
The Cholesky decomposition imposes a structure of stratification in several shared latent 
factors. In the case of our bivariate analysis, there is a main factor of global importance that 
loads on both variables, followed by a second factor that loads only on the last variable. In the 
full model all variance components (A, D and E) are structured this way. Significance of the 
individual path coefficients was tested by constraining paths to zero and comparing the fit 
with likelihood ratio tests. In the bivariate model, the heritability of the CAR was also 
estimated. Because of the design of the model, CAR heritability reflects the remaining genetic 
influence on the difference in cortisol levels between the two samples, after removing the 
heritability for the two individual mean cortisol levels. Akaike's Information Criterion 
(Akaike, 1987) was calculated for each of the univariate and bivariate models. AIC offers a 
quick approach to judging the fit of nested models and models that are not nested, like an AE 
and CE model. Those with lower (i.e. larger negative) values fit better than models with 





Of the 700 subjects that participated in the saliva collection for cortisol determination, 
587 had a complete diurnal profile of six samples (of these, 376 subjects participated in the 
second data collection wave, and provided seven samples). For 10 subjects less than four 
samples were present. Subjects complied moderately well with the instructed sampling times. 
Between 74% and 85% of the time-bound samples (11:00 h, 15:00 h, 20:00 h and 22:30 h) 
were reported to be taken within 15 minutes of the requested sampling time. Of the samples 
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outside the 30 minute window, the majority was taken later than the requested sampling time 
(1-3% was taken more than 15 minutes earlier, 21%-25% was taken more than 15 minutes 
later, and 14%-17% was taken more than 30 minutes later than the required sampling time).  
Looking at the individual profiles, most subjects (89%) showed the well-known 
diurnal rhythm of cortisol. For 77 subjects for whom both early morning samples were 
present, the cortisol awakening response was negative. Figure 7.1 shows the diurnal cortisol 
profile for those with a normal awakening response (black bars) and those with a negative 
response (gray bars). It is possible that these subjects showing a negative response really do 
have a deviant response to awakening. However, an alternative explanation might be that 
subjects woke up earlier than they reported, and that their data therefore represent the down 
stroke of the morning acrophase. To test this alternative explanation, we exploited the fact 
that we had simultaneous recordings of heart rate and body movement on the sampling days. 
For 59 of the 77 subjects an ECG/motility recording of the early morning hours was available. 
For 18 subjects ECG/motility data were missing due to signal loss in the middle of the night. 
We identified an earlier awakening moment than reported in 80% of the subjects with 
available ECG/motility data. Figure 7.2 shows the combined ECG/motility signal for one 
subject with a discrepancy between his actual awakening time and his reported 
awakening/sampling time. The time difference between actual awakening and reported 
awakening in this example was 35 minutes (range = 10 min – 02:15 h), which suggests that 
the negative awakening response is an artifact caused by sampling after the actual awakening 
response occurred. To determine whether these results on earlier awakening are also found in 
the group with a normal awakening response, a random sample of 77 subjects was drawn 
from those with normal awakening responses.  
 






epresented cortisol means are corrected for method of cortisol determination. Error bars 
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For eight of these randomly drawn subjects ECG/motility data were missing due to signal loss 
in the middle of the night. In 87% of the subjects with available ECG/motility data the 
reported awakening time corresponded with the actual awakening as judged from the ECG 
and body movement recordings. These observations indicate that waking up earlier than 
reported was indeed responsible for the majority of the apparent negative cortisol awakening 
responses. Because the awakening response was assessed incorrectly in these subjects that 
showed a negative CAR, their awakening response samples were excluded from further 
analyses. 
Table 7.1 shows the descriptive statistics for the cortisol samples. A clear circadian 
rhythm can be observed. The average cortisol concentrations at the seven sampling times 
were significantly different from each other and moderately correlated (between .08 and .47), 
with the exception of the awakening and 30 minutes post-awakening samples which were 
highly correlated (r=.65, p=.000).  
 
Table 7.1 Descriptive statistics & twin correlations for diurnal cortisol 








At visit 667 8:35 h (1:07 h) 20.87 (10.49) .33 (.13-.49) .16 (.05-.26) 
11:00 h 655 11:11 h (0:30 h) 8.69 (4.07) .11 (.00-.34) .09 (.00-.19) 
15:00 h 675 15:18 h (0:42 h) 6.14 (3.07) .08 (.00-.28) .13 (.03-.23) 
20:00 h 638 20:12 h (0:31 h) 2.85 (1.60) .20 (.00-.42) .18 (.08-.29) 
22:30 h 649 22:39 h (0:28 h) 2.37 (1.95) .00 (.00-.18) .19 (.09-.29) 
Awakening 563 7:16 h (0:51 h) 15.68 (7.36) .52 (.26-.68) .12 (.00-.24) 
Awake + 0:30 h 319 7:45 h (0:58 h) 23.91 (8.23) .41 (.00-.67) .14 (.00-.30) 
 N = number of subjects sd = standard deviation CAR = cortisol awakening response 
Means were corrected for cortisol determination method. For the correlations the 95% 
confidence intervals are given in parentheses. Italic: variables for which an ADE instead of 
an ACE model is fitted. 
 
Confounders 
When examining the association between the cortisol concentration at the time points 
and the potential confounding variables (sex, age, current mood state, BMI, sleep quality, 
sleep duration, current habitual smoking status (yes/no), and oral contraceptives use), no 
association reached the .01 significance level.  
 
Genetic model fitting 
Model fitting showed that the means and variances for MZ twins, DZ twins, and 
singleton siblings could be constrained to be equal. Male correlations were equal to female 
correlations and correlations were not significantly different between DZ twins and 
singletons. These results indicate that DZ twins and siblings may be treated as individuals 
from one group in further analyses. There was a significant mean effect of the method used to 
determine the cortisol concentration. Mean cortisol levels were higher in the second group of 
participants (when LIA was used) than in the first group of participants (when DELFIA was 
used). We therefore kept type of immunoassay as a covariate on the mean and the variance in 
the variance decomposition models. Estimation of the effect of type of immunoassay on the 
variance was performed following Purcell’s gene-interaction model (Purcell, 2002). 
 
Fam












Figure 7.2 Example of an ECG/motility signal accompanying a negative cortisol awakening response 
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The twin correlations from the final, most parsimonious model are presented in the 
final two columns of table 7.1. There were minimal differences in MZ and DZ/sib correlations 
during most of the day. Based on the pattern of correlations, substantial familiar influences 
are only present for the visit sample and the early morning measures of cortisol. In case of the 
two early morning measures (awakening, 30 min post-awakening) MZ correlations were more 
than twice as high as the DZ/sib correlations, suggesting the presence of dominance genetic 
effects. Therefore, we fitted ADE models for these measures. We continued model fitting 
with the most parsimonious saturated model, i.e. a model with equal means, variances and 
two correlations, including type of immunoassay as a covariate. Table 7.2 summarizes the 
model fitting results for all univariate variance decomposition models. The accompanying 
univariate model estimates and 95% confidence intervals are shown in Table 7.3.  
 
Univariate genetic analyses - For both the awakening sample and the 30 min post-awakening 
sample, dismissing the dominance genetic effect did not cause a significant worsening of fit. 
In the AE model, additive genetic factors accounted for 33% of the variance in cortisol levels 
at awakening, while non-shared environmental influences accounted for the remaining 67% of 
the variance. For the cortisol concentration at 30 minutes post-awakening, genetic factors 
explained 34% of the variance, while non-shared environmental factors explained 66% of the 
variance.  
For the daytime samples at 11:00 h and 15:00 h, leaving out both shared 
environmental and genetic influences from the model (E model) did not cause a significant 
increase in χ². This means that the cortisol concentration at these time points is completely 
determined by non-shared environmental factors. The 20:00 h and the 22:30 h sample showed 
a significant worsening of fit when both genetic and common environmental factors were left 
out of the model, indicating that there is an influence of familial factors on cortisol levels at 
these time points. Statistical power, however, was insufficient to discriminate between genetic 
influences and shared environmental influences, since the estimates for A and C were quite 
small (<22%).   
For the first sample, taken during the visit of the researcher, the pattern of twin 
correlations and the estimates in the full ACE model indicate that the AE model is the most 
likely model, although statistical power is insufficient to discriminate between genetic and 
shared environmental factors. In the AE model, variance in cortisol concentration is for 29% 
explained by genetic influences.  
 
Bivariate genetic analysis - To determine whether the same genes underlie the individual 
differences in the two cortisol samples of the awakening period (awakening and 30 minutes 
post-awakening), they were analyzed in a bivariate analysis, for which the initial ADE model 
is illustrated in figure 7.3. The dominance genetic factor could be dismissed from the bivariate 
model without a significant loss of fit, thereby reducing it to a model including only additive 
genetic and non-shared environmental influences (AE model). 
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Table 7.2. Summary of the univariate model fitting results 
Model -2LL df ∆ χ²* ∆ df p-value AIC 
At visit       
ACE 2029.880 661        
AE 2029.880 662 0.000 1 1.000 -2.000 
CE 2032.287 662 2.407 1 0.121 0.407 
E 2045.544 663 15.664 2 0.000 11.664 
11:00 h       
ACE 1299.591 649        
AE 1299.817 650 0.226 1 0.635 -1.774 
CE 1299.591 650 0.000 1 1.000 -2.000 
E 1302.269 651 2.678 2 0.262 -1.322 
15:00 h       
ACE 1131.653 669        
AE 1132.588 670 0.935 1 0.334 -1.065 
CE 1131.653 670 0.000 1 1.000 -2.000 
E 1135.770 671 4.117 2 0.128 0.117 
20:00 h       
ACE 754.749 632        
AE 755.23 633 0.481 1 0.488 -1.519 
CE 754.765 633 0.016 1 0.899 -1.984 
E 764.198 634 9.449 2 0.009 5.449 
22:30 h       
ACE 3906.054 641        
AE 3907.763 642 1.709 1 0.191 -0.291 
CE 3906.054 642 0 1 1.000 -2.000 
E 3911.967 643 5.913 2 0.052 1.913 
Awakening       
ADE 1451.323 557        
AE 1451.323 558 0 1 1.000 -2.000 
E 1460.687 559 9.364 2 0.002 5.364 
Awake + 0030 h 
ADE 814.871 314        
AE 815.609 315 0.738 1 0.390 -1.262 
E 820.233 316 5.362 2 0.032 1.362 
-2LL: twice the negative log likelihood, df: degrees of freedom, AIC: Akaike’s Information 
criterion. When the increase in χ² (=∆ χ²) is not significant (p>.05), the most restrictive model 
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Table 7.3 Variance component estimates for each of the 7 diurnal samples  
Sample A C E 
At visit    
ACE .29 (.00-.43) .00 (.00-.22) .71 (.57-.89) 
AE .29 (.14-.43) - .71 (.57-.86) 
CE - .16 (.07-.26) .84 (.84-.93) 
E - - 1.00 
11:00 h    
ACE .00 (.00-.29) .08 (.00-.18) .92 (.71-1.00) 
AE .13 (.00-.29) - .87 (.71-1.00) 
CE - .08 (.00-.18) .92 (.82-1.00) 
E - - 1.00 
15:00 h    
ACE .00 (.00-.26) .09 (.00-.19) .91 (.74-1.00) 
AE .13 (.00-.28) - .87 (.72-1.00) 
CE - .09 (.00-.19) .91 (.81-1.00) 
E - - 1.00 
20:00 h    
ACE .04 (.00-.36) .12 (.00-.23) .84 (.64-.95) 
AE .22 (.07-.37) - .78 (.63-.93) 
CE - .14 (.05-.23) .86 (.77-.95) 
E - - 1.00 
22:30 h    
ACE .00 (.00-.28) .11 (.00-.21) .89 (.72-.98) 
AE .16 (.00-.32) - .84 (.68-.99) 
CE - .11 (.02-.21) .89 (.79-.98) 
E - - 1.00 
Sample A D E 
Awakening   
ADE .33 (.10-.53) .00 (.00-.16) .67 (.47-.89) 
AE .33 (.12-.53) - .67 (.47-.89) 
E - - 1.00 
Awake + 00:30 h 
ADE .05 (.00-.59) .44 (.00-.72) .51 (.28-.94) 
AE .34 (.03-.61) - .66 (.39-.97) 
E - - 1.00 
-: not available, since this estimate was set to zero. A: additive genetic variance component; 
D: Dominance genetic variance component; C: common environmental variance component; 
E: Non-shared environmental variance component. For each estimate the 95% confidence 
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Figure 7.3 Path diagram of the bivariate model for cortisol during the early morning 
period 
 
A: additive genetic component, D: dominance genetic component, E: non-shared 
environmental component, CAR: cortisol awakening response. Letters along the paths 
represent path coefficients. Subtracting the cortisol concentration at awakening from the 
concentration 30 minutes later is established by setting the path coefficients originating from 
the two measured concentrations (and pointing towards CAR) to 1 (awakening) and -1 (30 
minutes post-awakening). The heritability for CAR in the AE model is computed following the 
formula: 
A E E A D D 
                                 (a1)2 + (a2)2 + (a12)2- (2 * a1 * a12) 
((a1)2 + (a2)2 + (a12)2 – (2 * a1 * a12)) + ((e1)2 + (e2)2+ (e12)2 – (2 * e1 * e12)) 
 
 
Next, we tested whether both awakening samples are influenced by a single common 
genetic component, or whether additional genes come into play 30 minutes post-awakening. 
Dropping genetic effects unique for cortisol levels at 30 minutes post-awakening (path a2 in 
figure 7.3) did not significantly worsen the statistical fit of the model, which indicates that 
one common genetic component influenced cortisol concentration at both sampling times. 
The genetic correlation (rG) therefore is 1.00 in this most parsimonious model. Path 
coefficients from this common genetic factor to cortisol at awakening and cortisol 30 minutes 
post-awakening were similar at .52. We further tested whether non-shared environmental 
effects on awakening cortisol levels also influenced cortisol levels 30 minutes later. Setting 
the appropriate path (path e12 in figure 7.3) to zero significantly reduced the fit of the model, 
indicating that a significant amount of non-shared environment influences both cortisol levels 
at awakening and at 30 minutes post-awakening. In the most parsimonious model, additive 
genetic components accounted for 34% of the variance of cortisol at awakening and for 32% 
of the variance of cortisol levels 30 minutes post-awakening. In this present model, the 
heritability of the CAR was also estimated. The common genetic factor may influence the 
second variable in a different degree than the first variable, even though all influence-exerting 
genes are shared. In that case, this is reflected in a difference in path coefficients, and a 
significant heritability for CAR. However, model fitting showed that there were no additional 
genetic factors influencing the CAR when heritability for the two mean cortisol levels is taken 
into account. Table 7.4 shows the variance decomposition results of the bivariate analysis. 
Cortisol at 
awakening 
Cortisol at 0:30 h 
post-awakening 
e12







92                            Chapter Seven 
 
Table 7.5 presents the accompanying estimates of genetic and environmental influences under 
the best fitting model. 
 
Table 7.4 Bivariate model fitting results for cortisol in the early morning period 
Model -2LL df ∆χ² ∆df Vs. p-value AIC 
ADE 2112.305 868      
AE 2113.148 871 0.843 3 ADE 0.839 -5.157 
Reduced AE1 2113.861 872 0.713 1 AE 0.398 -1.287 
Reduced AE2 2135.244 872 22.096 1 AE 0.000 20.096 
E 2127.868 874 14.72 2 AE 0.002 10.72 
 -2LL: twice the negative log likelihood, df: degrees of freedom, AIC: Akaike’s Information 
criterion. When the increase in χ² (=∆ χ²) is not significant (p>.05), the most restrictive model 
is accepted. Bold indicates the most parsimonious model. 
1 No non-shared additive genetic component for cortisol 30 minutes post-awakening 





To understand the underlying sources of individual variation in basal cortisol levels 
throughout the day, we analyzed cortisol data collected at seven fixed time points during the 
day in adult twins and their singleton siblings from 310 twin families. Results showed that the 
early morning cortisol concentrations were under considerable genetic control (34-32%), 
while later daytime samples (11:00 h – 22:30 h) were predominantly under environmental 
control.  
 
Table 7.5 Variance component estimates for the cortisol measures of the early morning 
period 
Sample A D E 
Awakening .34 (.13-.53) - .66 (.47-.87) 
Awakening + 00:30 h .32 (.05-.59) - .68 (.41-.95) 
CAR .00 (.00-.18) - 1.00 (.82-1.00) 
The estimates for the best fitting model (AE reduced1) are presented in this table. The 95% 
confidence intervals are given in parentheses. 
 
Our finding that the early morning cortisol concentration is under genetic control 
concurs in part with previous findings. Wüst et al. (2000a) reported significant heritabilities 
(40% and 48%) for the mean increase and area under the curve of the cortisol awakening 
response, but not for the awakening sample.  
Bartels et al. (2003a) showed that genetic factors influenced the awakening sample for 22-
24%, and the morning sample taken an hour after awakening for 56-59%. Our current results 
confirm the presence of significant genetic contributions to the variance of both cortisol levels 
at awakening and at 30 minutes post-awakening.  
The twin correlations for the early morning samples (awakening and 30 minutes post-
awakening) indicated that dominance genetic effects might influence cortisol levels in the 
early morning period but model fitting showed that the more parsimonious AE model was 
preferred over the ADE model. It should be noted that the statistical power to reliably detect 
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genetic dominance effects is small (Posthuma & Boomsma, 2000). For the first morning 
sample (taken during the researcher’s visit), the MZ correlation was exactly twice the DZ 
correlation and no genetic dominance effects were suggested. Model fitting showed that a 
model including familial factors, most likely genetic, was the preferred model. In contrast to 
Wüst et al. (2000a), we did not find a genetic influence for the cortisol awakening response 
(CAR). Our bivariate analysis showed that the genetic influence on cortisol levels at 
awakening and at 30 minutes post-awakening completely overlapped. As a result, no 
additional heritability for the CAR was found.  
Our results indicate that the variation in daytime cortisol levels, in particular during 
the late morning and afternoon, is predominantly influenced by non-shared environmental 
factors. The large impact of non-shared environmental factors on cortisol levels from late 
morning to evening agrees with the notion that cortisol is secreted as a reaction to disturbance 
in the homeostatic equilibrium. Whether shared environmental factors play an additional role 
remains unclear. Like Bartels et al. (2003a), the study lacked power to discriminate between 
the AE and CE model for some of the sampling times, although the power in our study was 
larger than in all previous studies. The extended twin design employed in the current study 
increases statistical power to distinguish between the components A, C and E compared to a 
design including only MZ and DZ twins, giving it a statistical power sufficient to reliably 
detect familial effects larger than 35%. For effects smaller than 35% over 1500 subjects are 
needed (Posthuma & Boomsma, 2000).  
Recently, several studies reported on the effect of birth weight on cortisol 
concentrations (Phillips et al., 2000; Kajantie et al., 2002; Kajantie et al., 2004). The lower 
birth weight in twins may impact, according to the “Barker hypothesis”, on HPA axis activity 
(Phillips et al., 2000). In the present study, we were able to test whether the results obtained in 
twins differed from those in singleton siblings. By comparing singleton siblings with twins 
from the same family, the two comparison groups are perfectly matched for familial 
influences (same parents, different intrauterine circumstances, same family environment). Our 
analyses showed that MZ and DZ twins and singleton siblings did not differ from each other 
in means or variances on any of the basal diurnal cortisol samples. Importantly, sibling-
sibling covariance did not differ from sibling-twin or DZ-twin covariance, which strongly 
argues against a special twin intrauterine disadvantage with deleterious effects on adult 
cortisol concentrations. The lower birth weight in twins therefore does not seem to be a sign 
of diminished growth in the womb, but seems a natural adaptation to a twin pregnancy. The 
absence of any twin-singleton difference further indicates that estimates of the heritability of 
cortisol from twin studies generalize to the population at large.   
The availability of electrocardiogram and movement registration allowed us to check 
whether the time the awakening sample was taken corresponded with the real awakening 
time. Our results indicated that the observed negative awakening response in a subset of 
subjects was most likely due to an earlier awakening time than reported, resulting in an earlier 
acrophase than assumed based on the reported sampling times. These results suggests we 
should be careful when dealing with deviant cortisol awakening responses, as a decreased or 
altered response might as well be an artifact due to an earlier awakening (Desir et al., 1981; 
Smyth et al., 1997; Kunz-Ebrecht, Kirschbaum, Marmot, & Steptoe, 2004). The same care 
should be taken when examining cortisol levels at other times throughout the day. These 
observations should encourage future studies to very carefully check whether the first 
morning samples are taken at the moment subjects actually awoke, not when they were about 
to get up. A way of checking the compliance of subjects is by an electronic monitoring device 
attached to the salivette that accurately time stamps the moment the salivette was used 
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(Kudielka, Broderick, & Kirschbaum, 2003). Although this device is very helpful in the 
precise determination of the sampling times, it cannot detect that a subject awakes, but does 
not take the awakening sample until later on. Additional ECG and/or motility recording of the 
night and early morning hours can provide the true awakening time.   
An explanation for the varying genetic influences found for basal cortisol may lie in 
the difference in the role of the HPA axis and cortisol in the early morning hours and during 
the day. In the early morning hours, the biological clock of our body, the suprachiasmatic 
nucleus, prepares the body for the upcoming period of activity by an anticipatory rise in 
among others heart rate and cortisol (Buijs, van Eden, Goncharuk, & Kalsbeek, 2003b). As 
shown by our and other results, genetic factors control the absolute values of cortisol levels in 
this awakening period. During daytime, the main objective of the HPA axis is to maintain 
homeostasis within the body. Therefore, the absolute daytime levels of cortisol will be 
controlled by environmental feedback. This overshadows any genetic influence on the 
individual differences in cortisol during the day.  
 Up until now gene finding studies for basal cortisol have focused on either baseline 
cortisol measured anytime between 8:00 h and 17:00 h (e.g. Baghai et al., 2002; Keavney et 
al., 2005), or at total diurnal cortisol (e.g. Rosmond, Chagnon, Bouchard, & Bjorntorp, 2001). 
The current study shows that, while cortisol levels in the awakening period are influenced by 
genetic factors, cortisol levels throughout most of the day are not heritable; indicating that 
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The research in this thesis was inspired by the well-known familial clustering of 
cardiovascular diseases and was designed to make a contribution to the ultimate goal of 
elucidating the genetic pathways to this medical condition, which is one of the most important 
sources of morbidity and mortality in Western societies, i.e. in 2002, one third of the deaths in 
the Netherlands were caused by cardiovascular disease (CVD) (Koek et al., 2003). This final 
chapter will give a summary of this study’s results, and will then discuss the results in the 
light of existing literature. 
 
Heritability of physiological risk factors for CVD 
Only a small part of the pathologies encompassed under the name cardiovascular 
disease are caused by a single mutation in the genetic material, following Mendelian patterns 
of transmission. Some examples of these rare conditions include the thrombosis-causing 
Factor V Leiden (Kaykcoglu et al., 2005), and several kinds of Mendelian hypertension, like 
Liddle’s syndrome and hyperaldosteronism (New, Geller, Fallo, & Wilson, 2005). Non-
Mendelian cardiovascular diseases, however, are much more common, and a wide variety of 
them exists. The underlying quantitative variation in susceptibility to these varieties of 
cardiovascular disease is influenced by multiple common genes, with small individual 
contributions and by multiple environmental factors, as well as gene-gene and gene-
environment interactions. Although many linkage and association studies have been carried 
out to search for genes causing complex diseases the past decade, only few have led to 
identification of an actual causal locus (Iliadou & Snieder, 2004). There are several ways to 
enhance detection probability, for example by increasing sample size, or by selecting subjects 
from the extreme ends of the data distribution. In addition, it is increasingly common to use 
cardiovascular risk factors in genetic analyses instead of the diagnosis of CVD. Since these 
endophenotypes lie closer to the genes in the biological pathway, their variance is expected to 
be explained by fewer genes, and therefore the probability to detect individual causal genes 
might be larger.  
 Before proceeding with linkage studies with these endophenotypes, this thesis took the 
first crucial first step of establishing meaningful genetic contribution to the cardiovascular 
endophenotypes. Using figure 1.1 as a guideline (see introductory chapter) we focused on the 
risk factors listed in table 8.1. Some of these factors had been studied before in adult twin 
studies (HR, BP, RSA) others had been almost completely neglected so far (cortisol, PEP, 
RR). Importantly, none had been measured in naturalistic settings before, whilst taking 
appropriate account of their sensitivity to circadian rhythms and the continuous changes in 
mental, emotional, and physical load that characterize such settings. 
Overall, substantial contribution of genetic factors to the variance in ambulatory 
physiological risk factors was found. An overview is presented in table 8.1. In the following 
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Table 8.1 Summary of the heritability of cardiovascular risk factors 




Heart rate variability SDNN index 35-47 % 43% 
 RMSSD 41-48 % 40% 
SBP 46-63% - Blood pressure DBP 44-57% - 
Heart rate HP 37-45 % 48% 
Respiratory sinus arrhythmia 
(parasympathetic tone) RSA  40-55 % 54% 
PEP 55-62 % 48% Cardiac contractility 
(sympathetic tone) PEP/LVET ratio 48-58 % 35% 
 HI 38-50 % 41% 
HPA axis activity Cortisol 0-34%  
 
Blood pressure 
Hypertension is a main risk factor for cardiac disease, stroke and renal disease 
(Franklin et al., 2001; Verdecchia et al., 1998; Pickering & Devereux, 1987) that is linked to 
sympathetic hyperactivity (Mussalo et al., 2001; Neumann, Ligtenberg, Klein, Koomans, & 
Blankestijn, 2004). Ambulatory blood pressure is a well-established measure that is often 
used in diagnosing hypertension. Chapter three presented estimates for genetic influence on 
hypertensive status and on ambulatory systolic (SBP) and diastolic blood pressure (DBP). 
Hypertension diagnosis was heritable for 61%, while SBP and DBP heritability ranged 
between 44 and 63%. 
 A further important goal in this analysis was to examine the effects of exclusion on the 
heritability estimates. We hypothesized that exclusion of (medicated) hypertensive subjects 
would be detrimental to blood pressure heritability estimates. To test this, all genetic analyses 
on ambulatory blood pressure were first performed on normotensive subjects only, secondly 
after exclusion of medicated hypertensive subjects, and finally without any exclusion. In this 
final analysis, including both normotensive and (medicated) hypertensive subjects, a subject-
specific blood pressure correction was carried out that was based on the antihypertensive 
medication subjects were taking at the moment of measurement. Comparing the results of 
these three analyses, it is evident that exclusion of hypertensive and medicated subjects alters 
twin correlations and causes a decrease in heritability. This makes sense, since including 
subjects with a daytime blood pressure in the hypertensive regions increases variance. In 
addition, from a genetic point of view these subjects probably are the most interesting ones. 
Based on the evidence provided by these results, future linkage and association studies should 
be encouraged to include hypertensive subjects in their studies and to apply a medication 
specific blood pressure correction for those on antihypertensive medication.  
 
Heart rate variability 
Vagal activation of the heart decreases heart rate and increases heart rate variability 
and has important protecting effects on the heart. For example, it protects the heart from 
arrhythmic events (Brooks, Verrier, & Lown, 1981) and atherosclerosis of the coronary artery 
(Beere, Glagov, & Zarins, 1984).  
There is substantial individual variation in heart rate variability levels (Huikuri et al., 
1990; Abdel-Rahman, Merrill, & Wooles, 1994; Ben Lamine et al., 2004). In chapter four and 
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five of this thesis we hypothesized that genes contribute considerably to this variance. Time-
domain measures of heart rate variability were used to determine the influence of genetic 
components on the individual differences in heart rate variability. Chapter four reported on 
SDNN index and RMSSD. These two short-term heart rate variability measures reflect vagal 
control over the heart. Indeed, it was found that individual differences in heart rate variability 
can for a large part be attributed to genetic influences, as revealed by the heritability 
estimates, which varied between 35% and 48%.  
 Chapter five presented the heritability results of the third heart rate variability measure, 
RSA, which specifically represents the natural cycle of arrhythmia that occurs through the 
influence of breathing on the flow of vagal impulses to the sinoatrial node. RSA was found to 
be heritable in a considerable degree (35% -55%) and the magnitude of this genetic influence 
was in congruence with the other two indices for heart rate variability. In addition this chapter 
also presented heritability estimates for heart rate (37-48%) and respiration rate (27-81%). 
Although the multivariate analyses including respiration, RSA and heart rate were carried out 
separately for each period of day, the results were highly comparable. Heritabilities of RSA 
and heart rate increased moderately with the progression of the day. Individual differences in 
respiration rate could almost be fully attributed to genetic factors during nighttime.  
 In contrast to the SDNN index or RMSSD, the RSA measure has not often been 
employed in cardiology. Nevertheless, several previous studies have pointed out that RSA is 
the more valuable diagnostic tool to assess parasympathetic control over the heart (Hrushesky 
et al., 1991; Moser et al., 1994). Our results show good congruence in heritability estimates 
between the measures SDNN, RMSSD, and RSA. This supports the notion that besides 
SDNN and RMSSD, RSA might be a valuable addition to genetic research in cardiology. 
 
Parasympathetic contribution to cardiorespiratory coupling 
The question whether RSA is a more valid index of between-subjects differences in 
cardiac vagal tone when individual differences in respiratory behavior are taken into account, 
is a much debated issue in the field of psychophysiology. It has even been suggested that the 
validity of RSA as a predictor for cardiovascular disease could potentially benefit from a 
correction for respiration rate. Results from a previous genetic laboratory study, however, 
already suggested that the well-established association between respiration rate and RSA 
might be substantially due to an overlap in genes contributing to these variables (Snieder et 
al., 1997). Chapter five extends this finding to ambulatory settings. A trivariate analysis 
including ambulatory respiration rate, RSA and heart rate, was performed to determine the 
genetic and environmental contributions to the covariances between these three variables. The 
study showed the presence of a single common genetic factor shared between respiration rate, 
RSA and heart period, possibly representing genes affecting general aspects of 
neurotransmission in either limbic or brainstem areas involved in cardiovascular and 
respiratory control (Bradley et al., 2002; Severson et al., 2003; Richerson, 2004). A second 
genetic factor was identified that is shared between RSA and heart period only. The 
pleiotropic genes influencing both RSA and heart rate might be involved in parasympathetic 
activation of the heart, e.g. genes playing a role in potassium signal transmission in the 
sinoatrial node (Gehrmann et al., 2002).  
Finally, our results showed the presence of a third factor that influenced heart period 
only, but none of the others. This final genetic factor represents all genetic influences on heart 
rate that cannot be attributed to either respiration or the parasympathetic nervous system. For 
example, such genetic influences might involve genes that influence the regulation of β-
adrenergic receptors (Koch, 2004). 
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 Besides the finding that RSA and respiration rate share a common set of genes, we found 
in an additional analysis that the heritability estimates from the analysis in which RSA was 
corrected for respiration rate were substantially lower than the estimates that resulted from the 
analysis on uncorrected RSA. It was concluded that the use of residualized scores of RSA in 
genetic studies is unfounded because this removes genetic variance shared by respiration rate 
and RSA. 
 
Sympathetic control over cardiac contractility 
Impedance-derived measures of sympathetic cardiac control have not been used in 
genetic studies that investigate etiological factors of cardiovascular disease. Chapter six of 
this thesis is the first report on the heritability of cardiac contractility, and does so in an 
ambulatory design. Substantial heritability was found for all contractility indices: the pre-
ejection period (48-62%), the PEP/LVET ratio (40-58%), and the Heather index of cardiac 
contractility (38-50%). These results suggest that genetic variation is a principal determinant 
of sympathetic inotropic drive. This has important consequences for the risk for left 
ventricular hypertrophy and heart failure where the sympathetic nervous system has been 
suggested to play a vital role (Rundqvist et al., 1997; Kaye et al., 1995; Swedberg et al., 
1990). Subjects with a genetic make-up that gives rise to an increased β-adrenergic drive to 
the left ventricle, evident in a shorter PEP and lower PEP/LVET ratio and an increased HI 
value, may be at larger risk to develop heart failure than subjects with lower inotropic drive. 
Specifically, a chronic state of sympathetic hyperactivity is thought to enhance age-related 
functional down-regulation of myocardial β-receptors (El Armouche et al., 2003; Bogaert & 
Fraeyman, 1991; Andersson, 1986; Xiao et al., 1999). Down-regulation in the face of 
chronically enlarged sympathetic inotropic drive might initially constitute a cardioprotective 
compensatory response, but in the long run will negatively affect cardiac output (Communal 
& Colucci, 2005; Engelhardt et al., 1999; Iwase et al., 1996). The resulting reduction in 
cardiac output is initially compensated by a further increase in cardiac sympathetic drive, 
supported by increased activity level of the renin-angiotensin system. In the disease phase, the 
effectiveness of the additional sympathetic activity is further reduced and net contractility is 
lowered. Indeed, studies employing impedance cardiography have shown that hearts with 
reduced left ventricular function show an increase in PEP/LVET ratio, and a severity-
dependent decrease in HI (Fuller, 1994). In addition, the failing heart has been associated with 
a prolonged PEP and a decrease in LVET (Weissler et al., 1968; Ahmed et al., 1972).  
 
Cortisol 
Chapter seven of the present thesis investigated the underlying sources of individual 
variation in basal daytime cortisol levels for seven fixed time points during the day. Recently, 
cortisol levels in the morning were found to be an independent risk factor for cardiovascular 
disease and diabetes (Rosmond & Bjorntorp, 2000). Our results showed that only the early 
morning cortisol levels (at awakening and 30 minutes later) were under the control of one 
genetic factor (34-32%). Levels of cortisol later during the day (11:00h-22:30h) were 
predominantly influenced by environmental components. It is our conclusion that, when 
investigating the biological mechanism underlying the relation between cortisol levels and 
cardiovascular disease, the early morning period is the most important period to collect 
cortisol.  
A stern requirement for obtaining reliable results is to assure good compliance of the 
participants with the salivary sampling procedure. Participants do not always take the samples 
at the indicated times. Results described in the present thesis show that participants have 
 
 
100  Chapter Eight 
 
trouble identifying the correct moment of awakening. Because the samples that are used to 
define the awakening response, are taken relative to the awakening time, imprecision of 
subjective estimates of awakening can have rather severe repercussions. As an unexpected 
bonus, the practice of salivary sampling with simultaneous motility and heart rate monitoring 
(in this thesis by the VU-AMS device) greatly improves the reliability of the former. 
  
Diurnal patterns in sympathovagal balance 
The well-known diurnal pattern of the sympathovagal balance, with sympathetic 
dominance during the day shifting to parasympathetic dominance during the night (Burgess, 
Trinder, Kim, & Luke, 1997; van Eekelen, Houtveen, & Kerkhof, 2004), is mirrored in the 
heritability estimates of the study’s parasympathetic and sympathetic indices. While the 
heritability of heart rate variability (parasympathetic) stays stable at night compared to 
daytime, the heritability of pre-ejection period (sympathetic) decreases. Taken together, the 
diurnal pattern in sympathovagal balance is in congruence with the finding that increased 
vagal activity at night is predominantly a function of sleep-onset, while the decreased 
sympathetic activity, reflected by an increase in PEP, is predominantly influenced by 
circadian factors (Carrington et al., 2003). 
For parasympathetic activity small (8% for RMSSD and 12% for SDNN index) sleep-
specific genetic effects were found. For sympathetic activity, new genetic influences emerged 
during the night, too. For the Heather index, these nighttime-specific genetic influences were 
even as large as the influence of the common genetic factor influencing all periods of day 
(20%). In animal models, metabolic gene expression in the heart shows considerable diurnal 
variation (Takekida, Yan, Maywood, Hastings, & Okamura, 2000; Martino et al., 2004) 
which may have external origins, such as diurnal variation in sympathetic nervous system 
activity driven by the suprachiasmatic nucleus (Buijs et al., 2003a), but may also be affected 
by factors intrinsic to the heart, such as endogenous transcriptional regulators and 
timekeeping genes (Young et al., 2001). Our results suggest that separate sources of genetic 
variation in sympathetic activity during wake and sleep periods also exist in humans.  
 
 
Comorbidity of depression and cardiovascular disease 
Families were selected for participation based on the requirement that at least two 
members of a family scored extremely discordant or concordant on a factor score that 
indicated genetic vulnerability for anxious depression. Because of the recruitment of 
additional siblings in the selected families, independent of their anxious depression scores, the 
distribution of the factor score approximated the normal distribution found in the population 
at large (Boomsma et al., 2000). To test whether the sample could be considered unselected 
for the physiological cardiovascular risk factors, the degree of their association to the anxious 
depression vulnerability score used in the original selection was computed. Throughout, very 
small non-significant correlations were found, suggesting that the sample was not biased for 
the risk factors examined. 
 Previous studies have pointed towards an association of anxiety, depression and negative 
emotions with cardiovascular morbidity and mortality (e.g. Gottlieb et al., 2004; Rudisch & 
Nemeroff, 2003) and have shown an overlap in alterations in cardiac autonomic tone in both 
disorders (Carney, Freedland, Miller, & Jaffe, 2002). Most of these studies used a patient-
versus-control-design, whereas we ascertained mostly healthy subjects from a population 
based register (twinning occurs randomly across many potential confounders like, for 
instance, SES). Only a limited amount of subjects that participated in the ambulatory 
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monitoring study actually had a lifetime diagnosis of clinical depression. In total, 688 of our 
816 subjects participated in a clinical interview (CIDI) that was described in the thesis of van 
den Berg (2002). Only 104 of the interviewed subjects qualified for a lifetime diagnosis of 
clinical depression (diagnosed according to the DSM-IV manual) which was mostly due to a 
single mild episode rather than recurrent severe depression. 
 Finally, most of the large epidemiological trials that find comorbidity between 
depression and cardiovascular disease risk, generally used subjects aged substantially older 
than the twins and singletons in our sample. Clearly, the absence of an association between 
physiological cardiovascular risk factors and anxious depression in our young, premorbid 
sample does not exclude the possibility that, over time, genes and environment will interact 
increasingly to influence both symptoms of depression and symptoms of cardiovascular 
disease. A better insight in these longitudinal gene-environment interactions may be needed to 
further our in understanding of the comorbidity of cardiovascular disease and depression.  
 
Twin-singleton differences 
In twin research it is important to know whether the used variables are influenced by 
twin-specific effects. The extended twin design that was employed in the present thesis 
provided an optimal case-control match for the twins: a non-twin sibling that is raised in the 
same household, by the same parents. They even have shared the same womb with the twins, 
although alone and not at the same time. Using such a matched twin-singleton design is ideal 
to test the assumption that results on twins generalize to the general population. This is 
particularly relevant in view of Barker’s “fetal origins hypothesis” that states that 
cardiovascular disease and non-insulin dependent diabetes originate through adaptations the 
fetus makes when it is undernourished. These adaptations may permanently change the 
structure and function of the body, and include the slowing of growth, but also may be of 
cardiovascular, metabolic or endocrine origin (Barker, 1999a; Barker, 1999b; IJzerman et al., 
2003).  
 Research on the Barker hypothesis, usually operationalizes fetal undernourishment by 
birth weight. In general, twins have a much lower birth weight than singleton siblings. In the 
NETAMB sample, for example, twins were on average 921.2 grams lighter than the 
singletons. In spite of this difference in birth weight, for all our physiological variables (heart 
rate variability, respiration rate, heart rate, blood pressure, systolic time intervals, cardiac 
contractility and cortisol) the monozygotic or dizygotic twins did not differ from singleton 
siblings in means, variances and covariances of any of the measured variables. Previous 
studies also have found no twin-singleton differences for several cardiovascular risk factors 
(Akiyama et al., 1999; Andrew et al., 2001; de Geus et al., 2001), personality, depression, and 
emotional behavior (Kendler, Martin, Heath, & Eaves, 1995; Johnson, Krueger, Bouchard, & 
McGue, 2002; Moilanen et al., 1999). This evidence strongly indicates the absence of special 
twin intrauterine disadvantages with potentially deleterious health effects. The lower weight 
of twins is not a sign of diminished growth in the womb caused by disadvantageous 
intrauterine influences, but a natural adaptation to a twin pregnancy (Blickstein, 2004). 
Several studies have indicated that twins slow down their growth rate early in gestation, 
possibly during the first trimester (Leveno, Santos-Ramos, Duenhoelter, Reisch, & Whalley, 
1979; Liu & Blair, 2002). Across twin pairs, the Barker association does hold as well as it 
does across singletons. Within the twin population, twins with relatively lower birth weights 
are at more risk than twins with relatively higher birth weights (Ijzerman et al., 2001). The 
lower absolute birth weight of twins compared to a singleton population does not, however, 
reflect the kind of impaired fetal environment relevant to the Barker hypothesis. 
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Age-dependent gene-expression 
It is commonly appreciated that the association between cardiovascular risk factors 
and subsequent cardiovascular pathology may change with age (e.g. Franklin et al., 2001). 
Several studies have reported on age-dependent heritability of cardiovascular risk factors 
(body mass index, systolic blood pressure and cholesterol). Almost all originate from the 
Framingham Heart Study. Their study population is large enough to examine age cohorts, and 
participants have been measured repeatedly over the past decades. In age-stratified 
longitudinal genetic analyses of systolic blood pressure, body mass index and cholesterol, 
Framingham researchers found little genetic variation over time (Brown et al., 2003; Mathias 
et al., 2003). These reports suggest that there is a stable genetic influence on the observed 
variation in these cardiovascular risk factors over decades. However, it does not rule out the 
possibility that different genes affect these risk factors at different ages.  
 We should, therefore, keep in mind that the NETAMB sample consisted of adults (males 
and females) who were for the majority between 20 and 40 years of age. Generalization of the 
results of this thesis beyond the main age range should be done cautiously. The amount of 
genetic influence on, e.g. heart rate variability or PEP/LVET ratio may change as our subjects 
grow older, but also the kind of genes that are expressed may be age-dependent (Volkova, 
Garg, Dick, & Boheler, 2005). In addition, we cannot be sure that the genes that are causing 
low heart rate variability or an elevated PEP/LVET ratio in the present are the same genes that 
cause low heart rate variability or an elevated PEP/LVET ratio later in life.  
   
Directions for future research 
 
Pleiotropy 
To date, studies on the genetic epidemiology of cardiovascular risk factors have 
chosen to model the risk factors separately most of the time. This approach was largely 
repeated in this thesis. In chapter five of the present thesis, however, it could be shown that 
heart rate and RSA are influenced by a shared genetic factor. The question arises whether the 
heritability of some (or all?) of our physiological risk factors also derives from common 
genetic factors. Previous research, that modeled independent risk factors for cardiovascular 
disease in multivariate genetic analyses, further supports this notion of genetic pleiotropy. Juo 
et al. (2004) showed that obesity and the thickness of the carotid intima-media may be 
affected by common genetic factors. In addition, a shared genetic component was reported for 
plasma cholesterol, systolic blood pressure, and body weight (Havill & Mahaney, 2003).  
Future multivariate genetic analyses on all of our cardiovascular risk factors (reduced to one 
daytime and one sleep time value) will provide more insight into the existence of a common 
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Gene finding 
The final step will be to identify the actual genes involved in the heritability of the 
physiological risk factors at hand. This can be done through linkage or association studies 
(Vink & Boomsma, 2002). In this regard, ambulatory data has a large advantage over 
conventional laboratory data. First, since ambulatory monitoring takes place during everyday 
life, in the subject’s own environment such measurements have high ecological validity. 
Possible negative consequences of excessive reactivity on cardiovascular health will derive 
from frequent exposure to stress during daily life. Therefore, assessing cardiovascular 
function in naturalistic settings during daily life makes good sense. Secondly, due to the 
intrinsic multivariate nature with highly correlated repeated observations, measurement error 
can be reduced and estimation of the latent genetic factor improved (Allison et al., 1998). In 
short, ambulatory monitoring of heart rate variability, blood pressure, heart rate, respiratory 
sinus arrhythmia, cardiac contractility, and cortisol can help us identify the genes influencing 
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De erfelijkheid van risicofactoren voor hart- en vaatziekten 





Hart-en vaatziekten zijn een belangrijke doodsoorzaak in Nederland. In 2002 was een derde 
van de sterfgevallen hieraan toe te schrijven (Koek et al., 2003). Hart- en vaatziekten is een 
verzamelnaam voor een verscheidenheid aan aandoeningen. Voorbeelden zijn herseninfarct, 
hartinfarct, angina pectoris en hartfalen. De oorzaken voor het ontstaan en het verloop van 
hart- en vaatziekten zijn complex, en vele factoren dragen hieraan bij. Zo is het duidelijk dat 
in sommige families hart-en vaatziekten vaker voorkomen dan in andere. Deze familiale 
component zou verklaard kunnen worden door een genetische aanleg, maar zou ook voort 
kunnen komen uit bepaalde omgevingselementen, zoals leefgewoonten. Dit proefschrift 
beschrijft de resultaten van een grootschalig genetisch epidemiologisch onderzoek naar hart- 
en vaatziekten. Het doel van dit onderzoek was het in kaart brengen van de relatieve invloed 
van genetische en omgevingsfactoren op een aantal belangrijke  risicofactoren voor hart- en 
vaatziekten.   
 
Het hart en de bloedvaten worden aangestuurd door het autonome zenuwstelsel. Het 
autonome zenuwstelsel heeft als taak de basale processen in de organen te reguleren die nodig 
zijn voor het normale functioneren van het lichaam. Het autonome zenuwstelsel bestaat uit 
twee takken: het parasympathische en het sympathische zenuwstelsel. Het parasympathische 
systeem heeft een remmend effect op het hart. Dat wil zeggen dat het de hartslag verlaagt, de 
hartslagvariabiliteit verhoogt en de bloeddruk verlaagt. Het sympathische systeem werkt 
tegenovergesteld en zorgt in het algemeen voor een verhoging van de hartslag en de 
bloeddruk. Gedurende de slaap is het parasympathische zenuwstelsel dominant in de 
aansturing van het hart en de vaten. Overdag tijdens de wakkere periode is de balans tussen 
het sympathische en parasympathische zenuwstelsel afhankelijk van de mentale en fysieke 
belasting. In rustige situaties heeft het parasympathische zenuwstelsel de overhand, terwijl bij 
fysieke belasting, zoals sporten, of mentale belasting, zoals sterke emoties, het sympathische 
zenuwstelsel actief wordt.  
 
Er bestaan verschillende maten die de activiteit van het sympathische en parasympathische 
zenuwstelsel weergeven. Hartslagvariabiliteit is voornamelijk parasympathisch van 
oorsprong, en veelgebruikte maten van hartslagvariabiliteit zoals SDNN-index, RMSSD en 
RSA kunnen worden gezien als indicatoren van de parasympathische sturing van het hart. De 
samenknijpkracht van het hart is voornamelijk sympathisch van oorsprong en maten voor de 
samenknijpkracht van het hart, ofwel ‘contractiliteit’, zoals de PEP en de Heather index 
kunnen worden gezien als indicatoren van de sympathische sturing van het hart. Het risico op 
hart- en vaatziekten wordt gekenmerkt door een algemene verschuiving van de balans tussen 
de activiteit van het parasympathische en sympathische zenuwstelsel in de richting van 
sympathische dominantie. Hierbij is er sprake van een verlaagde hartslagvariabiliteit en een 
verhoogde bloeddruk en hartslag. Dit zijn alledrie onafhankelijke voorspellers van het krijgen 
van of sterven aan hart- en vaatziekten. Het vinden van genen voor deze indicatoren van 
parasympathische of sympathische activiteit kan ons dus meer kennis verschaffen over het 
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Tot nu toe zijn de meeste studies naar de invloed van genen op het hart- en vaatstelsel gedaan 
door gegevens te verzamelen in een laboratoriumsituatie. Het is echter aannemelijk dat de 
genetische processen die een rol spelen bij het functioneren in het dagelijkse leven niet 
allemaal tot uiting komen in een kunstmatige laboratoriumomgeving. Daarom is er in dit 
onderzoek voor gekozen om de erfelijkheid van de risicofactoren te onderzoeken in 
‘ambulant’ gemeten gegevens. Ambulant meten is een methode waarbij met behulp van kleine 
draagbare meetapparatuur biologische gegevens verzameld worden bij proefpersonen die 
vrijelijk, in hun eigen omgeving hun normale dagelijkse bezigheden uitvoeren. 
 
Onderzoek bij tweelingfamilies 
 
Om dit onderzoek uit te voeren, hebben we een grote groep volwassen tweelingen benaderd 
voor deelname. Het vergelijken van de mate van overeenkomst voor een eigenschap tussen 
eeneiige (MZ) tweelingen, die dezelfde genen hebben, en de mate van overeenkomst tussen 
twee-eiige (DZ) tweelingen, die gemiddeld 50% dezelfde genen hebben, geeft informatie over 
de relatieve bijdrage van genetische en omgevingsinvloeden aan de individuele verschillen 
voor deze eigenschap. Als MZ tweelingen veel vaker op elkaar lijken dan DZ tweelingen is de 
eigenschap in grotere mate erfelijk bepaald. Naast de tweeling, hebben we ook de eventueel 
aanwezige enkelgeboren broers en zussen gevraagd voor deelname. Dit onderzoeksdesign 
wordt ook wel een uitgebreid tweelingdesign (extended twin design) genoemd. Zo’n design 
heeft voordelen ten opzichte van een klassiek tweelingdesign waaraan alleen maar tweelingen 
meedoen. Zo wordt het vermogen (power) om onderscheid te maken tussen genetische en 
omgevingsfactoren die gedeeld worden binnen een familie, groter door toevoeging van één of 
meerdere enkelgeboren broers of zussen.  
In totaal werd bij 816 proefpersonen met behulp van ambulante meetkastjes de bloeddruk 
gedurende de dag gemeten en een 24-uurs hartregistratie gemaakt. De opname had bij 
voorkeur plaats op een werkdag van de deelnemer, in zijn of haar dagelijkse omgeving. Op 
gezette tijden gedurende de meetdag verzamelden de proefpersonen speeksel, voor de 
bepaling van de concentratie van het bijnierschorshormoon cortisol. Om de enorme 
hoeveelheid gegevens die een 24-uursmeting met zich meebrengt, te reduceren, hebben we op 
basis van de zelfrapportage van houdingen en activiteiten in het dagboek van de 
proefpersonen en het bewegingssignaal uit ambulante hartmeter voor iedere deelnemer de 
meting opgedeeld in stukken waarin de houding van de proefpersoon gelijk bleef. Ook 
berekenden we gemiddeldes over dagdelen, gebaseerd op de door de proefpersoon 
gerapporteerde eet-, bed- en opstatijden. Voor elk van de gemeten risicofactoren maakten we 
steeds twee sets, één met de gemiddeldes van de gegevens in alle houdingen gedurende een 
dagdeel, en één met alleen de gemiddeldes gemeten tijdens een zittende houding gedurende 
een dagdeel. In de volgende paragrafen worden de resultaten voor de vier belangrijkste 





Elke 30 minuten werd gedurende de periode dat de proefpersoon wakker was de bloeddruk 
gemeten. De resultaten, beschreven in hoofdstuk 3, gaven aan dat 14.5% van de 
onderzoekspopulatie een te hoge bloeddruk had (een bovendruk hoger dan 135 mm kwikdruk, 
en/of een onderdruk hoger dan 85 mm kwikdruk, gemiddeld over de gehele dag). Mannen 
bleken een grotere kans te hebben om boven deze drempelwaarde te zitten, en die kans steeg 
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met leeftijd. Genetische analyse van de gegevens liet zien dat familiaire factoren, zoals genen 
en de gemeenschappelijke omgeving binnen een gezin, heel belangrijk zijn voor het hebben 
van een te hoge bloeddruk. Genetische invloeden verklaarden 61% van het verschil tussen 
mensen in het risico op hoge bloeddruk. Verder onderzochten we of gedurende de hele dag 
(ochtend, middag en avond) dezelfde genen een rol speelden of dat tijdens een werkperiode 
(ochtend, middag) andere genen een invloed uitoefenden dan tijdens een ontspanningsperiode 
(avond). We vonden dat over de dag heen één overkoepelende genetische factor de variatie in 
bloeddruk beïnvloedt. Verder testten we de hypothese dat de erfelijkheid van de bloeddruk 
zou worden onderschat als we de mensen met een te hoge bloeddruk of bloeddrukmedicatie 
uit de analyse weg zouden laten, een gebruikelijke handelwijze in veel studies naar de 
bloeddruk. De invloed van de algemene genetische factor op de bovendruk werd geschat op 
44 tot 57% bij het includeren van mensen met hoge bloeddruk en/of bloeddrukmedicatie en 
daalde met 7 tot 12% door het eruit laten van deze groep. De erfelijkheid van de onderdruk 
werd geschat op 46 tot 63%, en deze schattingen daalden met 8 tot 15% door weglating van 
de gegevens van de personen met hoge bloeddruk en/of bloeddrukmedicatie. Weglaten van 
personen met een te hoge bloeddruk en/of bloeddrukmedicatie is in genetische analyses dus 
niet verstandig, omdat de rol van de genen dan wordt onderschat.  
 
Tabel 1 Samenvatting van de erfelijkheidsschattingen voor de gemeten cardiovasculaire 
risicofactoren 
Risicofactor Maten Erfelijkheid 
overdag  
Erfelijkheid slaap 
HPA-as activiteit Cortisol 0-34% - 
SDNN index 35-47 % 43% Hartslagvariabiliteit RMSSD 41-48 % 40% 
SBP 46-63% - Bloeddruk DBP 44-57% - 




RSA  40-55 % 54% 
PEP 55-62 % 48% 




Normaal gesproken laat de hartslag een periodieke variatie zien in het tijdsinterval tussen 
opeenvolgende hartslagen. Dit fenomeen wordt ook wel hartslagvariabiliteit genoemd, en 
wordt gebruikt als maat voor parasympathische sturing van het hart. Een verlaagde 
hartslagvariabiliteit is een onafhankelijke voorspeller voor het ontstaan van, en het sterven 
door hart- en vaatziekten. Daarom is het belangrijk te weten hoe genen de variatie in 
hartslagvariabiliteit beïnvloeden. In hoofdstuk 4 en 5 werden drie maten van 
hartslagvariabiliteit behandeld. Hoofdstuk 4 ging over SDNN-index en RMSSD. Deze twee 
maten worden afgeleid uit het electrocardiogram, en worden veel in de cardiologische praktijk 
gebruikt. Het is dus erg relevant om van deze maten te weten te komen hoe erfelijk ze zijn, als 
ze gemeten zijn in een natuurlijke omgeving. We vonden dat één overkoepelende genetische 
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factor verantwoordelijk was voor een substantieel deel van de individuele verschillen in 
hartslagvariabiliteit over de gehele meetperiode (ochtend, middag, avond en nacht). Een 
samenvatting van de schattingen is te vinden in tabel 1. Gedurende de nacht vonden we een 
kleine additionele nacht-specifieke genetische factor (8-12%). Voor SDNN-index vonden we 
ook nog een kleine ochtendspecifieke genetische factor (7%). 
Hoofdstuk 5 beschreef een analyse waarin gelijktijdig werd gekeken naar de relatie tussen 
ademhaling, RSA en hartslag. Daarbij werd niet alleen voor elk van deze variabelen de 
erfelijkheid bepaald, maar kon tevens worden vastgesteld of het onderlinge verband tussen 
deze maten ook een erfelijke component heeft. Anders gezegd, werd er bepaald of deze maten 
deels door dezelfde genetische factoren werden beïnvloed. RSA is een speciale maat voor 
hartslagvariabiliteit waarbij uitsluitend gekeken wordt naar de ademhalingsafhankelijke 
variabiliteit in de hartslag. Tijdens inademing gaat de hartslag sneller, terwijl tijdens 
uitademing de hartslag iets vertraagt. Meer dan de eerder genoemde maten voor 
hartslagvariabiliteit, geeft de RSA de activiteit van het parasympatische zenuwstelsel weer. 
RSA blijkt sterk erfelijk bepaald (zie tabel 1). Tevens werd gevonden dat de genetische 
factoren die de RSA beïnvloeden voor een deel (8-16%) overlappen met de genetische 
factoren die ademfrequentie beïnvloeden en voor een deel (6-17%) overlappen met de 
genetische factoren die de hartslag beïnvloeden.. Voor toekomstige genetische studies 
betekenen deze resultaten dat RSA niet zomaar gecorrigeerd kan worden voor ademfrequentie 




De linker hartkamer wordt vrijwel alleen maar door sympathische zenuwen aangestuurd. Het 
sympathische zenuwstelsel heeft dan ook een dominante rol in de regulatie van de 
contractiliteit (samenknijpkracht) van het hart. Om meer te weten te komen over de invloed 
van erfelijke factoren op de sympathische sturing van het hart hebben we gedurende de 
ambulante meting een impedantiecardiogram opgenomen. Het impedantiecardiogram wordt 
gemaakt met behulp van vier electroden op de borstkas. De gemeten wisselstroomweerstand 
(impedantie) geeft de veranderingen in bloedvolume in de borstkas weer en daarmee indirect 
het slagvolume van het hart. In combinatie met het electrocardiogram kunnen we de tijd 
bepalen tussen het begin van de electrische impuls in de ‘pacemaker’cellen en het openen van 
de linker hartklep. Dit tijdsinterval, dat ook wel de pre-ejectie periode (PEP) wordt genoemd, 
is een indicator van de sympathische sturing van het hart. In hoofdstuk 6 rapporteerden we de 
resultaten van de genetische analyse van deze gegevens. We gebruikten drie maten voor de 
samenknijpkracht van het hart (PEP, PEP/LVET ratio en de Heather index). Deze maten 
werden voor een groot deel beïnvloed door genen (35-62%). Weer was er één overkoepelende 
genetische component, die over de hele 24-uursperiode van invloed was. De invloed van de 
genen nam wat af gedurende de nacht. In de slaap kwamen wel specifieke genetische 
invloeden te voorschijn die overdag niet zichtbaar waren. Deze hadden een geringe, maar 
significante (8-20%) invloed. De erfelijkheidsschattingen voor sympathische sturing van de 
knijpkracht van het hart staan in tabel 1. Het potentiële belang van de genen voor sympatische 
zenuwstelselactiviteit is groot. Te hevige of langdurige sympathische activiteit in reactie op 
allerlei fysieke en mentale prikkels wordt verantwoordelijk gehouden voor het risico op hoge 









Cortisol is een steroїd hormoon dat wordt uitgescheiden uit de bijnierschors, met een 
belangrijke rol in allerlei lichaamsprocessen zoals de regulatie van vaatvernauwing, het 
suikergehalte en het afweersysteem. Cortisol is het eindproduct van een zeer nauwkeurig 
afgestelde hormonale cascade die begint in de hersenen en via de hypothalamus en de 
hypofyse eindigt in de bijnierschors, met terugkoppeling van cortisol op elk van deze 
tussenstations. In hoofdstuk 7 werd beschreven hoe op 7 tijdspunten gedurende de 
meetperiode speeksel werd verzameld waarin later de basale concentratie cortisol werd 
gemeten.  
De resultaten lieten zien dat het cortisolniveau vroeg in de ochtend (meteen na het wakker 
worden, en een half uur daarna) voor een deel erfelijk wordt bepaald (32-34%), maar dat later 
op de dag erfelijke factoren weinig invloed hebben op het cortisolniveau. Een mogelijke 
verklaring voor de variërende genetische invloed die we vonden, kan liggen in de 
veranderende rol die deze hormonale cascade speelt in de ochtenduren en gedurende de rest 
van de dag. In de vroege ochtenduren bereidt de biologische klok in ons lichaam (de 
suprachiasmatische nucleus (SCN) in de hersenen) ons voor op de komende periode van 
verhoogde mentale en fysieke activiteit. De SCN doet dit door gedurende korte tijd de 
aanmaak van cortisol sterk te stimuleren en daarmee een aantal systemen ‘op scherp’ te 
zetten. Onze resultaten laten zien dat genen het cortisolniveau gedurende deze periode 
beïnvloeden. Gedurende de dag is de taak van cortisol vooral om lichamelijke processen weer 
terug in balans te brengen (‘homeostase’) als deze door allerlei prikkels van buiten af zijn 
verstoord. Het cortisolniveau gedurende de dag zal dus voornamelijk bepaald worden door de 
feedback die het systeem krijgt uit de omgeving en inderdaad vinden wij dat na 11 uur ‘s 
ochtends omgevingsfactoren de belangrijkste bijdrage leveren aan individuele verschillen in 
cortisol.  
 
Verschillen tussen tweelingen en enkelgeborenen? 
 
Tweelingen hebben over het algemeen een veel lager geboortegewicht dan enkelgeborenen (in 
ons onderzoek scheelde het 921.2 gram). Dit lagere geboortegewicht zou schadelijk kunnen 
zijn voor de tweelingen, als de Barker hypothese voor deze groep zou gelden. De Barker 
hypothese (“foetal origin hypothesis”) stelt dat aanpassingen die de foetus maakt als het 
ondervoed wordt, permanente veranderingen in het functioneren van het lichaam 
bewerkstelligt, en dat deze veranderingen hart- en vaatziekten en diabetes veroorzaken. 
Meestal wordt het geboortegewicht gebruikt als maat voor foetale ondervoeding. Omdat in 
onze studie zowel tweelingen als enkelgeborenen meededen, konden we bepalen of de 
tweelingen significant verschilden van de enkelgeborenen wat betreft hun fysiologisch 
functioneren. Wij hebben voor al de zojuist besproken fysiologische variabelen onderzocht of 
de gemiddeldes, de varianties en de covarianties van de tweelinggroep significant verschilden 
van die van de groep met enkelgeboren broers en zussen van deze tweelingen. Voor geen 
enkele variabele bleken tweelingen te verschillen van enkelgeborenen. Dit sterkt het idee dat 
het lagere geboortegewicht in tweelingen geen teken is van verminderde groei, maar een 








Samenvattend kan worden geconcludeerd dat alle bovenstaande risicofactoren voor hart- en 
vaatziekten in grote mate worden beïnvloed door genetische factoren. Een belangrijk verschil 
van dit proefschrift met veel voorgaande studies is dat die risicofactoren ambulant werden 
gemeten, dat wil zeggen tijdens een normale werkdag in de eigen natuurlijke omgeving van 
de proefpersonen. Een dergelijke ambulante meting heeft een hoge betrouwbaarheid omdat er 
veel herhalingen van hetzelfde type meting worden gedaan. Ook zal de voorspellende waarde 
voor de meeste ziekteprocessen hoger zijn dan die van metingen in een laboratoriumsituatie 
omdat immers veel dichter bij de dagelijkse werkelijkheid wordt gemeten.  
Deze ambulant gemeten risicofactoren zijn daarmee een veelbelovende aanwinst voor het 
koppelings- en associatieonderzoek waarmee de genen voor hart- en vaatziekten hopelijk op 
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WAT WORDT ER VAN U VERWACHT? 
De hartactiemeter en de bloeddrukmeter 
U krijgt de meters 's ochtends aan het begin van de werkdag bevestigd. Als de meters eenmaal 
gestart zijn hoeft u er verder niets aan te doen; u kunt uw dagelijkse activiteiten gewoon 
verrichten. De bloeddrukband wordt om het half uur automatisch opgepompt voor een meting 
en de hartactiemeter registreert de hartslag continu. Het kan gebeuren dat een 
bloeddrukmeting mislukt door teveel beweging van de arm. De meter blaast dan nog een keer 
op. Daarom is het van belang om tijdens een meting (duurt ongeveer 20 sec.) uw arm zo stil 
en ontspannen mogelijk te houden. De bloeddrukmeter mag u 's avonds vlak voor het naar bed 
gaan, afdoen. Vergeet hem niet uit te zetten! Graag zouden wij zien dat gedurende de 
meetdag u geen extreem fysieke inspanning verricht en niet teveel alcohol drinkt. De hartactie 
meter het liefst om houden totdat de onderzoeker er de volgende dag weer is. 
 
Invullen van het activiteitendagboek 
De gemeten biologische signalen (zoals hartslag en bloeddruk) worden beïnvloed door 
lichamelijke activiteit en lichaamshouding. Om de gegevens goed te kunnen interpreteren is 
het noodzakelijk een nauwkeurig beeld te hebben van uw activiteiten. Daarom vragen we u 
tijdens de ambulante metingen een activiteitendagboek bij te houden. U wordt om het half uur 
gewaarschuwd door middel van een langdurige pieptoon (uit te zetten door op het rode knopje 
op de hartactiemeter te drukken) dat het tijd is om het dagboek in te vullen (tijdens de uren 
waarin u slaapt zal de meter niet piepen). Na de pieptoon vult u eerst in het dagboek de begin- 
en eindtijd in. U kunt het beste de tijd die op de bloeddrukmeter staat gebruiken. Vervolgens 
vult u, op volgorde van tijd, in wat u sinds de vorige piep gedaan heeft. Van belang hierbij is 
dat u naast de soort activiteit ook de verandering in houding vermeldt. Als u bijvoorbeeld 
eerst aan tafel hebt gezeten en vervolgens een tijdje hebt gestaan, schrijft u dit dan op. Ook 
willen wij graag weten of u in gezelschap van mensen was of alleen. Vul ook de 4-punts 
schaal in, waarop u aangeeft hoe stressvol het afgelopen half uur voor u was. Probeer het 
dagboek elk half uur in te vullen. Mocht u de pieptoon niet hebben gehoord dan kunt u het 
dagboek alsnog bij de volgende piep bijwerken. 
 
Afdoen van de meters 
Als u wilt gaan douchen, moet u de meters afdoen. Op de instructiekaarten staat hoe dit in zijn 
werk gaat. Om de hartactie meter af te doen trekt u eerst de pluggen uit de aansluiting (het 
waarschuwingssignaal is nu niet erg en u kunt het stoppen door op de rode knop te drukken) 
en daarna maakt u de meetdraadjes los van de elektrodes. De elektrodes laat u (ook onder de 
douche) gewoon zitten. Bij het aansluiten sluit u de draadjes weer aan op de elektrodes (let op 
de nummers, zie instructiekaart) en steekt u de pluggen weer in de aansluiting. 
Om de bloeddrukmeter af te doen zet u deze op 'OFF', maakt u de slang los van de aansluiting 
op de bloeddrukmeter en trekt u tenslotte de band los van de arm. Leg de meters op een 
veilige plaats weg. Bij het aansluiten van de bloeddrukmeter bevestigt u de band weer om uw 
arm (zie instructiekaart, dit is het makkelijkst met de hulp van iemand anders). Daarna maakt  
u de slang weer vast aan de bloeddrukmeter en zet deze weer op 'ON'. 
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Overdag: 
 elk half uur dagboekje invullen 
 speekselverzameling op gezette tijden en schema invullen 
’s Avonds:  
 stemmingsvragenlijst en resterende vragen invullen 
 speekselverzameling op gezette tijden en schema invullen 
 bloeddrukmeter op ‘OFF’ zetten en afdoen 
 elk half uur dagboekje invullen 
’s Nachts:  
 hartactiemeter omhouden 
De volgende morgen: 
 speekselverzameling op de gezette tijden en schema invullen  
 hartactiemeter zo lang mogelijk laten meten, bij voorkeur tot 
onderzoeker er weer is 
 slaapkwaliteitslijst invullen 
 elk half uur dagboekje invullen 
 
Bij een alarmpiep de elektrodes controleren en opnieuw vastmaken 
Schema voor de speekselverzameling 
Een half uur voor speekselverzameling niets eten of drinken (behalve water) 
Verzamelingsmoment Werkelijke tijd  Opmerkingen… 
Als onderzoeker er is   
11.00 uur   
15.00 uur   
20.00 uur   
22.30 uur of bedtijd  Vul de stemmingsvragenlijst in en de resterende 
vragen naast de stemmingslijst in 
Wakker worden   
30 minuten na wakker 
worden 
 Vul de slaap kwaliteitslijst in  
Ontbijt dag 1:  ………………………….  uur 
Lunch dag 1:   ………………………….   uur 
Avondeten dag 1: ………………………….  uur 
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De speekselverzameling met de wattenrolletjes 
De eerste speekselverzameling vindt plaats waar de onderzoeker bij is. De volgende 
speekselverzamelingen vinden op vastgelegde tijden plaats. Het is de bedoeling dat u steeds 
de exacte tijd invult waarop u elke keer speeksel verzamelt, dit omdat de hoeveelheid 
hormoon ook afhankelijk is van het tijdstip op de dag. In het Speekselverzamelingsschema 
hiernaast kunt u dit invullen. De 2 speekselverzamelingen op de vroege ochtend van dag 2 
moet bij voorkeur geheel worden gedaan zonder dat u tussendoor het ontbijt nuttigt. U kunt 
gerust 
een glas water drinken. Het is van groot belang een half uur voor het nemen van elke 
speekselverzameling niets te eten, of caffeïne of alcohol te nuttigen. In de ruimte voor 
opmerkingen kunt u bijvoorbeeld aangeven als er iets niet helemaal goed is gegaan of als zich 
mischienn een uitzonderlijk voorval heeft voorgedaan. Het is van belang dat u niet vlak voor 




Op de aangegeven tijdstippen pakt u het buisje met het juiste nummer. U draait de dop van de 
buis en haalt het wattenrolletje eruit. Dan legt u het wattenrolletje in uw mond gedurende 1 
minuut. Door de gaatjes in het plastic hulsje wordt speeksel in het wattenrolletje opgenomen. 
Het is belangrijk (!) dat het wattenrolletje goed doordrenkt wordt. U kunt dit bevorderen door 
niet te slikken en licht op het wattenrolletje te kauwen. Stop het wattenrolletje terug in de 
genummerde buis en draai de dop erop. Schema achterin dagboekje invullen Bewaar de 
gebruikte genummerde buizen in een donkere bij voorkeur koele ruimte (bijvoorbeeld 
koelkast). De onderzoeker zal de speekselbuisjes tegelijkertijd met de hartactie- en 
bloeddrukmeters ophalen op een afgesproken tijdstip. 
 
De tijden waarop de speekselverzameling plaats vindt: 
1) als de onderzoeker er is 
2) 11.00 uur 's ochtends 
3) 15.00 uur 's middags 
4) 20.00 uur 's avonds 
5) 22.30 uur 's avonds of voor 't slapen gaan, als dit eerder is 
6) direct na het wakker worden 
7) 30 minuten na het wakker worden 
De buisjes zijn genummerd zoals boven aangegeven. 
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DATUM:  17 /08    /200 1       VOORBEELD 1 van een ingevuld 
dagboek. 
 
TIJD: van 7.15 tot 7.45
 
Vul in: activiteit, houding, aanwezigheid andere personen 
(collega, partner etc.), locatie (werk, thuis etc.) 
Kastjes werden omgehangen door onderzoeker, thuis, 
Zitten en staan, kop koffie gedronken 
 
Mate van ervaren stress          (laag)       1         2         3         4      (hoog) 
 
 
TIJD: van  7.45 tot 8.15
 
Vul in: activiteit, houding, aanwezigheid andere personen (collega, 
partner etc.), locatie (werk, thuis etc.) 
 
Alleen in huis, beetje opgeruimd, katten eten gegeven 
Om 8 uur naar buiten met vuilnis 
(lopen en staan) 
Daarna ongeveer 20 minuten naar werk fietsen 
 
Mate van ervaren stress          (laag)     1         2         3         4      (hoog) 
TIJD: van  8.15 tot 8.45
 
Vul in: activiteit, houding, aanwezigheid andere personen 
(collega, partner etc.), locatie (werk, thuis etc.) 
Kletsen met collega’s computer aangezet 
Mate van ervaren stress            (laag)      1         2         3         4      (hoog) 
 
TIJD: van  8.45 tot 9.15
 
Vul in: activiteit, houding, aanwezigheid andere personen 
(collega, partner etc.), locatie (werk, thuis etc.) 
Kletsen met collega’s staand (op kantoor) 
9.00 uur aan het werk  
PC werk (alleen) zittend  
Mate van ervaren stress         (laag)              1         2         3         4      (hoog) 
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DATUM:      /     /200____ 
 
TIJD: van  
______ tot 
______ 
Vul in: activiteit, houding, aanwezigheid andere personen (collega, 
partner etc.), locatie (werk, thuis etc.) 
 
Mate van ervaren stress            (laag)      1         2         3         4      (hoog) 
 
TIJD: van  
______ tot 
______ 
Vul in: activiteit, houding, aanwezigheid andere personen (collega, 
partner etc.), locatie (werk, thuis etc.) 
 
Mate van ervaren stress            (laag)      1         2         3         4      (hoog) 
TIJD: van  
______ tot 
______ 
Vul in: activiteit, houding, aanwezigheid andere personen (collega, 
partner etc.), locatie (werk, thuis etc.) 
 
Mate van ervaren stress             (laag)     1         2         3         4      (hoog) 
TIJD: van  
______ tot 
______ 
Vul in: activiteit, houding, aanwezigheid andere personen (collega, 
partner etc.), locatie (werk, thuis etc.) 
 
 
















Hieronder volgen 15 uitspraken over de kwaliteit van uw slaap. Het gaat erom dat u aangeeft 
of de uitspraak van toepassing is op uw slaap zoals die in de afgelopen slaapperiode was. 
De uitspraken lijken soms op elkaar, maar zijn nooit hetzelfde. Beantwoord elke vraag. 
 
1. Ik heb geen oog dicht gedaan. □ Ja  □ Nee 
2. Ik had, nadat ik wakker geworden was, moeite weer in slaap te 
vallen. 
□ Ja  □ Nee 
3. Ik ben tijdens de slaapperiode opgestaan. □ Ja  □ Nee 
4. Ik vind dat ik heel slecht geslapen heb. □ Ja  □ Nee 
5. Ik sliep makkelijk in. □ Ja  □ Nee 
6. Ik sliep niet langer dan vijf uur. □ Ja  □ Nee 
7. Ik lag langer dan een half uur wakker, voordat ik insliep. □ Ja  □ Nee 
8. Ik ben meerdere malen wakker geworden. □ Ja  □ Nee 
9. Ik lag erg te woelen. □ Ja  □ Nee 
11. Ik heb naar mijn gevoel maar een paar uur geslapen. □ Ja  □ Nee 
12. Ik had, nadat ik was opgestaan, een moe gevoel. □ Ja  □ Nee 
13. Ik ben naar mijn gevoel slaap tekort gekomen. □ Ja  □ Nee 
14. Ik voelde me, nadat ik was opgestaan, goed uitgerust. □ Ja  □ Nee 
15. Heeft u vannacht slechter geslapen als gevolg van de 
hartslagmetingen? 
□ Ja  □ Nee 
16. Hoe laat ging u naar bed? ....: ...... uur 
17. Hoe laat stond u op? ....: ...... uur 
 
 




Hieronder vindt u een lijst met woorden. Deze woorden beschrijven stemmingen of 
gevoelstoestanden. Lees ieder woord nauwkeurig en kruis dan een cijfer aan rechts van het 
woord, welke het beste weergeeft HOE U ZICH VANDAAG VOELDE. Denk niet te lang na 
over uw antwoord. Het gaat om uw eerste indruk. Er bestaan geen foute antwoorden. Elk 
antwoord is goed, als het maar uw eigen stemming weergeeft. Sla geen woord over. De cijfers 
betekenen hetvolgende: 
 
0 = helemaal niet 
1 = een beetje 
2 = enigszins 
3 = nogal 
4 = heel erg 
 
 
1. Neerslachtig 0  1  2  3  4 21. Woedend 0  1  2  3  4 
2. Slecht gehumeurd 0  1  2  3  4 22. Lusteloos 0  1  2  3  4 
3. Uitgeput 0  1  2  3  4 23. Vol energie 0  1  2  3  4 
4. Actief 0  1  2  3  4 24. Rusteloos 0  1  2  3  4 
5. Zenuwachtig 0  1  2  3  4 25. Onwaardig 0  1  2  3  4 
6. Hulpeloos 0  1  2  3  4 26. Knorrig 0  1  2  3  4 
7. Geërgerd 0  1  2  3  4 27. Doodop 0  1  2  3  4 
8. Helder 0  1  2  3  4 28. Schuldig 0  1  2  3  4 
9. Paniekerig 0  1  2  3  4 29. Opgeruimd 0  1  2  3  4 
10. Droevig 0  1  2  3  4 30. Angstig 0  1  2  3  4 
11. Vriendelijk 0  1  2  3  4 31. Droefgeestig 0  1  2  3  4 
12. Opstandig 0  1  2  3  4 32. Kwaad 0  1  2  3  4 
13. Vermoeid 0  1  2  3  4 33. Afgemat 0  1  2  3  4 
14. Levendig 0  1  2  3  4 34. Onzeker 0  1  2  3  4 
15. Gespannen 0  1  2  3  4 35. Wanhopig 0  1  2  3  4 
16. Eenzaam 0  1  2  3  4 36. Behulpzaam 0  1  2  3  4 
17. Bezorgd 0  1  2  3  4 37. Ontmoedigd 0  1  2  3  4 
18. Verbitterd 0  1  2  3  4 38. Mopperend 0  1  2  3  4 
19. Aan het eind van 
mijn krachten 
0  1  2  3  4   













Instruction cards VU-AMS device 
and Spacelabs BP monitor 
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Short Manual VU-AMS device 
Attachment of the VU-AMS device: 
1. Attachment of the electrodes      
Clean the skin at the 6 positions indicated in the figure. Rub the skin firmly with an alcohol soaked 
tissue or, if alcohol is not available, use a clean dry tissue. Attach an electrode by pressing the plastic 
brim of the electrode and subsequently pushing the metal stud at the center of the electrode firmly, to 
properly spread the contact gel. 
ECG: 1. Above the sternum, between the collar bones 
2. Under the left breast, 4 cm (1.5") under the nipple.  
3. At the right, between the lower two ribs. 
ICG: 4. At the sternum, where the ribs meet. 
5. At the back, on the spine, at least 3 cm (1") above electrode 1. 
  6. At the back, on the spine, at least 3 cm (1") below electrode 4. 
2. Attachment of the lead wires 
Attach the lead wires to the electrodes according to the color coding in the figure above: 
ECG leadset (with the yellow connector): Position 1: white 
Position 2: black 
Position 3: green 
ICG leadset (with the blue connector): Position 4: white 
Position 5: black 
Position 6: green 
Be sure to keep the leadwire connectors aside when you redress; they must be plugged into the VU-
AMS device. 
3. Attachment of the device 
Put the VU-AMS device in its carrier bag with its connector side up. Fasten the device with the Velcro 
strap in the bag and gird it on with the VU-AMS belt (if its more convenient, you can also use your 
own belt). Make sure the device is fixed in a vertical position. Use the additional shoulder strap if 
necessary. 
Do not forget to fill in your diary after the beep 
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Starting the measurement 
The VU-AMS device is always standby. Measurement will (re-)start 
after you plug in the 2 lead wire connectors. The ‘yellow’ ECG leadset 
has to be plugged in the yellow socket marked 'ECG'. The ‘blue’ ICG 
leadset has to be plugged in the blue socket marked 'ICG'. If plugged in 
correctly the VU-AMS device should start beeping in the rhythm of your 
heart beat for a few seconds, and subsequently followed by a single long beep. This long beep 
signifies a successful start of a new measurement. 
 
Marking an event 
A red button is placed on top of the VU-AMS device next to the 2 lead wire connectors. To 
mark a special event, push this red button. Pushing it will be confirmed by a short beep. Make 
a note of the event in your diary. 
 
Stopping the measurement 
If you want to stop the measurement temporarily (e.g. for taking a shower) unplug the 
connectors from the VU-AMS device. After this, snap off the leadwires. The VU-AMS device 
will react with the ‘alert beep’. You can silence the ‘alert beep’ by pressing the red button. 
The electrodes are waterproof and need not be removed. To restart the measurement, simply 
follow the instructions above starting at 'Attachment of the leadwires'. 
 
Still working? 
To check if the VU-AMS device is still working, push the red button for 5 seconds. If the 
measurement is still going on you will hear beeping in the rhythm of your heart beat for a few 
seconds. 
 
Something’s going wrong... 
• You hear a double pitch beep (the ‘alert beep’). 
Diagnosis:  One of the electrodes is loose or one of the connectors is out of its socket. 
Solution:   Check the electrodes and connectors for proper connection. While checking you 
can silence the ‘alert beep’ by pushing the red button. 
 
• There are no heart beat beeps after you have (re-)attached the leadwires. 
Diagnosis: Electrodes are not placed at the right spot or the connectors are not plugged in the 
right sockets or not deep enough into their sockets. 
Solution: Attach the electrodes at the right positions and connect the plugs properly. 
 
• An electrode gets loose or a plug is pulled out by accident. 
Solution: No worries. Just attach the electrode again (use a spare one if necessary) or put 
the plug back into the socket. You will hear the beep signaling your heart beat for 
a few seconds and the measurement will be continued. 
• Otherwise, for online help dial the number printed on your diary.  
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Short Manual Spacelabs Blood Pressure Monitor 
 
Fitting the monitor  
• Attach the carrying pocker for the blood pressure monitor to the belt. Tie the belt 
around your waist and wear the carrying pocket on your right side* (see figure above). 
• Fit the cuff on your left arm*, such that the word ‘ART.’ is situated on the inside of 
the arm, the arrow is pointing towards the inside of your elbow and there is 2.5 cm 
between the cuff the inside of the elbow. Make sure that the cuff is tight enough, so 
that it does not shift down your arm.  
• Then let the airtube hang around your shoulders, and attach the tube to the connector 
on the front side of the blood pressure monitor, by screwing it on.  
Starting the blood pressure measurements 
To start the blood pressure measurements, you will have to shift the on/off switch to ‘ON’. 
(The on.off switch is situated on the backside of the monitor).The digital display now gives 
the time. As long as the monitor stays on, every half hour there will bee a blood pressure 
measurement. 
  
* If you are lefthanded, then wear the cuff on the right side and the carrying pocket on your 
rightside.  
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Turning the monitor off. 
Short interruption:  to postpone a measurement, e.g. if you cannot relax your arm, you can 
push the on.off button once. The measurement stops, but after 3 minutes 
a new measurement is automatically started.  
Longterm interruption: to interupt blood pressure monitoring for longer periods, e.g when 
showering or going to bed, switch the monitor off, using the on/off 
button, remove the cuff, belt and carrying pocket. Staring the 
measurment again? Push the on/off button once. 
At night:   At night, remove monitor and cuff as is described above. 
 
There’s something wrong... 
• Measurement is repeated every three minutes 
Diagnosis: measurements fail because of too much movement or a cuff that is too losely 
fit. This automatically triggers the repeated measurements. 
Solution: a. Keep your arm as still and relaxed as possible during a measurement. 
b. Check if the cuff if fit tightly.  
• No measurements, although you did not swtch the monitor off yourself.  
Diagnosis: Cause may be that the airtube has become detached from either cuff or 
monitor, or that accidently you switched the on/off button to ‘off’.  
Solution: Check whether airtube is connected correctly to cuff and monitor and that the 
on/off switch is ‘on’.  
• Display shows a code such as EC00 or LLL.  
Diagnosis: code has to be addressed by the researcher 
Solution: Switch off blood pressure monitor, remove both cuff and monitor. Put monitor 
back in the bag that came with all equipment.  
• Other poblems? Call number in diary 
NB: Just before every measurement the monitor counts down from 5. The display wil show 
this: 5555, 4444, 3333, 2222, 1111. Then, the measurement starts. During the measurement 
you will see ‘ -----‘  This is normal procedure for the monitor. 
 














152             List of Frequently Used Abbreviations 
 
A   Additive genetic factor 
ABP   Ambulatory blood pressure 
ACE   Angiotensin converting enzyme 
AIC   Akaike’s information criterion 
BMI   Body mass index 
BP   Blood pressure 
C   Common/Shared environmental factor 
CAR  Cortisol awakening response 
Corr   Correlation 
CVD  Cardiovascular disease 
D   Dominance genetic factor 
DBP   Diastolic blood pressure 
DZ   Dizygotic 
dZ/dt  Change in impedance 
DOS   Dizygotic twin pair of opposite sex 
E   Unique/Non-shared environmental factor 
ECG   Electrocardiogram 
F   Female 
GR   Glucocorticoid receptor 
HI   Heather index  
HP   Heart period 
HPA axis  Hypothalamus pituitary adrenal axis 
HR   Heart rate 
HRV  Heart rate variability 
HVZ  Hart- en vaatziekten 
IBI   Inter-beat-interval 
ICG   Impedance cardiogram 
LVET  Left ventricular ejection time 
M   Male 
MZ   Monozygotic 
NETAMB Netherlands twin family ambulatory study 
NTR   Netherlands twin register 
OS   Opposite sex 
P   p-value 
PEP   Pre-ejection period 
QTL   Quantitative trait locus 
RMSSD  Root mean square of successive differences 
RR   Respiration rate 
RSA   Respiratory sinus arrhythmia 
SBP   Systolic blood pressure  
SDNN index Standard deviation of normal-to-normal intervals indexed over 5 min periods 
SES    Socio-economic status 
VU-AMS  Vrije Universiteit Ambulatory Monitoring System 
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Alle 816 deelnemers, die met toewijding de 24-uursmetingen ondergingen, en alle 
medewerkers aan het project verdienen een grote pluim. Ik wil hen dan ook van harte 
bedanken voor hun onmisbare inzet. Mireille, haar test-assistenten en stagiaires voor het 
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